Fakulteit Geneeskunde, Universiteit van die Oranje-Vrystaat ...
Fakulteit Geneeskunde, Universiteit van die Oranje-Vrystaat ...
Fakulteit Geneeskunde, Universiteit van die Oranje-Vrystaat ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Fakulteit</strong> <strong>Geneeskunde</strong>, <strong>Universiteit</strong> <strong>van</strong> <strong>die</strong><br />
<strong>Oranje</strong>-<strong>Vrystaat</strong>: Akademiese Jaardag,<br />
20 - 21 Augustus 1992<br />
Abstrakte<br />
'N ONTLEDING VAN DIE OORSAAK VAN STERPTES<br />
BY BORSKANKER.<br />
RS du ~oit*, J ~illemse* en L Goedhals+.<br />
Departemente chirurgieX en Onkoterapief,<br />
<strong>Fakulteit</strong> <strong>Geneeskunde</strong>, <strong>Universiteit</strong> <strong>van</strong><br />
<strong>die</strong> <strong>Oranje</strong>-<strong>Vrystaat</strong>, Bloemfontein.<br />
Inleidinq:<br />
Metastatiese siekte is <strong>die</strong> algemeenste en<br />
belangrikste oorsaak <strong>van</strong> dood by<br />
borskanker. Dit is egter nie alom bekend<br />
hoeveel pasiente aan ander "natuurlike"<br />
oorsake sterf nie.<br />
Doelstellinq:<br />
Om <strong>die</strong> sterfteprofiel <strong>van</strong> pasiente met<br />
bewysde borskanker te bepaal ten opsigte<br />
<strong>van</strong> oorsaak as gevolg <strong>van</strong> siekte en<br />
sonder siekte en dit te korreleer met<br />
stadium <strong>van</strong> siekte asook ouderdom <strong>van</strong><br />
pasient by diagnose.<br />
Pasiente en Metodes: . 1 -<br />
Kliniese notas is retrospektiewelik<br />
nagegaan <strong>van</strong> pasiente wat gesterf het met<br />
gediagnoseerde borskanker. By a1 hier<strong>die</strong><br />
pasiente is <strong>die</strong> presiese oorsaak <strong>van</strong> dood<br />
evalueer asook <strong>die</strong> metastatiese profiel<br />
by dood. Die ouderdom asook stadium <strong>van</strong><br />
siekte by diagnose <strong>van</strong> a1 <strong>die</strong> pasiente<br />
moes bekend gewees het vir insluiting in<br />
<strong>die</strong> stu<strong>die</strong>.<br />
Resultate :<br />
Bv 343 ~asiente was alle inliqting vir<br />
i;sluiti& in <strong>die</strong> stu<strong>die</strong> - bekend.<br />
~etastatiese siekte was <strong>die</strong> oorsaak <strong>van</strong><br />
dood by 252 gevalle (74%). By <strong>die</strong> 81<br />
(24%) gevalle wat dood is aan ander redes<br />
was 55 (16%) totaal skoon by dood en 26<br />
(8%) het we1 onderliggende siekte gehad.<br />
Die belangrikste nie-metastatiese redes<br />
vir sterftes was kardiovaskulGr 623,<br />
respiratories 26% en nefrologies 7%. Hoe<br />
vroeer <strong>die</strong> stadium <strong>van</strong> siekte, hoe beter<br />
was <strong>die</strong> kans dat <strong>die</strong> pasient aan In nie-<br />
metastatiese rede gesterf het, naamlik<br />
Stadium I = 36%, 11 = 27%, I11 = 26%, IV<br />
= 5%. Hoe jonger <strong>die</strong> pasient by<br />
diagnose, hoe swakker was <strong>die</strong> kans om aan<br />
In nie-metastatiese oorsaak te sterf,<br />
naamlik c50 jaar = 10%, 50-70 jaar = 22%,<br />
>70 jaar = 45%.<br />
Gevolatrekkinq:<br />
1. In Beduidende aantal pasiente (24%)<br />
met borskanker sterf aan<br />
"natuurlike" oorsake .<br />
VOL 82 DECEMBER 1992 443<br />
SAMJ<br />
2. In Pasient se kans om aan<br />
"natuurlike" oorsake te sterf<br />
korreleer direk met <strong>die</strong> stadium <strong>van</strong><br />
siekte maar omgekeerd met <strong>die</strong><br />
ouderdom by diagnose.<br />
3. Die ~ardiovaskul~re, respiratoriese<br />
en nef rologiese stelsels is<br />
verantwoordelik vir + 95% <strong>van</strong> alle<br />
"natuurlike" oorsake <strong>van</strong> dood.<br />
Opsomminq:<br />
Hier<strong>die</strong> stu<strong>die</strong> bevestig <strong>die</strong> huidige<br />
tendens om ouer pasiente met vroee<br />
borskanker minder aggresief te behandel.<br />
EWEKANSIGE KLINIESE STUDIE NA DIE ROL VAN<br />
ILEOSTOMIE NA PROKTOKOLEKTOMIE EN ILEO-<br />
ANALE RESERVOIRPROSEDURE<br />
S.P. ~robler*, K.B. Hosie. M.R.B. Keighley. Departments of<br />
Surgery. University of Birmingham. United Kingaom &<br />
University of the Orange Free State, South Africa .<br />
Doel. 'n Ewekansige kliniese proef het <strong>die</strong> voor- en nadele<br />
<strong>van</strong> 'n tydelike ileostomie na proktokolektomie en ileo-anale<br />
reservoirprosedure ondersoek.<br />
Metodes. Van 59 pasiente wat 'n gestandardiseerde operasie<br />
oor 'n periode <strong>van</strong> 36 maande ondergaan het, is 45 tot <strong>die</strong><br />
stu<strong>die</strong> toegelaat. Na voltooing <strong>van</strong> <strong>die</strong> ileo-anale reservoir is<br />
<strong>die</strong> pasicnte ewekansig vir tydelike proksirnale lusileostomie<br />
(n = 23) of geen ileostomie (n = 22) toegewys.<br />
Resultate. Die twee groepe was vergelykbaar in terme <strong>van</strong><br />
basislynkenmerke soos ouderdom en ondediggende<br />
siektetoestande. Die operasieduur (mediaan) was 160 minute<br />
vir <strong>die</strong> reservoirprosedure met ileostomie asook 45 minute vir<br />
<strong>die</strong> latere ileostomiesluiting in vergeleke met 150 minute vir<br />
<strong>die</strong> reservoirprosedure sonder ileostomie. Geen sterftes het<br />
voorgekom nie. 12 pasiente het ileostornie-verwante<br />
komplikasies ontwikkel (diaree-5; stomale retraksie-3;<br />
enterokutanefistel-l ; dermobstruksie-3; stomale breuk-2).<br />
Lekkasie <strong>van</strong> <strong>die</strong> ileo-anale anastornose het slegs in twee<br />
pasiente voorgekom, een in eke groep. Die pasient sonder<br />
beskermende ileostomie het 'n vedengde en gekompliseerde<br />
postoperatiewe verloop gehad. Ileo-anale stenose het in 5<br />
pasiente in <strong>die</strong> ileostomiegroep voorgekom teenoor slegs 1<br />
pasient sonder ileostomie. Die voorkoms <strong>van</strong> sepsis,<br />
dermobstruksie en ontstekiig <strong>van</strong> <strong>die</strong> dundermreservoir<br />
("pouchitis") was soortgelyk in <strong>die</strong> twee groepe. Die mediane<br />
totale hospitaalverblyf was 23 dae in <strong>die</strong> ileostorniegroep<br />
teenoor 13 dae by <strong>die</strong>gene sonder ileostomie (p~0.01<br />
Wilcoxon analise) .<br />
Slotsom. Hier<strong>die</strong> stu<strong>die</strong> dui op 'n lae risiko <strong>van</strong> bekkensepsis<br />
na ileo-anale reservoirprosedures. Die weglating <strong>van</strong> 'n<br />
proksirnale ileostomie het <strong>die</strong> sepsisrisiko in 'n geselekteerde<br />
pasientegrcep nie betekenisvd vermeerder . -nie. Die<br />
lusileostomie op sigself het verskeie komplikasies velsoorsaak.
DIE MIRURGIESE HANTEZUNG VAN<br />
PANRREAsKOPiURsINoon : K ~ O V E R S I ~<br />
ASPERfE.<br />
JJ Basson, RS du Toit, CJC Nel : Departement<br />
Chirurgie, VOVS . p<br />
Pankreaskopkarsinmm het gewoonlik 'n swak<br />
prognose. Die chirurgiese hantering moet gemik<br />
wees op optimale terapeutiese gewin met<br />
minimale gepaardgaande morbiditeit en<br />
mortaliteit, Kontroversie bestaan steeds oor<br />
<strong>die</strong> optimale galwegdreinasie vir obstruktiewe<br />
geelsug en <strong>die</strong> roetine gebruik <strong>van</strong> 'n<br />
profilaktiese duodenale omleiding om<br />
maaguitgangobstruksie te voorkom.<br />
DOEL VAN DIE STUDIE:<br />
Die stu<strong>die</strong> is onderneem om ons ondervinding met<br />
<strong>die</strong> chirurgiese hantering <strong>van</strong><br />
pankreaskopkarsinmm in <strong>die</strong> algemeen te<br />
evalueer . Palliatiewe prosedures, met klem op<br />
<strong>die</strong> bogenode kontroversies, is krities<br />
evalueer .<br />
PSI- EN -DES:<br />
Alle pasi&te met 'n diagnose <strong>van</strong><br />
pankreaskopkarsinmm wat tussen 1985 en 1990 in<br />
Universitas en Pelonomi Hospitale opgeneem is,<br />
is ingesluit- Kliniese notas is vir <strong>die</strong><br />
versameling <strong>van</strong> data gebruik. Pasiente wat<br />
chirurgie ondergaan het, is retrospektief in<br />
drie groepe verdeel. Groep I sluit pasiente met<br />
resekteerbare tumore in; groep I1 is pasiente<br />
met lokaal gevorderde siekte en/of maligne<br />
limfnodes en groep 111 sluit alle pasiente met<br />
metastases in. Groep 111 is verder onderverdeel<br />
in drie subgroepe. Groep IIIa : pasiente met<br />
lewer en verafgele6 metastases; groep IIIb :<br />
pasiente met slegs askites (insluitend<br />
peritoneale metastases) en groep IIIc :<br />
pasiente met beide askites en ander metastases.<br />
'n Operatiewe cholangiogram is gedoen by alle<br />
pasiente met onresekteerbare tumore en<br />
obstruktiewe geelsug. In Cholesistojejunostomie<br />
(CCJ) is gedoen as <strong>die</strong> vlak <strong>van</strong> obstruksie ><br />
2cm <strong>van</strong> <strong>die</strong> oarsprong <strong>van</strong> <strong>die</strong> sistiese buis was<br />
en 'n choledochojejunostomie (CDJ) is in a1 <strong>die</strong><br />
ander gevalle gedoen . In Duodenale omleiding is<br />
gedoen by gevalle waar tekens <strong>van</strong><br />
maaguitgangobstruksie teenwoordig was.<br />
RESULTATE:<br />
Die stu<strong>die</strong> sluit 165 pasiEnte (94 mans en 71<br />
vroue) in. Die gemiddelde ouderdom <strong>van</strong> <strong>die</strong><br />
groep was 65 jaar (verspreiding : 34 tot 91<br />
jaar) . Dertien persent (n = 22) was terminaal<br />
met opname en het geen aktiewe behandeling<br />
ont<strong>van</strong>g nie. Vier en tagtig persent (n = 138)<br />
het vir chirurgie gekwalif iseer. Slegs 7% (n =<br />
9) het resekteerbare tumore gehad (groep I) en<br />
'n pankreatikoduodenektomie is vir a1 <strong>die</strong><br />
pasiente gedoen met 'n gepaardgaande<br />
mortaliteit <strong>van</strong> 22%. Die mortaliteit <strong>van</strong><br />
palliatiewe chirurgie in <strong>die</strong> algemeen was 21%<br />
(n = 129). 'n Lae mortaliteit <strong>van</strong> 2% (n = 69)<br />
het in groep 11 voorgekom. In groep IIIa (n =<br />
36) was <strong>die</strong> mortaliteit 17% terwyl <strong>die</strong><br />
mortaliteit 79% en 100% in groep IIIb (n = 19)<br />
en IIIc (n = 5) onderskeidelik was. Herhaling<br />
<strong>van</strong> obstruktiewe geelsug het in 3% (2/78) <strong>van</strong><br />
pasiente met *n CCJ voorgekom. Almal was egter<br />
terminaal en het geen verdere chirurgie benodig<br />
nie. Geen profilaktiese du male omleiding is<br />
gedoen nie en slegs 6% ) <strong>van</strong> pasikte het<br />
later 'n dudenale omleiding benodig.<br />
0-:<br />
1 . Pankreaskopkarsinoora presenter laat in<br />
<strong>die</strong> verloop <strong>van</strong> <strong>die</strong> siekte.<br />
2. In<strong>die</strong>n pasiente god geselekteer word,<br />
kan palliatiewe chirurgie met 'n lae<br />
mortrilitiet <strong>van</strong> 2% ui tgevoer word.<br />
Askites dra by tot 'n hoe mortaliteit en<br />
. . behoort ' n kontraindikasie tot<br />
C - palliatieue chirurgie te wees .<br />
9<br />
. Die CCJ is 'n effektiewe galwegdreinasie<br />
en in slegs 3% <strong>van</strong> pasiente het 'n<br />
herhaling <strong>van</strong> obstruktiewe geelsug<br />
voorgekom.<br />
4. 'n Profilaktiesae duodenale omleiding is<br />
in <strong>die</strong> meerderheid <strong>van</strong> gevalle n ic nodig<br />
nie. -<br />
WHAT HAPPENS TO OUR PATHNl% WITH<br />
VITREOUS ~ LOSS?<br />
M Schultz, .Department of Ophthalmology, University of<br />
OFS<br />
Ekpulsive suprachoroidal haemorr e aside, the loss of<br />
vitreous is the most serious comp "k 'cation of cataract<br />
surgery. Our retrospective study evaluates comrtively<br />
the mechanisms and ement of vitreous m. The<br />
visual outcome and 7 etioogy of reduced vision are<br />
analysed and a strategy for improvement is<br />
PATIENTS AND METHODS: Our recor ?lor*' of 1 215<br />
cataract extractions performed at the National Hospital,<br />
Bloemfontein, between January 1987 and Decemhr<br />
1991, were stu<strong>die</strong>d and 41 cases of vitreous loss were<br />
identified. An analysis was made of the surgical<br />
technique employed, intra-ocular lens implantation, predisposing<br />
factors, the mechanisms of complications, the<br />
post operative visual acuity, secondary complications and<br />
the pattern of follow-up.<br />
RESULTS: Comphcated posterior chamber lens<br />
placement causing wtreous loss was conspicuous in our<br />
study. Primary anterior chamber lens implantation was<br />
implicated in poor visual outcome. Although 90 % of<br />
patients obtained excellent post-operative visual results,<br />
secondary complications directly related to vitreous loss<br />
was responsible for poor results in the remaining 10 %.<br />
An unsatisfactory attern of follow-up was evident.<br />
~~N~uI~KNv: L study confum~ vitreous loss as tbe<br />
most common visually detrimental complication of<br />
cataract surgery. It focuses attention on several<br />
previously unsus cted weaknesses and points to a<br />
number of logi car avenues for the further improvement<br />
of as yet excellent over-all visual results.<br />
'N PROSPEKTIEWE STUDIE IN OOGTROUMA<br />
GEDURENDE 1991 BY PELONOMI HOSPITAAL<br />
J du T Vos, Departement Oftalmologie, UOVS,<br />
Bloemfontein<br />
Omdat trouma 'n p t<br />
lading op ons Departement<br />
plaas, het ons 'n stu&e gedoen om 'n trouma profiel daar<br />
ts stel.<br />
Alie pasiznte met 'n besering <strong>van</strong> <strong>die</strong> oog of adneksae is<br />
in <strong>die</strong> stu<strong>die</strong> ingesluit.<br />
Die regteroog was btrokke in 403 % <strong>van</strong> beserings en<br />
<strong>die</strong> linkeroog in 56,7 %. In 3 % <strong>van</strong> gevalle was beide &<br />
beseer. Die ouderdomme het gewissel <strong>van</strong> 1 tot 88 jaar.<br />
Ongeskoolde werkers was betrokke by <strong>die</strong> meeste<br />
oogbese~gs. 80 % <strong>van</strong> beserings het in mans voor e-<br />
kom. Pasitnte met oo beserings het gemiddeld 2 L<br />
geneem om by <strong>die</strong> m&ek te rapporteer. Ongelukke<br />
was algemeen in kinders en be'aardes en aanrandings<br />
meer algemeen in <strong>die</strong> intermeditre ouderdomsgroepe.<br />
Oogliabeserhgs het <strong>die</strong> grootste persentasie <strong>van</strong> <strong>die</strong><br />
beserings uitgemaak. Visie <strong>van</strong> slegter as 20/200 was in<br />
60 % <strong>van</strong> beseerdes teenwoordig met <strong>die</strong> eerste besoek.<br />
Relatief tot soortgelyke oorsese stu<strong>die</strong>s, is <strong>die</strong> aanfal<br />
oogbese~jp wat evalueer is baie minder, maar dte<br />
graad <strong>van</strong> trouma was baie erger.
ABNORMALE PLAATJIE EN PLASMA VETSUUR-<br />
SAMESTEMNG VAN PASleNTE MET MUTE<br />
MlOKARDlALE INFARKSIES<br />
F l t , M Weman PN Badenhorst, Departement<br />
l&%ogie, UOVS, ~foemfontein.<br />
Plaatjies spel 'n baie belan rike rol b <strong>die</strong> ontwikkeling<br />
<strong>van</strong> artene trombose, wa? vqder & let tot akute<br />
miokardiale infarksies (MI). Di word ook algemeen<br />
aanvaar dat plaatjies 'n belangrike rot speel by<br />
aposkleyose, onafhyklik <strong>van</strong> ander faktore soos rook,<br />
hpertens~e en enetiese faktore. Pla?jks <strong>van</strong> pasiente<br />
met familiGle %ipercholesJerolemie, n toestand wat<br />
geassosieerd is met 'n hoe voarkoms <strong>van</strong> aterosklerose<br />
en S trombqtiese komplikasies, is hipersensitief vir sekere<br />
t~aa~e-agonste en produsey r k verhoo de<br />
oeve@h@e Wqboksaan A*. [M was-daq ook <strong>die</strong> 6681<br />
<strong>van</strong> hlerd~e studre om te be~aal of hierd~e funkslonele<br />
veranderinge gekop I kan ' word am 'n . defektiewe<br />
~laatiiemembraan. E hier<strong>die</strong> doe1 moes d~e ~lasma-,<br />
bw6l as <strong>die</strong> pl~iemembraanvetsuursamestdling vari<br />
pasiente met akute. miok~diale infarksie be<br />
vergelyk word met dte <strong>van</strong> n gepaarde nomae P groep en<br />
vryvvllhgers.<br />
EDTA-Moed <strong>van</strong> 15 siente met akute miokardiale<br />
infak5ie en 20 ouderd%ms-, save1 as gesla sgepaarde<br />
ulyunll~gers IS versamel. Die bloed :S gekolle5eer .b:nne<br />
ure na aanv~g <strong>van</strong> <strong>die</strong> mlokar'de ~nfarks~e. hp~ede<br />
IS ui be~de plaatyes en plasma geekstraheer volgens dre<br />
bekende Folch-metode. Die monsters is verseep en<br />
gemetileer volgens <strong>die</strong> metode <strong>van</strong> Morrison en Smith. Die<br />
vetsuurrnetidesters is met behulp <strong>van</strong> gasvloeistof-<br />
chromatografie geskei en geidentifiseer. Die resultate is<br />
U$ edruk of as relatiewe persentasies, of as nanogram of<br />
mtkgram vetsuur milliliter plasma of as nanograrn<br />
vetsuur per rnitjoen pgtjii.<br />
VOL 82 DECEMBER 1992 &S<br />
SAMJ c,<br />
INHIBISIE VAN ARTERICLE TROMBOSE DEUR 16N7C2, U1 <strong>die</strong> resuttate<br />
'N MONOKLQNALE ANTlLIGGAAM TEEN<br />
Myk dii dat <strong>die</strong> plasma <strong>van</strong> pasilinte met<br />
DIE M1 meer vetsure as norrnale plasma bevat Daar was<br />
GLIKOPROTEXN IIb/IIIa RESEPTOR-KOMPLEKS OP statisties betekenisvolle verskille tussen verskeie <strong>van</strong> <strong>die</strong><br />
DIE PLAATJIEMEMBRAAN.<br />
versadigde, mono-onversadi . e en poli-onversadigde<br />
Lam rech HF Kotz6, PN Badenhorst, M Meirin V <strong>van</strong> vetsure <strong>van</strong> <strong>die</strong> twee roe*. b plasma. <strong>van</strong> <strong>die</strong> MI grwp<br />
k'k'&clanyn Departement Hematologie, &o.v.s., en normale gmep f~et deseifde relattewe persentawe<br />
Bloemfpntein en 'Sentrum Trombose en Vaskul&e versadigde vetsure bevat, terwyl plasma <strong>van</strong> norrnale.<br />
Favorsmg, K.U.L., Leuven, Bel~e.<br />
persone relatief meer poli-onversad'gde vetsure bevat het<br />
as <strong>die</strong> <strong>van</strong> iGnte met MI. Verrassend er was <strong>die</strong><br />
pie antitrombotiese effekte <strong>van</strong> 16N7 'n monoklonale bevinding<br />
gntiliggaam, is in 7 bobbejane getoets. 16 3<br />
&? <strong>die</strong> plaatjiemembraan <strong>van</strong>%l pasi$nte<br />
7C2 blokkeer <strong>die</strong> minder vefsure as <strong>die</strong> kontrole. groep beyat. Die relattewe<br />
binding <strong>van</strong> fibrinogeen aan sy gliko roteien (G ) g /ma persentasle versadlgde en poll-onversad~ de vetsure was<br />
re? tor qp @e memb- <strong>van</strong> ge&veerde res qn ook h&r by <strong>die</strong> normale groep in verge&ng met <strong>die</strong> MI<br />
int&=er m- wfplaatjie aggregaslq v o ~ am ~ &e 9roeP.<br />
mtltrpmbmese e .ek te kwant@eer IS 'n smthasie-kamera<br />
ebd om d~e neerle <strong>van</strong> In-l11 em rkte Di is duidelik uit bogen~mde resuttge dat <strong>die</strong> p!asma- en<br />
%loedplaatjies op Dacrom vaswere prosteFes (0,?cmS) te plaa ~evetsuursamestell~ng <strong>van</strong> paslente met mlokardlale<br />
meet. Die pro:tese is as 'n verlengstuk m- 'n permanent mnfar!sies verskil <strong>van</strong> <strong>die</strong> <strong>van</strong> 'n gepaarde kantrle roe<br />
ingeplante arteno-veneuse fistel geplaas 15 mute nadat 0,3 Die presiese bydrae <strong>van</strong> her<strong>die</strong> verskille, t8 %<br />
mg per kg 16N7C2 intraveneqs ingespuit is. Die neerlegging yenaarnde abnormaliteke in pbtjiefunksie <strong>van</strong> pasiente<br />
<strong>van</strong> gemerkte plaa ies IS w 2 uur emeet, waarna &e me MI, moet egter nog verder ondersoek word.<br />
rostese weer.venvy a" er.& en bloedvloei%eur <strong>die</strong> pennanente<br />
&tel herstel a. Om &e langterm~ effqkte op trombase te<br />
bep*, is daar 24 en 48 uy na be +deh weer 'n-prostese<br />
m &e -1 ge laas en Le plaatJieneerl%wg w 2 uur<br />
gemeet. voor pking <strong>van</strong> <strong>die</strong> prostese is <strong>die</strong> m ntm laatjiea~gasierespom<br />
o ADP en kolageen; <strong>die</strong>. bloei&d; en<br />
sto m e (m, h en m gemet. V eo mute na<br />
behan%?kg was 5727% <strong>van</strong> &e G Zma. reseptore<br />
geblokkeer met 16N7C2; na 24 48 en 78uur was &e waardes PLAATJIE EN PLASMA VETSUURPROFIEL VAN<br />
onderskeidelik 46*5%, 3227d en 1825%. Op <strong>die</strong> dag <strong>van</strong> PASICNTE MET SLE.<br />
behandeling is daar feitlik geen plaatjies op <strong>die</strong> prostese<br />
neergel8 me. Na 24 uur was plaatjie neerlegging nog met JM de W F Cloete en PN Badephorst<br />
on eveer 79% ge- beer en-na 48 uy mef ongeveer 65.%. D@iE%t Hemtolope, <strong>Fakulteit</strong> <strong>Geneeskunde</strong>, UOVS<br />
BYE am geen + +tro a Tgasle het na msputm~,aasgewnd<br />
egasie IS na uur no met on eveer o en na 48 Sistemiese lupus eritematose (SLE is 'n outo-immuunsiekte<br />
ongeveer 25% ge-&beer. g~ en mute na wat oep veelwl'% <strong>van</strong> e orgaip aantasting<br />
ins uiting was <strong>die</strong> bloei d verlen na 202 r"<br />
L veroorsaak. 'n Sekere<br />
minute (kontrole<br />
e paslente onWel spontane trombose<br />
= 0,2 minute n? Z& was floeityd wser normaal. Die berieel en/of veneus). Die gomtptiese neiging h geko pel<br />
aP'IT PT en h IS me dew behandeh met 16N7C2<br />
&e aanwesighe~d <strong>van</strong> %oe<br />
beTn&ed niq. 'n Bolq inspuitin <strong>van</strong> 1&70 inhibeer =osfoli iedantili aamvlakke (aFa). Nie alle asiente met<br />
laat~ie funksie dus effehef w tot 63 uur sonder dat stolhng h& a~a-vhe on&el trombose rue en ander Paktore moet<br />
geipvloed wqrd. 16N7q kan gebw word w lan em dus ook betrokke wees. 'n Verandering in <strong>die</strong><br />
an&trombobew temple aangesien plaatjie-&& vetsuursamestelh <strong>van</strong> <strong>die</strong> laatjiemembraan in SLJ3<br />
trombusvorming geinhibeer word<br />
pasiente kan 'n sn&er wets w & interaksie men plaatjie~<br />
en aFa.<br />
Navorsers het onlangs aan etoon dat <strong>die</strong> konsentrasie <strong>van</strong><br />
Tromboksaan B2 (hoofs& dew laatjiegeproduseer) baie<br />
verhwg was in plasma vaq S& pasiente w?t qnlangs<br />
trombose-gehad het. Die bevmdm ondentem. he lupotese<br />
dat plaatjies belangrik is in <strong>die</strong> tromLtiese nei g.. Voord?<br />
enige gevolgtrekkmgs ten opsi e <strong>van</strong> moonge mterakse<br />
wen aFa en 'n veranderde p& 'iemembraan gernaak kan<br />
moqt <strong>die</strong> vetsuursimest&mg <strong>van</strong> &e plaatji4-<br />
mem ram m alle SLE paslente-pagegaan word en moet &t<br />
vergelyk word met normale plaatjles.<br />
Die doe1 <strong>van</strong> <strong>die</strong> stu<strong>die</strong> was om <strong>die</strong> plasma en<br />
plaat'iemembraap vetsuursamestelling <strong>van</strong> SLE pasiente te<br />
vergt!lYk met &e <strong>van</strong>o'n ouderdoms- en<br />
kontrole gr EDTA bloed a venamef?%-g%~&<br />
pasiegte en?& konpole per- Plaatjie. k p!asma en<br />
!i.+pe-arm l~ma IS deur mddel <strong>van</strong> senAgasie verkry.<br />
epied ekstr&ie <strong>van</strong> &e plaatjies en plasma IS volgens &e<br />
klassieke Folch metode gedoen Die monsters is daama<br />
verseeg en emetdeer volgens Morrispn and Srmth se metode.<br />
On eestenkxerde vetsuurbepahgs IS volgens Pace Asaak se<br />
mefode edoen. Vetsuur metielesters is geskei en<br />
gekwant&eer dew middel <strong>van</strong> gaschromatografie.<br />
Resultate het getoon dat plasma <strong>van</strong> SLE pasiente minder<br />
totale vetsure as normale lama bevat. Daar was statisties<br />
belangrike veqkille in <strong>die</strong> &nsent@e <strong>van</strong> soqmige <strong>van</strong>. <strong>die</strong><br />
plasma versa& de,-,mono-owersxbgde en pob-onversa&gde<br />
vetsure. he pfaa~~emembraan <strong>van</strong> SE paslente het meer<br />
vewe, venadi sowel as goli-onveqdig, as. nowe laatJas bevat baar W? statis belaqgnlre venue m &e<br />
fonsentrasie <strong>van</strong> somge <strong>van</strong> be plaatpemembraan vetsure<br />
tussen <strong>die</strong> twee groepe. Normale plasma het 'n hoer<br />
koqsentrasie on eesten£iseerde vetsure as plasma <strong>van</strong> SLE<br />
pauente eha8. Die konygasie vaq verskeie<br />
ongeeste&erde vetsure het statlsoes betekenwol men<br />
<strong>die</strong> wee verskil. Normale .-plaatjies het meer<br />
ongete&oeF eer e vetsure bevat as plaatpes <strong>van</strong> SLE paslente.<br />
Uit <strong>die</strong> resultate is dit duidelik da; <strong>die</strong> plasma- en plaatjievetsuursamestelhg<br />
<strong>van</strong> SLE paslente en normale persone<br />
verskil. Die verswe mag .belq@ wees in <strong>die</strong> patogenese<br />
<strong>van</strong> somrmge <strong>van</strong> &e komphkas~es <strong>van</strong> SLE.
*<br />
446 VOL 82 WEEMBER 1992<br />
SAMJ<br />
DLE PLCLNOSE~~ SWANGEBI~TAPSTOETS: 'n<br />
OMERSOEK NA DIE KORRELASZE TUSSEN SERUM EN<br />
URIENAS MEDL4<br />
MiiUer FR*, Tait M, Thorn G, Schall R, Faher lU<br />
Departement Obstetric eo G i s , Geaeskmde Faidkit,<br />
<strong>Universiteit</strong> <strong>van</strong> <strong>die</strong> OraqSe <strong>Vrystaat</strong>, Bloemfobteir, SuiAMra<br />
Inleiding: Meuslike chorioniese gonadotropien (Ha) bestaan uit Wee<br />
non-kovalentgebonde subeenhede, waar<strong>van</strong> <strong>die</strong> PHCG-sllbeeoheid<br />
struktureel uniek is. Die teenwoordigheid <strong>van</strong> BHCG m <strong>die</strong> mien vom <strong>die</strong><br />
basis <strong>van</strong> baie hedendaagse swangerskapstoetse. Die aigemeerste sykamerswange~skapstoets<br />
wat deesdae gebruik word, is <strong>die</strong> lateks6kwietoets.<br />
waar<strong>van</strong> Phmse& h vombee1d is. Dit km koosentrasies <strong>van</strong> 1500 tot<br />
3000 Im HCG in <strong>die</strong> urien opspoor en word in <strong>die</strong> BloemfooteioSe<br />
opZeidin&~hospitale onder andere gebruik om psi- me1 h vermDedelike<br />
ektopiese swangerskap vir sonografie te sif. Omdat <strong>die</strong> Phnm&toets<br />
egter mien benodig om uitgevoer te word en <strong>die</strong> pasibt 'n -1 blaas nodig<br />
het vir sonografie, sou 'n sykamertoets op serum m piaas <strong>van</strong> urieo <strong>van</strong><br />
wade kon wees.<br />
- Doel: Om <strong>die</strong> waarde <strong>van</strong> <strong>die</strong> Pld-toets te ondersoek waneer<br />
serum in plaas <strong>van</strong> urien gebruik word orn dit uit te voer.<br />
Metode: Vir 'n tydperk <strong>van</strong> drie weke is uriemonsters versamel by<br />
. pasicnte met 'n geskiedenis <strong>van</strong> arnenoree en waar <strong>die</strong> ldiniese vermoede<br />
bestaan bet dat <strong>die</strong> pasiEnt swanger mag weeS. PasiEnte waar<strong>van</strong><br />
urienmonsters nie beskikbaar was nie of met bloed kontamincer was. of<br />
waar<strong>van</strong> <strong>die</strong> serum- enlof urienmonsters meer as 24 uur oud was, is nie in<br />
aanmerking geneem nie. Van elk pasient wat aan <strong>die</strong> insluitingskriteria<br />
voldoen het, is urieo eo 5 m1 gatolde bloed versamel. Een druppel <strong>van</strong> <strong>die</strong><br />
urien is vir <strong>die</strong> uitvoer <strong>van</strong> <strong>die</strong> Planasec@-tocts gebruik. Die bloed is<br />
afgeswaai en een druppel serum is gebruik om 'n Phme&-toets uit te<br />
vow. Die res is na Biochemie gestuur vir serum+HCG-bepalings<br />
Resultate: 28 pasiente het aan <strong>die</strong> projek deelgenaem. b 10 gevalle was<br />
<strong>die</strong> PHCG, soos deur <strong>die</strong> laboratorium bepaal, positief. Die laboratniiumtoetsuitslae<br />
is as <strong>die</strong> "goue standaard" aanvaar. Die sewtoets wa5 in alle<br />
gevalle positief. Die urientoets het in.9 gevalle 'n ware positief getoon, in 1<br />
geval 'n vals positief en in 1 geval 'n vals negatief. Om <strong>die</strong><br />
metingsooreenkoms tussen <strong>die</strong> twee toetse te bepaal is kappa (~kstatistiek<br />
aangewend. Die ooreenstemmingstoets tursen <strong>die</strong> urientoets m <strong>die</strong><br />
laboratoriumbepaalde PHCG het K = 0.84 gelewer, wat dui op goeie<br />
ooreenstemming. Die ooreenstemmingstoets tussen <strong>die</strong> senuntoets m <strong>die</strong><br />
laboratoriumbepaalde BHCG het K = 0 gelewer, wat beteken dat daar geen<br />
ooreenstemmlng tussen <strong>die</strong> twee toet% bestaan me.<br />
Semitiwiteit en spesifiitek<br />
* Urientoets: Semtlwiteitr 9/10 = 9056; 90% V1 61% tot<br />
Spesdlitelt: 17/18 = 94%; W% V1 76% tot 99.7%<br />
* SerumuKts:Sens~t~wlteit: 10/10 = 100%; 95% V1 74% tot 10%<br />
Spesdiite~t: 0118 = 0%; 95% V1 0% tot 15%<br />
In<strong>die</strong>n dle sensitlwiteit en dle spesKiiteit <strong>van</strong> <strong>die</strong> lwee toetse met mekaar<br />
vergelyk word deur mlddel <strong>van</strong> <strong>die</strong> K-toets, word K gelyk aan 0 gevlod, met<br />
'n kansverhoudmg ("Odds Ratio") <strong>van</strong> 0.<br />
Gevol&&king: Sew kan me m <strong>die</strong> plek <strong>van</strong> urieo amgewend word m<br />
dle uitvoer <strong>van</strong> d~e PhusedB swangetskapstoe2s me, waarskphk as<br />
gevolg <strong>van</strong> non-spesifieke binding met LH se a-subeenheid en prdeiie<br />
(SODS bv. albumien) in <strong>die</strong> sew.<br />
A COMPARISON OF HEMODYNAMIC DATA OBTAINED<br />
BY BIOIR@EDANCE VERSUS lliERMODLUTION<br />
METHODS<br />
*L SKEAD J Diederieks, G J&<br />
~epartwat df~aaestbesi~~, U.O.F.S.<br />
The golden standard thermodilution method of obtainin k<br />
hemodvnamic data has associated morbidity and mortality .<br />
A ne\; non-invasive method using &rack electrid<br />
bioimpedance (TEB)2 could be usey during coronary artery<br />
bypass graft (CABG) surgery. Ttus S* determined the<br />
.agreement between TEB and thermoddution values of<br />
- ardiac index (cr),. stroke vohune index (SV) and systemic<br />
-,vascular resistance 1nde.x (SW) for Merent ardiac outputs<br />
*- . in open and closed chest conditions during CABG surgery.<br />
Permission for the S was obtained fiom the U.0P.S.<br />
ethical committee. In "", 1 patients undergoing CABG surgery<br />
cardiac output was determined with a thermodilution<br />
technique (SwanGanz catheter in iulmonary artery) and<br />
TEB (external electrodes on both si es of the thorax m the<br />
rni- lipe at xiphisternum level and on both sides at the<br />
base of the neck). The electrodes measure changes in<br />
electrical bioimpedance caused by the flow of blood through<br />
the thorax. S five paired samples were obtained with an<br />
open chest and '2- 9 paired samples with a closed chest Using<br />
both methods, measurements were taken simultaneously for<br />
CI, SVI and S W To determine the agreement between<br />
the two methods7 intraclass correlations were calLulated by<br />
using analysis of variance that took into account the number<br />
of patients as well as the number of measurements per<br />
pahent.<br />
Sam le A includes all data and shows a r correlation for<br />
a &r for SW and good fa SVRl (Ta. However, this<br />
group included a patient with a very large left ventricular<br />
aneurysm. The aneurysm could have affected the TEB<br />
measurements. All data from this patient were excluded<br />
from sample B which shows a ood correlation for SVI and<br />
S W but only fair correlation for CL Agreement was good<br />
for SW in the open chest but only fair for the closed chest<br />
while agreement for SVRI was good in the open and closed<br />
chest.<br />
Table of correlation toe-nts<br />
SampkA SampleB<br />
open Closedopen Closed<br />
0.42 0.60 0-69 0.73<br />
0.65 0.64 0.81 0.71<br />
0.85 0-80 0.88 086<br />
This study shows that a reasonable to good correlation for<br />
CI, SW and SVRI exists between the TEB and<br />
thermodilution methods for dete 7 cardiac outw when<br />
no or a small aneurysm is present. owever, the extreme<br />
Werences obtained in one patient with a large<br />
suggest that other factors my deem the values o b x Y<br />
the TEB method unreliable. There were no marked<br />
differences between the open and closed chest<br />
measurements.<br />
1. Robin, ED: The Cult of the Swan-Ganz Catheter. Int<br />
& Crit Care Digest, 1986, V01.5, No.l:18.<br />
2. Bernstein, DP: Continuous non-invasive real-time<br />
monitoring of stroke volume and cardiac output by<br />
thoracic electrical bioimpedance. Crit Care Med,<br />
1986, Vo1.14, No.1&898.<br />
DIE ARBCHIDONSUURPIETABOLISME IN PLAATJIES<br />
VAN UREMIESE PASIBNTE MET VERLENGDE<br />
BLOEITYE -<br />
B F Botha, F C ~loet~', P N ~adenhorst*,<br />
Afdeling Nefrologie. Dept Hematologie,<br />
UOVS, Bloemf ontein.<br />
Somige uremiese pasiente ontwikkel 'n<br />
bloedingsneiging wat bydra tot morbiditeit<br />
en mortali teit . ' n Verlaging in tromboksaan<br />
A, produksie in uremiese plaatjies is een<br />
<strong>van</strong> <strong>die</strong> oorsake <strong>van</strong> <strong>die</strong> abnormale<br />
plaat jiefunksie . ~ i e verlaagde tromboksaan<br />
AZ produksie word veroorsaak deur 'n defek<br />
in <strong>die</strong> plaat j ies se arachidonsuurmetabolisme.<br />
Hier<strong>die</strong> def ek is<br />
praksimaal tot <strong>die</strong> siklo-oksigenase stap in<br />
<strong>die</strong> arachidonsuurmetabol i sme gelee .<br />
Arachidonsuur (Aa) word deur arachidoniel<br />
KoA-sintetase in <strong>die</strong> plaat j iemembraan<br />
ingebou. Die hipotese is dat <strong>die</strong><br />
aktiwiteit <strong>van</strong> arachidoniel KoA-sintetase<br />
verlaag is by <strong>die</strong> uremiese pasiente.
Die doel <strong>van</strong> <strong>die</strong> stu<strong>die</strong> is <strong>die</strong> andersoek<br />
<strong>van</strong> <strong>die</strong> Aa-metabolisme in uremiese<br />
plaatjies.<br />
Metodes: Bloed <strong>van</strong> 10 uremiese pasiente<br />
met verlengde bloeitye op permanente hemo-<br />
dialise en 10 normale persone is geana-<br />
liseer. Vetsure in <strong>die</strong> plasma en plaatjies<br />
is met behulp <strong>van</strong> gaschromatografie bepaal.<br />
Die aktiwiteit <strong>van</strong> arachidoniel KoA-<br />
sintetase is bepaal deur <strong>die</strong> inbouing <strong>van</strong><br />
radioaktiewe Aa in <strong>die</strong> fosfolipiede <strong>van</strong> <strong>die</strong><br />
plaatjie te meet. Die vetsure is met hoe<br />
verrigting vloeistofchromatografie geskei<br />
en <strong>die</strong> radioaktiwiteit met behulp <strong>van</strong> 'n<br />
vloeimeter bepaal. Die vrystelling <strong>van</strong><br />
arachidonsuur uit <strong>die</strong> plaatjies is bepaal<br />
deur siklo-oksigenase met ETYA te inhibeer<br />
en dan <strong>die</strong> Aa-konsentrasies in <strong>die</strong><br />
supernatant en plaatjiemembrane te bepaal.<br />
Resultate: Uremiese plasma bevat beteke-<br />
nisvol hoer konsentrasies totale en<br />
ongeesterifiseerde Aa. Uremiese plaatjies<br />
bevat betekenisvol laer konsentrasies <strong>van</strong><br />
Aa. Die aktiwiteit <strong>van</strong> arachidoniel KoA-<br />
sintetase is beduidend laer in uremiese<br />
plaatjies. Die defek in <strong>die</strong> aktiwiteit <strong>van</strong><br />
arachidoniel KoA-sintetase kan in normale<br />
plaatjies geynduseer word deur inkubasie in<br />
uremiese plasma en . <strong>die</strong> defek in<br />
ensiemaktiwiteit kan herstel word word deur<br />
inkubasie in normale plasma. Die<br />
vrystelling <strong>van</strong> Aa uit uremiese plaatjies<br />
is normaal.<br />
Gevolgtrekkings: Die verlaagde Aa-konsen-<br />
trasie in uremiese plaat j ies word veroor-<br />
saak deur 'n defek in <strong>die</strong> aktiwiteit <strong>van</strong><br />
arachidoniel KoA-sintetase. Die vrysteling<br />
<strong>van</strong> <strong>die</strong> Aa uit <strong>die</strong> uremiese plaatjies is<br />
normaal . Die verlaagde tromboksaan A2<br />
produksie in uremiese pasiente met<br />
verlengde bloeitye word veroorsaak deur 'n<br />
verlaagde Aa-konsentrasie in <strong>die</strong> plaatjies.<br />
DIE ONYIKKELING VAN 'N NIE-LNDRINCENDE<br />
FARMrLKODRVAMZESE ONDERRIGMODEL VIR VOOR-<br />
GRAADSE MEDLESE STVDENTE<br />
Miillw P, Hattingh 4 Miiller FO, S&U R, Barnard HC.<br />
Departement Fannakdogie, Fekulteit CenegkuiuJe, UniverJiteit <strong>van</strong><br />
<strong>die</strong> Oraqie-V- Bloemfonteln, Suid-APrika<br />
Inleiding en doek Die doe1 <strong>van</strong> hier<strong>die</strong> projek was om 'n praktige- onderrigmodel<br />
met betrekking tot geneesmiddel-wisselwerking te ontwikkel deur<br />
furosemied-geinduseerde nafriurese as ma~tstaf te geb~ik. Die farmake<br />
dinamika k& sodoende op 'n nie-indringende wyse vcrgcstslp word.<br />
PotensiW vlakke <strong>van</strong> geneesmiddel-wisselwerking is geidentifiseer en<br />
verskeie middels is in kombinasie met furosemied toegedKa om <strong>die</strong><br />
interaksies te demonstreer. Maaglediging is versnel dew <strong>die</strong> toe<strong>die</strong>ning <strong>van</strong><br />
metokloprmnied en vertraag deur propmrtellien. Cholesnrmien is aangewend<br />
om absorpsie <strong>van</strong>af <strong>die</strong> maagdermkanaal te veminder. Misie<br />
<strong>van</strong> <strong>die</strong> aldostemonrespoas is deur knptopril teweegebnng en hhbise <strong>van</strong><br />
prastagWiensintese deur iRdome&%ien. Plasebo is as konmle toeeen.<br />
Metode: Agttien jong, gesonde manlike en vroulike vrywilligers he3 aan 'D<br />
plasebo-beheerde, gerandomiseerde, W-fase oorkmisstu<strong>die</strong> deeigeneem.<br />
Behandelings is as volg toeged~en:<br />
A. Lasd (furosemied) 40 mg 1 uur M plasebo Pkta m kapsuk)<br />
B. Lasixm 40 mg 1 uur na 75 mg IndocidCO (indornetaslen) op <strong>die</strong> proef<br />
dag en 12 me <strong>van</strong>tevore<br />
C. LasixB 40 mg 1 uur na 25 mg Capotd (kaptopd), plus 25 mg<br />
Capten@ 3 ure na Lasix@-mname<br />
D. LasixB 40 mg saam met 9g Questran@ (cholestiramlen)<br />
E. Las- 40 mg 1 uur na 20 mg Maxolon@ (metoklopramied)<br />
F. Lass 40 mg 1 uur na 30 mg Pro-Banthin& @ropantehbcomied)<br />
VOL 82 DECEMBER 1992 447<br />
OD proefdae is urien op <strong>die</strong> volgende tye versamel: 0-1 uur, 1-2 uur, 2-3<br />
I&-3-4 uur, 4-5 uur, 5-6 uur m 68 uur na Lasix@-inname.<br />
Resultate:<br />
Gemiddelde Gemiddelde Gemiddelde<br />
Mandeling:<br />
hxx@ + ...<br />
(SD) totak<br />
urienvolume<br />
uitgeskei oor 8<br />
(SD) totale<br />
wi&e<br />
natriurn-<br />
(SD) totale<br />
uridre kaliumuitskeiding<br />
oar<br />
uur (ml) uitskeiding oor<br />
8 uur (mrnol)<br />
8 uur (mmol)<br />
A. Plasebo 2255(431) 179(,55) 39( 9)<br />
B. Indocia<br />
C. &poten@<br />
1793(498)<br />
=wc“v<br />
1@%56)<br />
202(W<br />
30(10)<br />
4V7)<br />
1372(555) 67(51) 21(10)<br />
~holekrarnien en indoiaetasien het natriu- klinies en statisties<br />
betekenwol onderdruk. Propantelien het (rniskien onvewags) 'n klinies<br />
en statisties betekenisvolle versterking <strong>van</strong> furosemied-geindtiseerrte<br />
natriuwe vemorsaak, rnoontlik as gevolg <strong>van</strong> verhoogde intragastriese pH.<br />
Kaptqd het h klinies waameembare verhoging in natriurese veroorsaak.<br />
MetnWoprcUnied het geen noemenswaardige effek op furosemiedgeindlt~eerde<br />
natriurese g W nie.<br />
GevolgtreWdng: Die gebruik <strong>van</strong> furosemied-ge-museerde natriurese as<br />
maatsraf vlr <strong>die</strong> demwtraue <strong>van</strong> middel-middelwisselw~ op 'n nieindringeode<br />
wyse is potensieel bmikbaar in <strong>die</strong> ond-g <strong>van</strong> vowgraadse<br />
mcdh studente.<br />
LAPAROSKOPIESE CHOLESISTEKTOMIE - VROEe<br />
ONDERVINDING IN IN OPLEIDINGSHOSPITAAL.<br />
SM Smit, GF Ferreira, RS du Toit, R<br />
Barry, CJC Nel. Departement Chirurgie,<br />
UOVS , Bbemf ontein.<br />
DOEL: Die doel <strong>van</strong> <strong>die</strong> stu<strong>die</strong> was om<br />
vas te stel of laparoskopiese<br />
cholesistektomie (Le) voldoen aan <strong>die</strong><br />
vereis tes gestel vir minimaal<br />
ingrypende chirurgie nl verminderde<br />
PY~I verminderde post-operatiewe<br />
komplikasies en verkorte<br />
hospitaalverblyf.<br />
PASI~NTE EN METODES: Alle pasiente wat<br />
tussen Aug 1991 en April 1992 tot<br />
Universitas Hospitaal toegelaat is met<br />
simptomatiese galsteensiekte en geen<br />
kontra-indikasies vir chirurgie gehad<br />
het nie, is ingesluit in <strong>die</strong> stu<strong>die</strong>.<br />
Die operasie is onder algemene narkose<br />
uitgevoer volgens <strong>die</strong> beskryfde 4<br />
trogar tegniek <strong>van</strong> Cuschieri en ~erci'.<br />
In Nasogastriese buis en urienkateter<br />
is in elke geval passeer en direk post-<br />
operatief verwyder .<br />
RESULTATE: 60 pasiente is ingesluit,<br />
12 mans en 48 vroue. Die gemiddelde<br />
ouderdom was 53,5 jaar. Operatiewe<br />
probleme is in 18 gevalle ondervind wat<br />
insluit bloeding <strong>van</strong>af sistiese<br />
arterie, galblaas perforasie,<br />
choledochus besering en verklewings.<br />
In 4 gevalle is In intra-operatiewe<br />
cholangiogram uitgevoer wat normaal<br />
was. In <strong>die</strong> reeks moes daar in 8<br />
gevalle tot oop cholesistektomie<br />
oorgegaan word. Die gemiddelde<br />
narkosetyd was 85 minute en <strong>die</strong>
448 VOt 82 DESEMBER 1992<br />
SAMJ<br />
gemiddelde operasie tyd 40 minute.<br />
Post-operatiewe komplikasies sluit in 1<br />
pasient met erge onverklaarde buikpyn<br />
wat binne 12 uur opgeklaar het. Een<br />
pasient is in <strong>die</strong> post-operatiewe<br />
tydperk oorlede aan In beroerte. A1<br />
<strong>die</strong> pasiente was binne 12 uur mobiel en<br />
het binne 24 uur In normale saal<strong>die</strong>et<br />
gevolg . Post-operatiewe pyn was<br />
minimaal. Die gemiddelde post-<br />
operatiewe hospitaalverblyf was 38 uur<br />
(<strong>die</strong> omskakelings uitgesluit). Die<br />
meeste pasiente kon binne 8 dae weer<br />
terugkeer na hulle werk.<br />
GEVOLGTREKKING: LC beantwoord aan <strong>die</strong><br />
vereistes ges tel vir minimaal<br />
ingrypende chirurgie. Om <strong>die</strong><br />
komplikasiesyfer laag te hou moet <strong>die</strong><br />
chirurg opgelei wees in laparoskopiese<br />
tegnieke en disseksie moet met<br />
versigtigheid gedoen word.<br />
~a~aroscopic biliary surgery 1 990.<br />
Alfred Cuschieri and Georqe Berci.<br />
L -<br />
- - .r - - . . .<br />
-. c-.<br />
i<br />
THE ENIGMATIC RELATION BElWEEW TRAUMA AND<br />
SEPSIS: BACTERIAL TRANSLOCATION - A<br />
MYTH. AN EPIPHENOHKNON OR TREATABLE<br />
SYNDROME? A PIL#l' STUDY<br />
SJA Smit, EJ Theron, CJC Nel, S v Riet H<br />
v Wyk, F vd Watt, SS ant sol, R schal12 -<br />
Department of Surgery, Department of<br />
~icrobiolo~~ l Department o f<br />
Biostatistics 1 , UOFS, Bloemfontein<br />
Aim : The use of animal models to<br />
evaluate bacteremia in shock creates a<br />
problem of interpretation. The dog, for<br />
example, has a normal bacteremic<br />
splanchnic circulation. The<br />
investigation of bacterial translocation<br />
in the shocked patient frequently gives<br />
opposing results as noted by recent<br />
stu<strong>die</strong>s. (Rush confirmed and Moore<br />
questioned). Thus a prospective clinical<br />
study was done to determine the incidence<br />
as well as the character of bacteremia in<br />
shocked patients.<br />
Patients and methods: Fifteen acutely<br />
shocked patients were assessed. None of<br />
them had received antibiotic prophylaxis.<br />
Aerobic and anaerobic blood cultures were<br />
taken on admission. The specimens were<br />
procured under sterile conditions from a<br />
selected site.<br />
Results: The incidence of positive blood<br />
cultures was 47%. Two groups of patients<br />
were distinguished. Patients with a<br />
systolic BP >70mmHg (40% of the study<br />
group) had a 17% incidence of positive<br />
blood cultures whereas patients with a<br />
systolic BP
Resultate word in <strong>die</strong> ondemtaande tabel aangetoon :<br />
I Mans I Vrouens I I<br />
I Pieksistoliese<br />
vloeisnelheid<br />
Minimum<br />
diastoiiese<br />
vloeisnelheid<br />
(cmisek)<br />
Gemiddelde<br />
vloeisnekid<br />
(cmisek)<br />
Mans<br />
- 30,7 (s=8,71)<br />
Vrouens<br />
-24,6 (S= 8,75)<br />
KOSTE-EFFEKTIEWE KLINIES-FARHAKOLO6IESE SliQIES<br />
B.H. Heyer. Hoechst-Navorsingseenheid, Dept.<br />
Farmakol ogie. UOVS<br />
In <strong>die</strong> lig <strong>van</strong> <strong>die</strong> toenemende aantal kliniese<br />
stu<strong>die</strong>s wat in ons fakulteit teen vergoeding in<br />
opdrag <strong>van</strong> firmas uitgevoer word is dit belangri k<br />
dat kennis geneem word <strong>van</strong> koste faktore by <strong>die</strong><br />
uitvoer <strong>van</strong> stu<strong>die</strong>s en <strong>van</strong> <strong>die</strong> belang <strong>van</strong> koste uit<br />
<strong>die</strong> oogpunt <strong>van</strong> <strong>die</strong> opdraggewer.<br />
Innoverende werk in <strong>die</strong> farmaseutiese areld is<br />
riskant, tydrowend en baie duur. Slegs 0.1% <strong>van</strong><br />
nuwe entitei te berei k ooit <strong>die</strong> mark.<br />
Ontwi kkel ingskoste <strong>van</strong> nuwe middel s word slegs in<br />
'n 1/4-1/3 <strong>van</strong> produkte verhaal . Talle groot<br />
maatskappye verkry 50% <strong>van</strong> hulle verkope uit 1-3<br />
middels. Die gemiddelde ontwi kkel ingskoste <strong>van</strong> een<br />
nuwe mi&del het astronomies toegeneem <strong>van</strong> 51.2 mil .<br />
in 1962 tot $231 mil. in 1990. Die tyd nodig vir<br />
ontwikkeling <strong>van</strong> 'n nuwe geneesmiddel is 12 jaar.<br />
Dit tesame met hoe koste het groot renteverliese<br />
tot gevolg.<br />
BEPERKING VAN KOSTE VAN KLINIESE STUDIES: Die<br />
eenvoudigste benadering is om <strong>die</strong> koste verbonde<br />
aan 'n stu<strong>die</strong> in sy komponente af te breek en te<br />
besluit of elke komponent verminder kan word.<br />
Voorbeeld: Die kwotasie vir 'n stu<strong>die</strong> met 4 fases<br />
in 36 vrywilligers wat in elke fase vir 10 dae 'n<br />
nuwe geneesmiddel ont<strong>van</strong>g en waari n<br />
farmakokinet iese asook verdraagsaanheidsverander-<br />
likes gemeet word, is R6 340 per vrywill iger per<br />
fase of R228 240 vir <strong>die</strong> hele stu<strong>die</strong>. Dit is nodig<br />
VOL82 DECEMBER 1992 449<br />
SAMJ<br />
M <strong>die</strong> aantal herhalings <strong>van</strong> hematologie, chemiese<br />
patologie en urine ondersoeke na te gaan en te<br />
bepaal of dit verminder kan word, sonder prysgawe<br />
<strong>van</strong> noodsaaklike data. Dit geld ook vir bepalings<br />
<strong>van</strong> hormone, fisiese ondersoeke en EKG's. Oorweeg<br />
ook of proef persoomvergoedi ng beperk kan word,<br />
asook of <strong>die</strong> aantal bepalings <strong>van</strong> <strong>die</strong> konsentrasie<br />
<strong>van</strong> <strong>die</strong> middel verminder kan word. Dit mag oorweeg<br />
word on te bespaar op statistiese en far-<br />
makoki net i ese berekeni nge en versl aggewi ng , maar<br />
dit met in gedagte gehou word dat swak statistiek<br />
'n hele stu<strong>die</strong> kan verongeluk. In genoesde<br />
voorbeeld kan sowat R30 000 bespaar word, met <strong>die</strong><br />
risiko dat <strong>die</strong> stu<strong>die</strong> nie statisties lewensvatbaar<br />
sal wees nie, en later herhaal met word.<br />
EFFEKTIWITEIT VAN STUDIES: Om <strong>die</strong> regte ding te<br />
doen en M dinge reg te doen is hier ewe belangrik.<br />
Tydsduur <strong>van</strong>dat opdrag gegee is tot voltooiing <strong>van</strong><br />
<strong>die</strong> stu<strong>die</strong> is 'n uiters belangrike koste faktor.<br />
Die regte stu<strong>die</strong>s moet gedoen word en hier<strong>die</strong> keuse<br />
moet vooraf in 'n algemene strategie vasgeld word.<br />
Om dinge reg te doen is kardinaal, want dit verhoed<br />
dat 'n stu<strong>die</strong> herhaal met word.<br />
Oosonmend: Van <strong>die</strong> kant <strong>van</strong> <strong>die</strong> opdraggewer is dit<br />
belangrik dat professionele mense met baie ervaring<br />
en 'n goeie naam gekies word om <strong>die</strong> stu<strong>die</strong> uit te<br />
voer. Hulle sal goeie raad kan gee aangaande<br />
beplanning, protokol le, goeie kl iniese en<br />
laboratoriumpraktyk, uitmuntende statistiese<br />
analise en verslaggewing. Sulke stu<strong>die</strong>s sal nie<br />
herhaal hoef te word nie en sal op enige plek in<br />
<strong>die</strong> wdreld aanvaarbaar wees.<br />
DIE ROL VAN DIE ARBEIDSTERAPEUT IN DIE<br />
ONTWW(EL1NG EN BEDRYF VAN DIE<br />
D C Nienkemper<br />
Kinderinligtingsentrum<br />
Dept. Pdatrie en Kindergesondheid, U.O.V.S.<br />
Die doe1 <strong>van</strong> <strong>die</strong> stu<strong>die</strong> was om te bepaal wat <strong>die</strong> rol <strong>van</strong> <strong>die</strong><br />
arbeidsterapeut by <strong>die</strong> Bloemfontein Kinderinligting-<br />
sentrum (ELKIS.) is.<br />
Die BXIS. is gesetel in <strong>die</strong> Dept. Pediatrie <strong>van</strong> <strong>die</strong> <strong>Fakulteit</strong><br />
<strong>Geneeskunde</strong> <strong>van</strong> <strong>die</strong> <strong>Universiteit</strong> <strong>van</strong> <strong>die</strong> <strong>Oranje</strong>-<strong>Vrystaat</strong><br />
en funksioneer as 'n onafhanklike eenheid Vie <strong>die</strong><br />
departement en <strong>die</strong> <strong>Universiteit</strong>.<br />
Op 'n prospektiewe wyse is 145 persone <strong>van</strong> <strong>die</strong> O.V.S. en<br />
Nhpstreek wat <strong>van</strong> <strong>die</strong> <strong>die</strong>nste gebruik maak, in <strong>die</strong><br />
stu<strong>die</strong> ingesluit. Die vraelys aan <strong>die</strong> ouers is dew middel<br />
<strong>van</strong> onderhoudvoering uitgevoer.<br />
Daar is vasgestel dat <strong>die</strong> ouers (48%) 'n behoefte het aan<br />
en leiding ten opsigte <strong>van</strong> korrekte<br />
ers op hul mylpaal ontwikkeling. A1<br />
<strong>die</strong> ouers was positief oor <strong>die</strong> <strong>die</strong>nste en <strong>van</strong> mening dat hul<br />
behoefies deur <strong>die</strong> BXIS. bewedig word.<br />
Daar is tot <strong>die</strong> gevolgtrekking gekom dat <strong>die</strong><br />
arbeidsterapeut met haar keMis oor s ~ en l ontwikkeliig 'n<br />
defnitiewe rol het in <strong>die</strong> ontwikkelmg en bed$ <strong>van</strong> 'n<br />
Kinderinligtingsentnun.<br />
Dit is duidelik deur <strong>die</strong> stu<strong>die</strong> dat Kinderinligtingsentra 'n<br />
rol as onderstemings<strong>die</strong>ns in <strong>die</strong> gemeenskap het. Met <strong>die</strong><br />
kennis wat ingewin is oor <strong>die</strong> behoeftes <strong>van</strong> <strong>die</strong> ouers wat<br />
aan <strong>die</strong> stu&e deelgeneem het, kan <strong>die</strong> BXIS. in <strong>die</strong><br />
toekoms 'n groot rol speel in <strong>die</strong> totale primere<br />
gesondheidsorg plan in Bloemfontein en omliggende ara
650 VOL 82 DESEMBER 1992<br />
SAMJ<br />
AM)LESCENTS WITH LEARNING DISABILITIES AND<br />
THE MASTERY OF LIFESKILLS NEEDED IN THE<br />
WORKPLACE<br />
Jeanne Pretorius, N Coetzee, J Du Preez, S J Serfontein, C<br />
Vivie~ Demrtment of Occu~ational Therapy, UOFS<br />
child& whh learning disabaties receive tlieir education in<br />
special schools where the emphasis is on practical subjects<br />
such as weldin panelbeating, plumbing, hairdressing, office<br />
management, k ome management, etc. It was established<br />
that the children are well able to meet the job demands<br />
after leaving school, but are unable to comply with the<br />
social demands. The p se of this study was to determine<br />
which of the social lifesxneeded in the workplace present<br />
the biggest problems, to the children still busy with their<br />
schoohg.<br />
Three questionnaires were designed in order to test<br />
knowledge, attitude and skill in terms of twelve carefully<br />
selected lifeskills. Situational descriptions were used to<br />
evaluate attitude and skill, and a multi-choice questionnaire<br />
for the testing of knowledge. A sample taken at random<br />
from the a, b and c classes from standard 6, 7 and 8 were<br />
subjected to the tests. The results showed the following:<br />
1. Extremely high percentages of the goup as a whole<br />
have got problems with the lifeslulls being tested.<br />
They score better on the knowledge test than on<br />
attitude and skill. The handling of conflict, making<br />
decisions and the handling of criticism seems to be<br />
the biggest problems.<br />
. There are very slight differences in the scores of the<br />
standard 6, 7 and 8 groups respectively. The four<br />
biggest problems in each standard are basically the<br />
same, only in a different order.<br />
3. Overall the grou s from the c-classes had lower<br />
scores. and there P ore bigger problems with most of<br />
- *<br />
the lifeskills.<br />
In order to lace these kids successfullv in anv kind of iob,<br />
they must 6e able to com ly with s&al no&, relatd to<br />
other people in an accepta g le way and handle tricky social<br />
situations. In light of the above results it is clear that it is<br />
extremely important to teach the learning disabled child the<br />
social lifeskills needed in the workplace, as it seems as if<br />
these skills do not develop through the normal<br />
developmental processes. The reason for this might be<br />
because most of these children come from economically<br />
deprived areas.<br />
THE INCIDENCE OF COINFECIION WITH HTLV-I IN<br />
HIV-l SEROPOSITIVE PATIENTS WITH NEUROLOGIC<br />
COMPLICATIONS<br />
E. <strong>van</strong> der Rvsc MS. Smith; k Pretorius<br />
Department of Virology; UOFS Bloemfontein, South<br />
Africa<br />
Human immunodeficienq virus 1 (W-1) and human<br />
T-lymphotro ic virus type I =V-I) infections share<br />
common risf: factors that include sexual contact, vertical<br />
transmission and transfusion of contaminated blood or<br />
blood products. Both HIV-1 and HTLV-I are endemic in<br />
South Africa and coinfedon might not be uncommon. Both<br />
HIV-1 and HTLV-I are associated with neurologic<br />
abnormalities. HIV-1 can cause a wide range of neurologic<br />
complications, including myelopathy. HTLV-I is the<br />
etiologic agent of tropical spastic paraparesis (TSP).<br />
AIM : To determine the seroprevalence of anhies<br />
against IFlZV-I among HIV-1 seropositive patients with<br />
neurolo 'c complications, and to investigate the role of<br />
HTL+v-~ in the neurologic complica~ons of HIV-l<br />
seropositive patients.<br />
PATIENTS AND METHODS : Fifty HIV-1 seropositive<br />
patients with neurologic complications were selected. Their<br />
sera were tested for antiies against HTLV-I with a<br />
commercial enzyme linked immunosorbent assay (ELISA)<br />
test kit. e- and sex-matched control groups<br />
3<br />
consisting of 50 h thy HIV-1 seronegative patients and 50<br />
HIV-1 seropositive patients without neurologic<br />
complications were also tested.<br />
RESULTS : Seven of the 50 (14%) HIV-1 seropositive<br />
patients with neurologic com lications had anties<br />
against HTLV-I, while 1/50 (277 o of the HIV-1 seropositive<br />
patients without neurolo 'c complications had antibo<strong>die</strong>s<br />
against HTLV-I @=0.03$ None of the healthy HIV-1<br />
seronegative patients tested positive for HTLV-I antibo<strong>die</strong>s.<br />
CONCLUSIONS : The incidence of coinfection' with<br />
HTLV-I in HIV-l sero sitive atients with neurologic<br />
complications is high, an&hL.V-fmight play an important<br />
role in the neurologic complications found in HIV-1<br />
seropositive patients.<br />
DUPLEX SONOGRAPHY OF CAROTID ARTERIES IN<br />
DIABETICS<br />
J. Brunova, Department of Internal<br />
Medicine, University of the Orange Free<br />
State, Bloemfontein<br />
Macrovascular complications are the<br />
commonest cause of death in diabetics. In<br />
order to detect the extend of<br />
atherosclerotic changes in diabetic<br />
patients, duplex sonography of the carotid<br />
and femoral arteries was used.<br />
PATIENTS AND METHODS: We investigated 107<br />
newly diagnosed diabetic middle-aged men<br />
using Toshiba, SSA, 270A Sonolayer Alpha.<br />
The presence of arterial atherosclerotic<br />
changes was correlated with levels of serum<br />
triglycerides, cholesterol, HDL-cholesterol<br />
and immunoreactive insulin in diabetic<br />
patients.<br />
RESULTS: Minimal atherosclerotic changes of<br />
the arteries were present in 23% of<br />
patients; 20 - 4-% stenosis were present in<br />
18% of diabetic patients. Arterial stenosis<br />
more than 40% of diameter was present in<br />
2,7% of patients. Atherosclerotic plaques<br />
were found mainly 'in the internal carotid<br />
artery. Severe stenosis of the femoral<br />
artery was found in 3,8% of patients, but<br />
almost 50% of patients had atherosclerotic<br />
changes. A correlation was found between<br />
the prevalence of carotid artery<br />
atherosclerosis and the level of serum<br />
triglycerides, total cholesterol/~~L<br />
cholesterol ratio and levels of<br />
immunoreactive insulin in diabetic<br />
patients.<br />
CONCLUSION: 1. The ultrasonography is<br />
useful in diagnosis of the early<br />
atherosclerotic changes.<br />
2. The higher levels of triglycerides,<br />
t.otal cholesterol/^^^ cholesterol ratio and<br />
higher levels of immunoreactive insulin<br />
were risk factors for carotid artery<br />
disease in newly non-insulin dependent<br />
diabetes mellitus.
PHENYTOIN INTOXICATION, CEREBELLAR<br />
ATROPHY AND SO CALLED STANDARD<br />
DOSAGE IN SOTY.<br />
CH <strong>van</strong> d Meyden , AJ ICrugerl, T D e villiers2,<br />
F0 ~ulle3. epartments of Neurology , ~adiolod,<br />
Pharmacoloz UOVS, Bloemfontein<br />
AIM: Diiscription of phenytoin (DPH) toxicity,<br />
cerebellar atrophy and their relation to dosage in the<br />
Sotho.<br />
METHOD: Patients presenting with both DPH toxicity<br />
and cerebellar atrophy on computer tomography of the<br />
brain at the Pelonomi hospital e ilepsy clinic between<br />
the 1st of January 1991 and the &th of February 1992<br />
are descriid. The number of DPH intoxications and<br />
their dosages were calculated for the period 1st June<br />
1989 to 31st December 1991 at the same clinic.<br />
RESULTS: Seven young mentally handicapped<br />
patients (5 Sotho) with tonic clonic convulsions were<br />
identified of which 2 showed severe, 3 moderate and 2<br />
mild degrees of cerebellar atrophy. The episodes of<br />
DPH intoxication were prolonged in 6, repetitive in 4<br />
and associated with a dosage of DPH lOOmg tds in 6<br />
During 7,475 outpatient visits 55 instances<br />
DPH mtoxication were noted of which 36<br />
occurred at a dosage of 300mg or less per day.<br />
CONCLUSION: The close temporal association<br />
between DPH intoxication and the onset of sustained<br />
clinical cerebellar deficit su ested a causal<br />
relationship. The hypotheses of a%igher incidence of<br />
DPH toxiaty in the Sotho compared to the Caucasian at<br />
a so called standard DPH dosage of lOOmg tds may<br />
relate to a lower weight status or a slower genetic<br />
oxidative metabolism. Awareness of these preventable<br />
complications is mandatory.<br />
DIE EFFEK VAN PIMOBENDAN OP ISCHEMIESE<br />
MIOKARDIUM<br />
Diedefieks CP Herb$, N Uys, J B-r. De artement<br />
kesteslolodc. B~ofisb em proefdmeenhekf UOVS,<br />
Blpx$onte%,<br />
Ber&e stu&e ondersoek <strong>die</strong> effek <strong>van</strong> pimobendan o<br />
miokardiale funksie wanneer 'n area <strong>van</strong> <strong>die</strong> linker ventrik3<br />
met krities beperkte bloedvloei ischemies gernaak is deur 'n<br />
verhoogde konsentrasie halotaan.<br />
Na remedikasie met 0,8 =/kg morfien intrampkulCr, is<br />
*<br />
narfose by 7 Beagles mber met 15 k bopentmn<br />
jntraveneus, en in stapd gehou me? 0,s-13% otaan tydens<br />
mnstnunentasle. Mer ventnk@re en .aorta druk,<br />
bloedvloei in <strong>die</strong> stwende aorta en Mer antenor afdalende<br />
koronere arterie dishil tot <strong>die</strong> tweede perforerende tak, en<br />
streeksfunksie in <strong>die</strong> apks en basis <strong>van</strong> <strong>die</strong> linker ventdel<br />
is emeet en data met n rekenaar versamel. 'n Mikrometer-<br />
befieerde lus om <strong>die</strong> linker afdalende koronere arterie,<br />
onmiddellik distaal tot $e vloeimeter is gebruikpm kritiese<br />
mnko0rpngg<strong>van</strong> bloedvloei te verkry. ha chlrur e s 'n yr<br />
stabherq teen 0,7% halo- met nodl e koronere<br />
bloedvloel foe elaat en toe kontrole hemodmamese leslngs<br />
versamel. Atiese inper yan vl~i na <strong>die</strong> linker<br />
ventrikulere apeks is aange % l-gs herhaal, en<br />
halot- tpe verrpeerder na??,2% waarna verdere<br />
hemodmarmew lesmgs venamel S.<br />
m /k is intraveneus toe edip en data versamel Pimobendaq, na F:<br />
12.26.25, 35, 45, en d mute. Da@ is vemrk met<br />
<strong>van</strong>ansie-se yr herhaalde mebngs en 95%<br />
vertrouensmtervalle s bereken.<br />
Daar we geen. verslegting v*. globale- of streekj<br />
hartfunksie met &e aanbnn <strong>van</strong> lrntres beperkte bloedvloe~<br />
me. Verho g na 12%%a19taan he$ elei tot matige<br />
ischeme m gapex verhogmg m post-s1st&ese verkortmg)<br />
en de ressie <strong>van</strong> obale en streeksmiokardiale funlcs~e<br />
(tabelf Pimqben d het globale- (+e/dt, tabel) en<br />
streeks- (helhg <strong>van</strong> a X en bass se druk/lengte<br />
verhou+ng) kontr+iliteIS" verwg. Honvel statistics<br />
onbedwdend, het pmbendan gelei tot 'n neiging om perifere<br />
vasku!&re weerstand te vemder en slagvolume en<br />
hartmtwerp te vermeerder 500s gesien aan 95%<br />
vertrouensmte~alle<br />
VOL 82 DECEMBER 1992 451<br />
SAMJ<br />
(/mi4<br />
MAP 89 (9). 67 (6) 64 (8) S6 (10). 53 ((U)*<br />
(-W)<br />
dP/dt 1440 (W)* l(L30 (230) 1400 (170). 1410 (110). l460 (140).<br />
(mmW=k)<br />
QaSS 24 (7). 17 (5) 17 (8) 18 (9) 17 (8)<br />
%S Basis 16 (6). 17 (7) 21 (8). 18 (6) 21 (8).<br />
LADEDL 105 (1.9). 11.1 (2.3) 10.7 (22p 9.8 (13). l03 (W*<br />
(-1<br />
Waarde. is Gemiddeld(SD), p
452 VOL 82 DESEMBER 1992<br />
SAMJ<br />
DIE IMPAK VAN STERIUSASIE AS GEBOORTE-<br />
BEPERKINGSMETODE IN SEKERE DELE VAN DIE<br />
ORAN JE VRYSTAAT<br />
J D N a n G JV'DeptObsteW&enGinekolog'i,UOVS<br />
Manlike en vrolllike sterilisasies is weeldwyd <strong>die</strong> mees algemene<br />
metode <strong>van</strong> kontrasepsia Deur verbeterde tegnieke kan dii Mndag as<br />
'n -we onder W e verdowing uitgevoer iwrQrd met 'n he<br />
~orko&'<strong>van</strong> komplikasies en newe Sterilii is 'n<br />
eenmdige en pemranente rnetode - hasgenoemde is waarskynlik ook<br />
diigroatstenadee4.<br />
Me doe1 <strong>van</strong> <strong>die</strong> sWe was om te be@ wat <strong>die</strong> gemiddekle<br />
ouderdom en parteit was <strong>van</strong> vrouens wat dew <strong>die</strong> s t e r i l i i <strong>van</strong><br />
<strong>die</strong>DepartementObstetrieenGii mdele<strong>van</strong><strong>die</strong>OVSvir<strong>die</strong><br />
tydpedc 1988 tat 1991, onder lokaie verdowing gesterllii is.<br />
Me ppukb was pasiiinte in dele <strong>van</strong> <strong>die</strong> 0 V S op wie .ntenml<br />
laparoskopiese sterili llitgevoer is Mnaf l988 tot 1991.<br />
SWst&ke is verkry <strong>van</strong>af <strong>die</strong> Bloernfordeinse Sbeekskantoo~ <strong>van</strong> <strong>die</strong><br />
-<strong>van</strong> Nashaie Gesondheid en Bevdkingsontwikkelii<br />
Dieresultatewasasvdg:<br />
'n Totad <strong>van</strong> 4 485 vroue is in <strong>die</strong> 4 iaar gesterili. Die gemiddekle -<br />
ouderdom w&s 35.25 jaar en <strong>die</strong> geid& pariteit 4.9.<br />
GEVOLGTAW(ING: Sterilii was in <strong>die</strong> tvd verd uitaevoer OD<br />
ouer pasi&te wat waamky@k nie meer so f&el is nie.- Km&indi<br />
vk scmmige metodes, byvoorbeekl <strong>die</strong> kombii, is<br />
moonUii ook 'n rede waarom sterili-es aanbeveel word in hier<strong>die</strong><br />
pasilinta Met 'n pariteit <strong>van</strong> 2 5 speel sterilisasie waarskynlik nie 'n<br />
graot rd h <strong>die</strong> vennhdering <strong>van</strong> <strong>die</strong> gebooctesyfer nie.<br />
AANBEVEUNGS: SWlisasie behooft sy vdwaardige plek in te neem<br />
as 'n k v e . Daar sal gekyk moet word na metodes om<br />
vmwns <strong>van</strong> 'n her pariteit vir sterilii te motiveer. Woubare<br />
omkeerbare konbasepsie vir <strong>die</strong> jong fertiele vrou wat bar<br />
swangerskappe wil uitstel of spasieFtr is steeds uiters belangrik en moet<br />
nk wwaarlaos word ten koste <strong>van</strong> sterilii nie.<br />
LYMPHOGRAPHY IN LYMPHATIC<br />
AND CHYLE STASIS<br />
Dr J Bruna Department of Diagnostic<br />
Radiology, University of the Orange Free<br />
State / Universitas Hospital,<br />
Bloemfontein.<br />
Lymphography is used in the diagnosis of<br />
lymphatic and chyle stasis.<br />
The involvement of lymphatics by<br />
metastases, filariasis, retroperitoneal<br />
fibrosis, anomalies and ad<strong>van</strong>ced<br />
malignant lymphomas are the main causes<br />
of lymphatic stasis.<br />
Lymphography demonstrates not only the<br />
changes in lymph nodes, but also abnormal<br />
lymphatic circulation.<br />
The collateral lymphatic circulation<br />
depends on to ographic localization of the<br />
lymphatic o g struction and on the<br />
anatomical variation of the lymphatic and<br />
venous systems.<br />
Both typical and non-typical lymphatic<br />
pathways are found in malignancy and<br />
filariasis. This paper deals with the typical<br />
lymphatic collaterals (parietal, perivisceral<br />
and subcutaneous) and non-typical<br />
lymphatic pathways such as lymphovenous<br />
com~nunications, internal lymphatic<br />
fistulae and extravasation.<br />
This finding is very important from the<br />
surgical, physiotherapeutical and<br />
pathophysiological points of view. -<br />
SIR EN GRAAD VAN ALKOHOL<br />
NOODGEVHLLE<br />
M de Villiers<br />
Dept Huisartskunde<br />
-n Opname <strong>van</strong> bloedalkoholvlakke is gemaak<br />
<strong>van</strong> 500 pasignte wat <strong>die</strong> Pelonomi<br />
noodgevalle afdeling besoek het.<br />
Die doe1 <strong>van</strong> hier<strong>die</strong> stu<strong>die</strong> was om te<br />
bepaal wat <strong>die</strong> om<strong>van</strong>g en patroon <strong>van</strong><br />
alkohotverbruik by hier<strong>die</strong> pasignte is.<br />
Uit <strong>die</strong> 500 pasignte wat getoets is, was<br />
daar 25% wat *n positiewe bloedalkoholvlak<br />
gehad het.<br />
Die insidensie <strong>van</strong> positiewe alkoholvlakke<br />
het oor naweke tot 94.3% gestyg.<br />
Na analise <strong>van</strong> <strong>die</strong> data, het dit onder<br />
andere getoon dat oor naweke 53% <strong>van</strong> <strong>die</strong><br />
pasihte na <strong>die</strong> trauma afdeling verwys is.<br />
Van hier<strong>die</strong> pasignte het positiewe<br />
bloedalkoholvlakke gehad.<br />
Daar is oak gevind dat <strong>die</strong> persentasie<br />
geintoksikeerde pasisnte wat weekliks be:<br />
soldig word, feitlik 100% meer is as <strong>die</strong><br />
geintoksikeerde pasiente wat maandeliks<br />
betaal word.<br />
Na aanleiding <strong>van</strong> <strong>die</strong> bevindinge word<br />
enkele aanbevelings voorgestel.
RIsIgOF- m KORONeBeVATSIEklE IN U LANDELZgE<br />
EN W SFEDEddKE OBANlEvaYSTABTSE S W q BEVOLKpG<br />
WE. m A. M- M. Steyn, G. Joabert , K Steyp , GM.<br />
~DJ~Weich.Departement~Geneeslnmde, ~fd&g<br />
Bimtatistieken Me<strong>die</strong>seNa * 3.<br />
AGTERGROND EN -WPPZE.- Die voorkoms <strong>van</strong> ko&Mtsielde<br />
@VS) is steeds laag onder <strong>die</strong> swart bevolkiag <strong>van</strong> Suid-m Min<br />
bevokiagsgebaseerde idigtbg is beskikbaar omtrent <strong>die</strong> voorkoms <strong>van</strong><br />
kardiovashEre risikofaktore m <strong>die</strong> swart bevow <strong>van</strong> <strong>die</strong> RSA en<br />
derhalwe is hier<strong>die</strong> stu<strong>die</strong> ondernee~a<br />
METODES: Qwatpa is gekies as <strong>die</strong> hdelike en Mangaung as <strong>die</strong><br />
stedelike gebied. Die teikengroep het bestaan nit p n e <strong>van</strong> 25 jaar en<br />
ouer. Die voorkoms <strong>van</strong> <strong>die</strong> volgende kardiovaskulbe risikofaktore is<br />
bepaal: bloeddruk, Serumlipiede, rook, 1'- -in&ks, middelheupomtrek-verhoudiag<br />
@lW) en diabetes mellitus.<br />
RESULTATE: Agthonderd drie en vgftig respondente Mnuit Qwaqwa en<br />
758 respondente <strong>van</strong>nit Mangaang het aan <strong>die</strong> stn<strong>die</strong> Die<br />
voorkoms <strong>van</strong> hipertensie (na ouderdam en na <strong>die</strong><br />
be~lkiagsstrulduur) was 345% in Qwaqwa en 303% in Mangaung en<br />
het gestyg met toenemende ouderdom. Insgelyks was <strong>die</strong> voork01~ <strong>van</strong><br />
diabetes meltitOS 4.7% m <strong>die</strong> Qwaqwa-bevolkiag en 6.0% m <strong>die</strong><br />
Maugaung- bevolking. Die rook <strong>van</strong> meer as 10 sigarene per dag was baie<br />
meer algemeen onder mans as onder vrouens. Obesiteit was veral<br />
algemeen onder vrouens en <strong>die</strong> piek-voorkoms was 543% onder<br />
Mangaung vrouens in <strong>die</strong> 45-54 jaar groep. Die gemiddel& MHV vir alle<br />
ouderdoqoepe vrouens het OS Oorsiqy. Totale serum chalwerol in<br />
<strong>die</strong> h& risiko kategorie was teenwoodig in 125% en 6.0% <strong>van</strong> Qwaqwa<br />
en Mangaung mans mspdttkwelik in <strong>die</strong> 25-34 jaar ouderdomsgroep. Die<br />
wree~~~temmende syfess vir matige risiko hipercholesterolemie was 34%<br />
en 448% en het afgeneem met toenemende ouderdom.<br />
GEVO-G: Weinige verskille in <strong>die</strong> ris?rofakto'pro&l <strong>van</strong> <strong>die</strong><br />
twee bemlkings kon aangetoon word. DrastieSe maatr&ls sal getref moet<br />
word om <strong>die</strong> riskofaktorprofiel <strong>van</strong> <strong>die</strong> swart bevolking te verbeter om<br />
&nde <strong>die</strong> ontstaan <strong>van</strong> KVS en ander chroniese lewensstyltoestande<br />
te probeer verhoed.<br />
DIE VERLOOP EN UITKOMS VAN SWANGERSKAPPE<br />
SOOS VERWEK IN DIE REPRODUKTI EWESORGEENHEID,<br />
UNIVERSITAS HOSPITAAL, BLOEMFONTEIN<br />
Wessels PH, Wessels M, Van Drimelen M<br />
Reprodukt iewesorgeenheid, Departement<br />
Obstetrie en Ginekologie, UOVS ,<br />
Bloemfontein.<br />
DOEL: Die doe1 <strong>van</strong> hier<strong>die</strong> stu<strong>die</strong> was om<br />
ondersoek in te stel na <strong>die</strong> verloop en<br />
uitkoms <strong>van</strong> swangerskappe wat na<br />
infertil iteitsbehandel ing in <strong>die</strong> plaasl i ke<br />
Infertil i tei tskl iniek verwek is.<br />
STUDIE-ONlHERP: 'n Retrospektiewe stu<strong>die</strong> i S<br />
uitgevoer op data soos verkry per<br />
telefoniese navraag aan <strong>die</strong> pasiCnte self.<br />
PASIGNTE: Ses en tagti g opeenvol gende egpare<br />
wat na behandel ing in <strong>die</strong> p1 aasl i ke eenheid<br />
swanger geraak het, is deur <strong>die</strong> ondersoekers<br />
ondervra. 'n Retrospektiewe anal i se i S<br />
hierna gedoen <strong>van</strong> <strong>die</strong> data verkry.<br />
Spesi fieke aandag i S aan kompl i kasies tydens<br />
swangerskap en <strong>die</strong> verlossing self geskenk.<br />
VOL 82 DECEMBER 1992 453<br />
SAMJ<br />
RESULTATE: Van <strong>die</strong> 86 swangerskappe het 15<br />
geaborteer, 61 was enkel voudi ge<br />
swangerskappe en 10 (14%) was meerlinge.<br />
Vier en veertig seuns (54%) is gebore<br />
teenoor 38 dogters (46%). Bykans <strong>die</strong> heffte<br />
<strong>van</strong> alle swangerskappe is deur middel <strong>van</strong> 'n<br />
kei sersni t verl OS (49%) Geen<br />
noemenswaardige intrapartum komplikasie is<br />
gevind nie.<br />
GEVOLGTREKKING: Die uitkoms <strong>van</strong> swangerskap<br />
na infertil i tei tsbehandel ing het oor <strong>die</strong><br />
algemeen gunstig voorgekom en het goed met<br />
<strong>die</strong> <strong>van</strong> <strong>die</strong> algemene populasie vergelyk.<br />
Geen oormatige be1 adi ng op verl oskundige<br />
sowel as op neonatale gesondheids<strong>die</strong>nste is<br />
waargeneem nie. Dit is egter so dat hier<strong>die</strong><br />
pasihte meer angstig oor hul swangerskap en<br />
<strong>die</strong> verloop daar<strong>van</strong> is, en dat dit<br />
waarskynlik ook 'n invloed op <strong>die</strong><br />
verloskundige het. Vandaar <strong>die</strong> besondere hoe<br />
kei sersni tsyfer .<br />
DIE LIPOTROPIESE EAEK VAN INDOOL-<br />
VERBINDINGS<br />
AJ <strong>van</strong> Rensburg en FA MGller<br />
Departement Geneeskundige Fisiologie, <strong>Universiteit</strong> <strong>van</strong><br />
<strong>die</strong> OVS, Bloemfontein<br />
Uit <strong>die</strong> literatwr blyk dat daar deur verskeie navorsers,<br />
uit verskillende weefseltipes, 'n verbinding / verbindin s<br />
gekstraheer is wat lipotropiese effekte besit. Hiercfe<br />
verbinding(s) is tot op hede nog nie geidentifiseer nie.<br />
So is <strong>die</strong> bestaan <strong>van</strong> 'n sogenaarnde 'lipocaic" (wat vet<br />
uit lewer mobiliseer), in 1939 reeds gepostuleer.<br />
Waarnemings in ons laboratorium dui daarop dat <strong>die</strong><br />
metaboliete <strong>van</strong> triptofaan 'n invloed mag M op <strong>die</strong><br />
mobilisering <strong>van</strong> vette uit verskillende weefseltipes.<br />
Aangesien daar destyds min bekend was oor <strong>die</strong> bestaan<br />
<strong>van</strong> triptofaan en sy metaboliete, is dit waarskynlik dat<br />
hier<strong>die</strong> verbindings in vr-e eksperimente onwetend<br />
ge6kstraheer kon gewees het.<br />
Urine <strong>van</strong> normale rotte, onder vastende en normale<br />
voedingstoestande, is versarnel en indoolverbindings is<br />
get%tmheer. Die opbrengs is met behulp <strong>van</strong><br />
dunlaagchromatografie geskei. Die verskillende verbind-<br />
ings is by lewer- en vetweefsel gevoeg, en <strong>die</strong> weefsel is<br />
in Krebs-Ringer-bikarbonaatbuffer geinkubeer. Na<br />
inkubasie is <strong>die</strong> vry vetsure in <strong>die</strong> buffermedim,<br />
gekwantifiseer.<br />
Dit wil voorkom asof hier<strong>die</strong> verbindings groot<br />
hoeveelhede vetsure uit beide <strong>die</strong> lewer a&<br />
vetweefsel, mobiliseer. Hier<strong>die</strong> uitgesproke lipotropiese<br />
effek <strong>van</strong> indoolverbindings kan dus moontlik sekere<br />
onduidelikhede rondom "lipocaic", asook ander<br />
lipotropiene, opklaar.<br />
"--
454 VOL 82 DESEMBER 1992<br />
SAMJ<br />
ARBOVIRUSSE EN HUL GEASSOSIEERDE MUSIi.<br />
VEKTORE IN DIE WESTELIKE ORANJE-VRYSTAA'I<br />
R <strong>van</strong> Staden, MS. Smith (Dept Virologie); T.C. de K.<br />
der Linde (Dept Dierkunde-Entomologic), U(<br />
Bloemfontein.<br />
Arbovirusse word deur bloedvoedende arthropods vek:<br />
waar<strong>van</strong> muskiete <strong>die</strong> belangrikste is, oorgedra.<br />
Gedurende <strong>die</strong> somer en herfs <strong>van</strong> 1974175<br />
buitengewoon baie reen oor <strong>die</strong> grootste gedeelte <strong>van</strong> 5<br />
Afrika geval. Oor <strong>die</strong> droe Karoo, westelike Kaapprov<br />
en <strong>die</strong> <strong>Oranje</strong>-<strong>Vrystaat</strong> het dit gunstige toestande vir<br />
aanwas <strong>van</strong> muskiete geskep. Die gevolg was dat 'n g<br />
epidernie <strong>van</strong> Sindbis, Wes-Nyl en Wesselsbron in <strong>die</strong><br />
<strong>van</strong> <strong>die</strong> land uitgebreek het. 'n Episoonose<br />
Slenkdalkoors het in groot dele <strong>van</strong> <strong>die</strong> land voorgekor<br />
<strong>die</strong> eerste gevalle <strong>van</strong> mortaliteit by <strong>die</strong> mens is aangete!<br />
Die doe1 <strong>van</strong> <strong>die</strong> projek was om <strong>die</strong> ekologie <strong>van</strong> se<br />
muskietspesies en hulle vektorpotensiaal te onders<br />
Muskietpoele bestaande uit 1 tot 55 muskiete, gegroe<br />
volgens spesie en versamel <strong>van</strong>af 1989 tot 1991, is vir<br />
teenwoordigheid <strong>van</strong> arbovirusse deur inokulasie in '<br />
selkulture in vitro ondersoek.<br />
Drie <strong>van</strong> <strong>die</strong> 200 poele wat getoets is, was positie<br />
arbovimsse. A1 drie poele was positief vir Slenkdalkl<br />
vims soos bepaal deur neutralisasietoetse. Die feit d.<br />
min virusse gelsoleer is, mag te wyte wees aan <strong>die</strong> fei<br />
1989 en 1990 besondere droe jare was. Hier<strong>die</strong> stu<strong>die</strong> I<br />
ook bewys dat Slenkdalkoorsvirus in <strong>die</strong> afwesigheic<br />
siekte by <strong>die</strong> mens en <strong>die</strong>r we1 in <strong>die</strong> natuur sirkuleer.<br />
'N EENVOUDIGE MEETMETODE VIR DIE<br />
RUIMTELIKE VERSPREIDING VAN DIE<br />
ENERGIESPEKTRUM VAN ,#E VERSTROOIDE<br />
GAMMASTRALE VANAF 'N mTc PUNTBRON IN<br />
WATER<br />
DE Serfontein, CP Herbst, A <strong>van</strong> Aswegen, MG Liitter<br />
en PH Pretorius.<br />
Dept. Biofisika, UOVS, Posbus 339, Bloemfontein.<br />
Compton verstrooiing benadeel <strong>die</strong> beeldkwaliteit en<br />
<strong>die</strong> akkuraatheid <strong>van</strong> kwantifisering in<br />
sintillasiekamerabeelde, waarmee sekere<br />
siektetoestande in Kerngeneeskunde gediagnoseer<br />
word. Om verstrooiingskorreksietegnieke te evalueer is<br />
dit noodsaaklik om <strong>die</strong> energiespektrum <strong>van</strong> <strong>die</strong><br />
verstrooide fotone by elke punt in <strong>die</strong> beeld sowei as <strong>die</strong><br />
untverspreidingsfunksie (PSF) <strong>van</strong> <strong>die</strong> verstrooide<br />
rotone, te ken. Daarom was <strong>die</strong> doel <strong>van</strong> hier<strong>die</strong> stu<strong>die</strong><br />
om bogenoemde twee groothede te meet en om dan<br />
hier<strong>die</strong> i-ng te gebruik om <strong>die</strong> kanaalverhouding<br />
(KV) verstro "n skorreksietegniek te evalueer.<br />
Metode: 'n puntbron is in 10 energievensters<br />
<strong>van</strong> 2% elk, wat <strong>die</strong> normale 20% energievenster dek,<br />
gebeeld. Dit is herhaal. Sodoende is <strong>die</strong> totale PSF in<br />
eke energievenster bereken. Die totale PSF is toe<br />
geskei in sy primere en verstrooide komponente, deur 'n<br />
eksponensiele passing op <strong>die</strong> stertgedeelte (sle~<br />
verstrooiing) te doen, en dit terug te ekstrapoleer na <strong>die</strong><br />
brongebied waar primere en verstrooide komponente<br />
saarn voorkom. meruit is <strong>die</strong> primere PSF verkry.. Die<br />
ener 'espektrum <strong>van</strong> <strong>die</strong> verstrooide fotone kon<br />
bere en word. Die algoritme vir <strong>die</strong> KV is toe op<br />
hier<strong>die</strong> inligting toegepas en sodoende is 'n skatting <strong>van</strong><br />
<strong>die</strong> verstrooide PSF verkry, wat toe vergelyk is met <strong>die</strong><br />
ware verstrooide PSF. Die totale aantal verstrooide<br />
fotone, sowel as <strong>die</strong> totale aantal primere fotone is ook<br />
bereken en hieruit is <strong>die</strong> verstrooiingsfraksie bereken,<br />
wat vergelyk is met resultate <strong>van</strong> Monte Carlo<br />
sirnulasies uit <strong>die</strong> literatuur.<br />
Resultate: Die gemete verstrooiingsfraksie <strong>van</strong> 462 2<br />
0,09 vergelyk goed met <strong>die</strong> Monte Carlo resultaat <strong>van</strong><br />
456. Die KV-verstrooiingskorreksie oorskat <strong>die</strong><br />
verstrooiing ver <strong>van</strong> <strong>die</strong> bron, teyl dit <strong>die</strong> naby aan<br />
<strong>die</strong> bron onderskat.<br />
Gevolgtrekking: Die getoetste meetmetode is akkuraat<br />
en eenvoudig om toe te pas en aangesien <strong>die</strong><br />
dataverwerking gemaklik op 'n persoonlike rekenaar<br />
edoen is, is dit 'n goedkoo alternatief vir <strong>die</strong><br />
%erekenin@-intensiewe Monte 8 arlo simulasies. Die<br />
resultate <strong>van</strong> <strong>die</strong> meetmetode het sekere tekortkorninge<br />
by <strong>die</strong> KV-verstrooiingskorreksietegniek aangetoon en<br />
daar kan dus nou gepoog word om 'n verbeterde<br />
weergawe <strong>van</strong> hier<strong>die</strong> tegniek te ontwikkel.<br />
'N VERGELYIUNG TUSSEN ESMOLOL EN NATRIUM<br />
NI'I'ROPRUSSIED VIR DIE HANTERING VAN<br />
HIPOTENSIEWE NARKOSE<br />
C Lkbenberg, J Diederieks, R Schall, A Stassen<br />
Departemente Aaestes'ilogie en Biistatistiek, U.O.V.S.<br />
Die doel <strong>van</strong> hier<strong>die</strong> stu<strong>die</strong> was om <strong>die</strong> effektiwiteit,<br />
veiligheid en neweeffekte <strong>van</strong> natrium nitroprussied (NW)<br />
en esmolol te vergelyk warmeer hier<strong>die</strong> middels ebruik<br />
word om hipotensie tydens nark- te induseer. %wintig<br />
pasitnte wie almal oor, neus en keel of plastiese chirurgiese<br />
prosedures ondergaan het, is bestudeer. A1 20 pasitnte was<br />
ASA 1 of 2 mans of nie-SW er vroue tussen <strong>die</strong><br />
9<br />
ouderdomme <strong>van</strong> 18-60 jaar. asiEnte met kliniese<br />
betekenisvolle kardiale, pulmonale, renale of hepatiese<br />
siektes is uitgesluit. Proefpersone het ingeligte slmftelike<br />
toestemming gegee vir deelname aan <strong>die</strong> stu<strong>die</strong>.<br />
Groep 1 het 'n bolus normale soutoplossing gevolg deur 'n<br />
infusie <strong>van</strong> 03% kg/min NNP ontv Die infusietempo is<br />
eke 5 min in dremente <strong>van</strong> O,s&- verhbog tot 'n<br />
maksimum <strong>van</strong> 5 /kg/min of tot &e teiken emene<br />
arteritle bioedmbu?~~~) <strong>van</strong> 80 -g bereik is. &roep 2<br />
het 'n bolus esmolol <strong>van</strong> 5OO&ig onwan$ gevolg deur 'n<br />
infuus <strong>van</strong> 15Opg/kg/mh Laasgenoemde a eke 5 rnin in<br />
idmemente <strong>van</strong> 5Opg/kg/min verhoog tot 'n maksimum <strong>van</strong><br />
35Opg/kg/miu of 'n GAD <strong>van</strong> 80mmHg bereik is.<br />
Harttempo en perifere sumtofversadigiug is deurentyd<br />
gemonitor.
Daar was 'n neighg om <strong>die</strong> teikenbloeddruk ' er met<br />
plNP as met em0101 te bereik, -=tiewe<br />
wolgtrekldngs kon nie op <strong>die</strong> klein getalle edoen word nie.<br />
baa~ was egter mreenkoms tussen csm~lof en in <strong>die</strong><br />
iyd wat dit geneem het om bloeddruk by <strong>die</strong> teikenwaarde te<br />
]IOU (tabel). Dit word toegeskryf aan tagifilakse, waarvwaarvoor<br />
bekend is.<br />
NNP ESMOUlL verskil 9546Vergonens<br />
interval vir <strong>die</strong><br />
verska<br />
ndbt 3 min 103 min 73min -20 tot 1<br />
GAD<br />
m-m<br />
Qd tot l0 min 125 min 2,!5 min -13 tot 8<br />
GAD<br />
80mmHg<br />
yir >3 min<br />
h 7 uit 10 gevalle is <strong>die</strong> teikenbloeddruk bereik met<br />
i , S&-lmin-1 NNP of minder en in 9 uit 10 evalle is <strong>die</strong><br />
met 25-lmin-1 of min%r esmolol.<br />
Tagkude IS beskou om teemoordig te wees in<strong>die</strong>n <strong>die</strong><br />
verskil tussen <strong>die</strong> gemene hartqmd tydens <strong>die</strong> 7de tot a te<br />
minuut periode <strong>van</strong> <strong>die</strong> infusie en <strong>die</strong> eerste minuut meer as<br />
was. Ses pasiEnte in pep 1 het 'n<br />
gehad teenoor geen pasiEnte in groep 2<br />
suurstofdesaturasie of ander newe-<br />
effekte is in enige <strong>van</strong> <strong>die</strong> groepe gemerk nie.<br />
mltiple Endocrine Meoplasia Type 2B:<br />
Report of a 13 year old female<br />
WF Mollentze, S Jansen, R Barry, M Koning,<br />
J Kuyl, A Kruger, M Wolfaardt, H Pelser, L<br />
Wolmarans, C Nel, J Rossouw, R de Lange<br />
Bloemfontein MEN Study Group, OFS<br />
The clinical findings of a patient with<br />
multiple endocrine neoplasia type 2B (MEN<br />
2B) are presented. Hypotonia was present<br />
at birth. At age 10 years the mother<br />
noticed a lump in the girl's neck.<br />
Subsequent lobectomy and histology lead to<br />
the diagnosis of medullary carcinoma of the<br />
thyroid, and MEN 2B. A total thyroidectony<br />
was performed one year later and thyroid<br />
hormone replacement therapy instituted.<br />
She was then referred to our study group<br />
for follow-up investigations. The patient<br />
was the only affected member of the family.<br />
On examination she displayed the typical<br />
phenotype of MEN 2B. A combined calcium<br />
chloride / pentagastrin calcitonin<br />
stimulation test was performed. The basal<br />
serum calcitonin concentration was 124<br />
pg/ml and the maximum -stimulation<br />
concentration 762 pg/ml. rf"I MIBG scan<br />
of the neck was performed and activity<br />
noted in the suprasternal area. Re-<br />
exploration of the area of interest was<br />
undertaken and some residual thyroid tissue<br />
was removed. No clinical metastases were<br />
noted on operation. Repeat calcitonin<br />
stimulation testing revealed a basal serum<br />
concentration of 123 pg/ml and a 9 minute<br />
concentration of 1310 pg/ml. These results<br />
indicated subclinical metastases.<br />
VOL 82 DECEMBER 1992 455<br />
SAMJ<br />
AMBULATORY BLOOD PRESSURE M0NFM)RING IN<br />
MILD TO MODERATE HYPERTENSION TREATED<br />
WITH A L ONGANG NISOLDIPINE TABW<br />
FORMULATION<br />
F0 Miiller*, HG bus, DP Myburgh, LH Opie, C Rosendorff, P<br />
Sareli, DJV Weich<br />
South African Multi-Centre "ANCHOR" Study<br />
*Department of Pharmacology, Faculty of Medicine, University<br />
of the Orange Free State, Bloemfontein. South Africa<br />
Non-invasive ambulatory monitoring of blood pressure<br />
(ABPM) was employed to assess the 24-hour profile of blood<br />
pressure in 137 out-patients aged 20 to 74 years (mean 52.4)<br />
with mild to moderate arterial hypertension and normal day-<br />
night activity cycles The technique was further used to measure<br />
the blood pressure response to nisoldipine (NIS), a<br />
dihydropyridiie calcium antagonist. This was a 10 week<br />
(including a 4-week run-in period), multicentre, randomized,<br />
placebo controlled, parallel group comparison of once daily<br />
(mane) NIS 'CoatCore' (long-acting formulation) 10mg 20mg<br />
and 30mg, conducted from January through December 1990 in 5<br />
centres. Baseline (week 4) ABPM showed that all the patients<br />
had circadian curves of established arterial hypertension.<br />
Variables calculated from ABPM Mean values (standard<br />
deviation). Diastolic blood pressure = DBP; Systolic blood<br />
pressure = SBP.<br />
Me= (SW<br />
change (0-24) in<br />
SBP (mm Hg) at<br />
week 10 from<br />
barelioe<br />
Mean (SD) SBP<br />
(mm Hg! (0-24)<br />
at week 10<br />
NIS 1bg<br />
0 0 0<br />
-5.2(55)<br />
88.7(73)<br />
-9.2(96)<br />
138.6<br />
(12.4)<br />
NIS %g<br />
-9.q.1)<br />
83.475)<br />
-15q115)<br />
1373<br />
(115)<br />
NIS 3 bg<br />
-8.q7.2)<br />
833(7-6)<br />
-1431 1.9)<br />
h this population, clinically acceptable blood pmswe lowering<br />
by NIS 'CaatCore' over a -our period was demonstrated<br />
over the entire dose range. Heart rate was not influenced at any<br />
dose level and adverse drug reactions were negligible.<br />
Verhoogde- sekretoriese aktiwiteit en <strong>die</strong><br />
mikrotubulere netwerk <strong>van</strong> B-selle <strong>van</strong> <strong>die</strong> pankreas<br />
A Crous, AM de Beer, EJ Visser 81 LJ Duyvene de Wit<br />
Depte. Geneeskundige Fisiologie en Anatomiese<br />
Patologie, <strong>Universiteit</strong> <strong>van</strong> <strong>die</strong> OVS, Bloemfontein<br />
'n Funksionele mikrotubul8re stelsel as intrasellulQre<br />
organel is essensieel vir volgehoue insulienvrystelling uit<br />
B-selle <strong>van</strong> <strong>die</strong> pankreas . Die doe1 <strong>van</strong> <strong>die</strong> ondersoek<br />
was om <strong>die</strong> organisasie <strong>van</strong> sitoplasmiese mikrotubuli<br />
tydens verhoogde sekretoriese aktiwiteit te monitor.<br />
h-
$56 VOL 82 DESEMBER 1992<br />
METODES: Rot-eilandweefsel is in vivo asook in vitro<br />
met glukose gestimuleer waarna weefselmonsters<br />
geneem is om beide fases <strong>van</strong> <strong>die</strong> insulien-<br />
vrystellingsrespons te verteenwoordig. Elektron-<br />
mikrograwe (x40 000) <strong>van</strong> individuele B-selle is in<br />
montage saamgestel ten einde vdledige selprofiele teen<br />
h06 vergroting te konstueer. Deur morfornetriese analise<br />
is <strong>die</strong> totale sowel as regionale verspreiding <strong>van</strong><br />
mikrotubuli vir elke betrokke sel bepaal.<br />
RESULTATE: Mikrotubuli was nie ongeorden in <strong>die</strong><br />
sitoplasma versprei nie, dog in 'n spesifieke<br />
verspreidingspatroon georganiseer. Onder bade<br />
ornstandighede was <strong>die</strong> mikrotubulQre verspreidings-<br />
digtheid in <strong>die</strong> subplasmalemma-area relatief her as in<br />
<strong>die</strong> perinukldre gebied. Hier<strong>die</strong> verspreidingspatroon<br />
het gedurende <strong>die</strong> eerste (vinnige) fase <strong>van</strong> glukose<br />
gestimuleerde insulienvrystelling, onveranderd gebly.<br />
Gedurende <strong>die</strong> tweede (volgehoue) vr)fstellingsfase het<br />
'n verskuiwing in <strong>die</strong> mikrotubulere verspreiding<br />
plaasgevind. Die persentasie mikrotubuli in <strong>die</strong><br />
perinukldre en subplasmalemma-areas is onderskeidelik<br />
her en laer aangepas. Geen betekenisvolle verandering<br />
het in <strong>die</strong> sentrale sitoplasma voorgekom nie. Die totale<br />
mikrotubulQre inhoud <strong>van</strong> <strong>die</strong> selle het deurgaans<br />
konstant gebly.<br />
GEVOLGTREKKING: Uit <strong>die</strong> resultate word afgelei dat<br />
vrystelling <strong>van</strong> sekresiegranules geposisioneer digby <strong>die</strong><br />
selmembraan, geen modulasie in <strong>die</strong> mikrotubuldre<br />
stelsel verg nie. Volgehoue vrystelling <strong>van</strong> insulien (wat<br />
aktiewe transport <strong>van</strong> sekresi ranules <strong>van</strong>af <strong>die</strong> Golgi-<br />
area na <strong>die</strong> selmembraan vere3 word egter verged <strong>van</strong><br />
o5nskynlik doelgerigte organisatoriese veranderinge in<br />
<strong>die</strong> mikrotubuiQre sisteem. Sekretoriese aktiwiteit kan<br />
dus verhoog, terwyl <strong>die</strong> selluldre tubulien-mikrotubulus<br />
ewewig (mikrotubulQre inhoud) nie gewysig word nie.<br />
FANCONI ANAEMIA - A CLINICAI+ CYTOGENETIC<br />
AND MOLECULAR GENETIC INVESTIGATION OF<br />
SOUTH AFRICAN FAMILIES<br />
T. Pears04 l, M woIfaardt1, c.pnga2, S. Jansen<br />
1 ,<br />
C.Math .<br />
1. Division of Human genetics,<br />
2. De t. of Paediatrics, UOFS, Bloemfontein,<br />
3. 9 edical and Molecular Genetics, Guy's hospital,<br />
Fanconi Anaemia (FA) is a rare autosod recessive<br />
genetic disorder showing progressive bone marrow failure,<br />
and various phenotypic abnormalities. The lymphocytes<br />
show an increased sensitivity to the clasto enic agents<br />
<strong>die</strong>poxybutane (DEB) or mytomycin C (MM&, measured<br />
as chromosomal aberrations. The latter is used to confirm<br />
the clinical diagnosis of FA homozygotes, but<br />
heterozygotes and non-carriers cannot be idenbfied.<br />
The gene(s) which are mutated in this disorder have not<br />
been identified, but a defect in some aspect of DNA repair<br />
is suspected. Mann et al have suggested that FA is<br />
genetically hetero eneous, with one FA gene being located<br />
on chromosome &U.<br />
FA patients were identified according to their clinical,<br />
haematologic and cytogenetic appearance. Results<br />
obtained from the above criteria are m accordance with<br />
the literature. Molecular results shown firm roof for the<br />
existence of genetic heterogeneity in FP A but less<br />
convincing evidence with respect of gene localization.<br />
RFLP- AND PCR-ANALYSIS OF MEN 1 FAMIIdES<br />
H.F. F.n, U Wolfaardf S. Jansen, W.F. MnllencrP.,<br />
R H. Pelser, L Wolmaram, R delLange, CJ-C.<br />
4 , M er, RV. Thakker<br />
Faculty of Med~cine, U%, B1oemfontein<br />
1. Hammersmith Hospital, London<br />
Familial multiple endocrine neo lasia type 1 (MEN 1) is<br />
an autosod dominant disorgr characterized .by the<br />
combined occurrence of tumors of the oids, the<br />
pancreas, and the pituilifuy. Previously m ter , we used<br />
three Restriction fragment length polymo hism m)markers<br />
to detect gene carriers for &l. This<br />
technique is time-consllmin& especially when results are<br />
required with ur ence. As an alternative, the<br />
chain reaction (h)-technique was used, yie p"lwer= ding faster<br />
and better results.<br />
Three RFLP markers and two sets of PCR primers were<br />
used to detect gene carriers in MEN 1 farmlies. Results<br />
obtained with W-merkers, PCR-primers and<br />
biochemical screening, were compared<br />
I~STIOATION OF A POSSIBLE<br />
ImRACTION BETWEEN WARFARIN AHD<br />
SFEPPIROME<br />
N de la Rey, BH Meyer, FO Miiller,<br />
HG Luus,<br />
PN ~adenhorst+, E ~renke**<br />
Departments of Pharmacology and<br />
~aematolo~~+, University of the<br />
Orange Free State, Bloemfontein,<br />
%$public of South Africa.<br />
Hoechst AG, Frankfurt, Federal<br />
Republic of Germany<br />
Introduction<br />
Cefpirome (HR 810) is a new<br />
cefotaxime-like cephalosporin of the<br />
third generation for parenteral use.<br />
It has a broad spectrum of activity<br />
and is active against bacterial<br />
strains which are frequently<br />
resistant to third generation<br />
cephalosporins. In view of the fact<br />
that many patients have to take oral<br />
anticoagulants on a regular basis and<br />
that many drugs interact with<br />
anticoagulants, the question arose<br />
whether cef pirome may elicit<br />
detrimental effects due to<br />
interaction with warfarin.<br />
Aim<br />
The aim of the study was to assess<br />
the effects of cefpirome on the<br />
pharmacodynamics of warfarin.<br />
Methods<br />
Fourteen healthy male volunteers<br />
participated in this randomised,<br />
placebo-controlled, cross-over study.<br />
Cefpirome (l g v.) or placebo was<br />
given twice daily, on a randomised<br />
basis, from Day 1 through 6 of each
phase. On Day 3, a single dose of<br />
25mg warfarin was administered<br />
grally . Blood samples for<br />
c3etermination of prothrombin time<br />
(PT) and factors 11, V11 and X<br />
activity were taken before and 12,<br />
24, 36, 48, 72, 96, 120 and 144 hours<br />
after medication of warfarin. A<br />
piash-out period of 14 days was<br />
allowed between warfarin doses.<br />
Results<br />
Mean values<br />
Warfarin Uarfarin Point<br />
& +olacebo +cef~irome estimate (Cl#<br />
PT (Day.sec) 117 113 97 (93 - 102)<br />
factor 11
458 VOL 82 DESEMBER 1992<br />
SAMJ<br />
2 D~~INI <strong>van</strong> aFstewa in<strong>die</strong>n bekend.<br />
S Toesrandtyderrrlaastebesoek. HG Lu F0 Miiller, DP Myburgh, LH Opie, C<br />
km P Sneli, YK D Weich F Baaa and J<br />
m k e m * a ~ i W p m~ e<br />
gesterf het sonder dab <strong>die</strong> hospitaal in kennis gestel is as& modike<br />
vemuishg mst anafgelewerde telegramme. Baumann<br />
Die mdtab <strong>van</strong> <strong>die</strong> stud& was as vdg: South African Multi-Centre "ANCHOR* Study.<br />
pasiente %) was F Department of Pharmacology, University of the OFS,<br />
waat<strong>van</strong><br />
Bloemfontein RSA<br />
32 143.8 %) binne 6 maande<br />
15 i20.5 %j m 6 - 12 maande<br />
l4(19.l%)nal tot2jaar<br />
20 (19.2 %) Is oorlede : 11 (55 %) binne 1 jaar<br />
~(40%)<br />
m1-2jaar INTRODUCIION: Nisoldipine is a new calcium channel<br />
%) het nog Hewe gehad blocker belonging to the same chemical group as<br />
nifedipine. It has been under clinical investigation for its<br />
ha<br />
G E V O L G ~ ~ me met<br />
senrikskarshoom (70.2 %) was m 6 jaar veriore vir opvdg. Die swak anti-angina and antihypertensive effects since '1981. Many<br />
oprdg het tot '- dat <strong>die</strong>- W koste behandeling <strong>van</strong><br />
V nie optimaal deur padhte benut word nie. Hie<br />
bevindhgs hw emstige bnplikasies in vir mvorsing oor hier<strong>die</strong><br />
stu<strong>die</strong>s- have failed to demomtrate control of blood<br />
'N ANALISE VAN NIE<br />
DIAGNOSTIESE RiiNTGEN<br />
OPNAMES<br />
C Barnard Departement Diagnostiese<br />
Radiologie, Universteit <strong>van</strong> <strong>die</strong><br />
<strong>Oranje</strong>- <strong>Vrystaat</strong> / Universitas<br />
Hospitaal, Bloemfontein.<br />
Die doel <strong>van</strong> <strong>die</strong> pmjek was om <strong>die</strong><br />
volgende te be@<br />
1) Perxntasie en koste <strong>van</strong> films wat<br />
agv. 0-e<br />
beeldkwaliteit weggegooi word<br />
2) Oorsake vir onaawaarbare<br />
beeldhualiteit<br />
MEIODE: 'n Analise <strong>van</strong> <strong>die</strong><br />
weggooifilms is &a& oor 'n<br />
periode <strong>van</strong> vier weke uitgevoer. Die<br />
aantal films per ondersoek gebruik en<br />
weggegooi is dew <strong>die</strong> radiograaf wat<br />
<strong>die</strong> ondenoek gedoen het,<br />
aangeteken.<br />
RESULTAAT: 'n Totaal <strong>van</strong> 8 5%<br />
films is gebtuik waar<strong>van</strong> <strong>die</strong> volgendf<br />
weggegooi is: 2 463 films agv<br />
-bare beeldkwaliteit, 3T<br />
6lms &&v. donkerkamedoute en<br />
toe- op X-straalapparaat 28.61%<br />
<strong>van</strong> radiogra6ese opnames word ag.v.<br />
0-e beeldkwaliteit herbal.<br />
Die totale persentasie film wat<br />
weggegooi 4 was 31,61% wat 281%<br />
vierkante meter film is, met 'n<br />
filmkoste <strong>van</strong> R6 035.17.<br />
Te bi5 beelddigtheid: 21.76%<br />
Te lae beelddigtheid : 2229%<br />
Posisionering : 3678%<br />
Beweging : Z8%<br />
Pr-ring : 138%<br />
Ander : 14,98%<br />
GGVOKTREKKING: Die totaal <strong>van</strong><br />
31,61% film wat weggegooi is, is<br />
onaanvaarbaar hoog en bring <strong>die</strong><br />
geskane koste op meer as R70 000 per<br />
jaar te staan Daar bestaan nie 'n<br />
norm vir 'n aanvaarbare penentasie<br />
fib wat weggegooi word nie, maar 'n<br />
aanvaarbare persentasie vir 'n<br />
Departement waar geen vorm <strong>van</strong><br />
kwaliteitskon!mle toegepas word nie,<br />
is in <strong>die</strong> omgewing <strong>van</strong> 12% 'n<br />
Dringende behoefte vir 'n<br />
kwaliteitskontrole pmgmn en<br />
in<strong>die</strong>nsopleiding is geidentifiseer om<br />
<strong>die</strong> persentasie film wat weggegooi<br />
word, te verminder.<br />
pressure for 24 hours with a single daily dose of<br />
nisoldipine in an ordinary tablet formulation. A new<br />
galenic formulation of nisoldipine, the longer acting<br />
nisoldipine coat-core (NE) tablet, is now being<br />
investigated for once daily treatment of patients with<br />
hypertension and angina.<br />
AIM The main objective of this study was to compare the<br />
antihypertensive effect and safety of three daily doses of<br />
NIS, namely lhg, 20mg and 30mg with placebo in<br />
patients with mild to moderate hypertension (baseline<br />
supine diastolic blood pressure of between 95 and 1 l4 mm<br />
Hg).<br />
STUDY DESIGN: Following a four-week single-blind<br />
placebo run-in period, 208 patients (2 were not evaluable)<br />
from 7 centres were randornised to either placebo (n=58)<br />
for six weeks, NIS lOmg (1149) for 6 weeks, NIS l0mg<br />
for l week and NIS Uhng (n=51) for 5 weeks, or NIS<br />
l0mg for 1 week and NIS 30mg (n=48) for 5 weeks.<br />
Patients visited the clinic at weeks -4, -2,O (baseline), 5 4<br />
and 6 during which trough supine and standing blood<br />
pressure and supine heart rates were measured. The supine<br />
diastolic blood pressure @BP) at the last valid visit was<br />
the main efficacy criteria<br />
RESULTS: Efficacy: The mean difference (95%<br />
confidence interval) of "m-PIA" in the change from<br />
baseline of supine DBP was<br />
-3.2 mm Hg (-5.9 to -0.5 mm Hg) between PIA and NIS<br />
lhg<br />
-6.7 mm Hg (-9.3 to -4.0 mm Hg) between PLA and NIS<br />
20mg<br />
-8.0 mm Hg (-10.7 to -5.3 mm Hg) between PLA and MS<br />
3bg<br />
There were 17% responders (patients in whom supine<br />
DBP dropped by at least 10 mm Hg, or who had a supine<br />
DBP of 90 mm Hg) in the PLA group, 35% in the NIS<br />
lOmg group, 47% in the NIS 2Omg group and 63% in the<br />
NIS 30mg group.
fhfcty analysis: The percentage of patients experiencing<br />
at least one adverse event in the PLA, NIS 10mg NIS<br />
-g and NIS 30mg groups was 4096,41%, 30% and<br />
M% respectively. The most fkequently reported adverse<br />
event was headache.<br />
CONCLUSION: Nisoldipine coatcore at dosages of<br />
'-g and 30mg once daily was effective as compared to<br />
placebo in reducing blood pressure in patients with mild to<br />
moderate hypertensions. The effect of the lOmg dose was<br />
smaller. The study confirmed that nisoldipine, in these<br />
dosages, is a safe and well-tolerated agent; the incidence<br />
md severity of adverse events were commensurate with<br />
other antihypertensive agents.<br />
STAFF RADIATION DOSES DURING SEVEN YEARS<br />
IN A NUCLEAR MEDICINE RADIOPHARMACY.<br />
SE Jansen, A <strong>van</strong> Aswegen, CP Herbst, MG Utter and<br />
Biophysics and Nuclear Medicine Departments,<br />
University of the Orange Free State, Bloemfontein,<br />
South Africa.<br />
Data on radiation doses to staff in the radiopharmacy<br />
and nursing staff responsiile for injecting radionuclides<br />
were gathered for seven years. In addition to the<br />
compulsory dosemeters issued monthly by the South<br />
African Bureau of Standards' Radiation Protection<br />
Service (RPS), radiation doses received on the hands<br />
and whole body were monitored by lithium fluoride<br />
thermoluminescent dosemeters (TLD) every week. The<br />
workload (number of patient stu<strong>die</strong>s each year) and-the<br />
estimated amount of Tc-99m received per month were<br />
also established. The highest total radiation dose<br />
received in any one year by any one person was 22353<br />
mSv on the hands, and 1020 mSv and 837 mSv to the<br />
whole body dependent on the dosemeter used. The<br />
radiation doses to staff were well within the limits<br />
prescni this is attributed to the practice of<br />
maintaining a high awareness of radiation safety and<br />
meticulous training and rotation of staff in the<br />
radiopharmaq.<br />
VOL 82 DECEMBER 1992 459<br />
SAMJ<br />
'N VERGELYKING VAN DIE<br />
BEELDINGSEIENSKAPPE VAN ITERATIEWE EN<br />
TERUGPROJEKSIE TOMOGRAFIESE<br />
REKONSTRUKSIE TEGNIEKE D.M.V. OWK<br />
ANALISE<br />
H Naude. C.P. Herbst, A <strong>van</strong> Aswegen, MG Utter.<br />
Dept Biofisika, UOVS, Posbus 339, Bloemfontein.<br />
Enkelfotonemissietomografie beelde wat dew middel<br />
<strong>van</strong> iteratiewe tegnieke gerekonstrueer is besit beter<br />
kwantitatiewe eienskappe as beelde wat met <strong>die</strong><br />
- teruwrojeksie tegnieke verkry is. Die doe1 <strong>van</strong> <strong>die</strong><br />
stu&e was om ook <strong>die</strong> kwalitatiewe eienskappe <strong>van</strong><br />
iteratiewe en terugprojeksie rekonstruksie tegmeke met<br />
mekaar te ver elyk deur <strong>van</strong> ont<strong>van</strong>ger<br />
waarnemingskenmerf (OWK) analise gebruik te maaL.<br />
'n Standard breinfantoom is met 99q~ gevul.<br />
Vullingsdefekte is ewekansig o 5 verskillende posisies<br />
veroorsaak. 'n Totaal <strong>van</strong> 30 a 1 normale en 45 normale<br />
areas is gebruik. 64 beelde is tomografies deur 360<br />
grade versamel en d.m.v. beide <strong>die</strong> iteratiewe en<br />
terugprojeksie tegnieke op 'n SUN werkstasie<br />
gerekonstrueer. Die moontlike abnormale areas is<br />
visueel volgens 'n 5 punt skaal gegradeer en gebruik om<br />
OWK krommes te genereer.<br />
Die resultate toon am dat <strong>die</strong> iteratiewe tegnieke<br />
beelde lewer met struktuur wat met di6 <strong>van</strong> planare<br />
beelde ooreenstem. Die oppervlaktes onder <strong>die</strong> OWK<br />
krommes vir <strong>die</strong> iteratiewe tegniek was 495 en <strong>die</strong><br />
volgens <strong>die</strong> terugprojeksie 0,936 wat daarop dui dat<br />
beter resultate met <strong>die</strong> iteratiewe tegnieke verb word.<br />
Iteratiewe rekonstruksie word dus aanbeveel waar dit<br />
prakties moontlik is.<br />
"h VERGELYKING OM DIE EFFEKTIWITEIT VAN h<br />
ULTRASONIESE NEBULISEERDER EN h AeRObOL=<br />
SISTEEM DEUR MIDDEL VAN ISOTOOPINASEHING<br />
TE BEPAAL. "<br />
R.Y. <strong>van</strong> den Berg , E. Fourie. A. Haarhoff.<br />
D. Knekemoer, Departement F isioterap ie .<br />
Die doe1 <strong>van</strong> <strong>die</strong> stu<strong>die</strong> is om <strong>die</strong> "Meda=<br />
snn i c Scn ior Drugnebul izer" --- ultra=<br />
snnissc nebul iseerder met <strong>die</strong> "Resp i-Neb"<br />
--- akrnsnlsisteem te vergelyk deur middsl<br />
<strong>van</strong> <strong>die</strong> inaseming <strong>van</strong> isotope.<br />
15 Proefpersone bo 20 jaar, <strong>van</strong> fnigs<br />
geslag, met normale longfunksies sonaer<br />
enige longpatologiek is gebruik. Elkc<br />
proefpersoon is vir 10 minute met dis<br />
Medasnnic genebuliseer en na h week met<br />
<strong>die</strong> Respi-Neb. In albei gevalle is h op=<br />
lnssing <strong>van</strong> isotope en saline gebruik. h<br />
Posterior statiese beeld <strong>van</strong> twee minute<br />
is direk na nebulisering <strong>van</strong> elke pro$f=<br />
personn geneem, waarna <strong>die</strong> isotoopdistri=<br />
busie <strong>van</strong> albei longe op <strong>die</strong> rekenaar<br />
vasgel? is deur gebruik te maak <strong>van</strong> <strong>die</strong><br />
garnmakame ra .<br />
Uit <strong>die</strong> resultate is h hoogsbeduiaenae<br />
verskil in effektiwiteit tussen aie twee<br />
apparate. verkry wat daarop dui aat <strong>die</strong><br />
"Medasonic Senior Drugnebul izer" meer<br />
effektief is as <strong>die</strong> "Respi-Neb".<br />
.<br />
7
460 VOL 82 DESEMBER 1992<br />
SAMJ<br />
DRUGS IN SPORT: RESULTS OF THE PAST 6<br />
YEARS OF DOPE TESTING IN SOUTH<br />
AFRICA<br />
P J Van Der Merwe, H S% Kruger<br />
Department of Pharmacology<br />
University of The Orange Free State<br />
Bloemfontein<br />
Screening procedures were performed on 2066 urine<br />
specimens collected from competitors in 17 different sports<br />
during the period 1986 - 1991. Samples were tested for-the<br />
presence of stimulants, narcotics and anabolic steroids by gas<br />
chromatography and gas chromatography/mass<br />
spectrometery.<br />
Drugs classified as forbidden substances by the International<br />
Olympic Committee were detected in 113 (5,5%) of the<br />
samples Fencamfamine was the stimulant detected most<br />
frequently and 19-nortestosterone the anabolic steroid<br />
detected most frequently. The ephedrines as a group<br />
accounted for 35 (31,0%) of the urine samples containing<br />
banned substances.<br />
This high incidence of the use of banned substances indicates<br />
that the dope testing program to curb their use by competitors<br />
in sport, should continue and be expanded to other sports.<br />
RISIKOFAKTORE VAN KORONeRE<br />
HARTVATSIEKTE.<br />
GRAAD, INSIDENSIE EN DIE INVIDED VAN<br />
LEWENSWYSE DAAROP<br />
A de Wad, MS Calitz*. Departement Farmakologie, UOVS<br />
Departement Huisartskunde, UOVS<br />
Inkicaing<br />
Die insidensie <strong>van</strong> miokardiale hfarksie onder <strong>die</strong> Suid-<br />
Afrikaanse bevolking is ontstellend hoog en <strong>die</strong> bestuder@ <strong>van</strong><br />
<strong>die</strong> betrokke risikofaktore is <strong>van</strong> Lardinale belang.<br />
Docl<br />
Hier<strong>die</strong> stu<strong>die</strong> is onderneem om 'n aanduiding te verkry <strong>van</strong> <strong>die</strong><br />
insidensie <strong>van</strong> <strong>die</strong> onderskeie algemene risikofaktore en om vas<br />
te stel tot watter mate deelnemers gemotiveer kan word om hul<br />
lewenswyse so aan te pas dat <strong>die</strong> graad <strong>van</strong> <strong>die</strong> risikofaktore<br />
verminder kan word<br />
Metode<br />
Ecn honderd, klaarblyklik gesonde manspersone, tussen 40 en<br />
45 jaar in 'n stedelike omgewing is ondersoek vir risikofaktore<br />
<strong>van</strong> kom6re hartvatsiekte naamlik hipercholesterolemie,<br />
hipertensie, familiele geskiedenis <strong>van</strong> koronSre hartvatsiekte,<br />
fiksheidsgraad, oormassa en rookgewoonte. Die resultaat <strong>van</strong><br />
eke deelnemer se ondersoek is visueel aan horn met behulp <strong>van</strong><br />
'n rekenaarprogram wat vir dik doel ontwikkel is, voorgestel en<br />
<strong>die</strong> deelnemer is gemotiveer om risikofaktore, Mien<br />
teenwoordig, te elimineer, of om sy lewenswyse so aan te pas<br />
dat <strong>die</strong> graad <strong>van</strong> 'n betrokke risikofaktor verminder kan word.<br />
Die betrokke persone is na vedoop <strong>van</strong> een maand<br />
geherevalueer.<br />
Resultate<br />
Dit is bevind dat daar by %% <strong>van</strong> <strong>die</strong> proefpersone ten minste<br />
een <strong>van</strong> bogenoemde risikofaktore teenwoordig was 60% <strong>van</strong><br />
<strong>die</strong> proefpemne kon met aanpassing in hul lewenswyse 'n<br />
verandering in <strong>die</strong> graad <strong>van</strong> risikofaktore te weeg bring.<br />
PLAATJIEFUNKSIE, STOLLING EN FIBRINOLISE IN<br />
PASIENTE OP CHRONIESE PERITONEALE EN<br />
HEMODWSE<br />
V. yan Wvk, H.F. Kotzt, P.N. Badenhorst, KC. Alexander<br />
en -B.P. Botha<br />
Departement Hematologie en h eme <strong>Geneeskunde</strong>.<br />
Abnormale bloedin$neigings is algemene komplikasies by<br />
pasiente met chromese nierversakin . Ten spyte hieman is<br />
aterosklerose steeds een <strong>van</strong> <strong>die</strong> hookorsake v-<br />
by hier<strong>die</strong> pasiente. Die doel <strong>van</strong> hier<strong>die</strong> stu<strong>die</strong> was om<br />
hkmostase iolledig te ondersoek in pasiente met cluoniese<br />
nierversaking (CNW. Plaatiiefunksie, stolling en fibrinolise<br />
is gemeet. viertien ~~vpasi~nte (kreaeen opruiming<br />
< lOml/min), is in <strong>die</strong> stu<strong>die</strong> ingesluit. Sewe asiente was op<br />
chmniese ambulatoriese peritoneale dialise [CAPD) en 7 op<br />
instandhoudingshemodialise (HD). Die gemidelde<br />
plaatjietelling <strong>van</strong> <strong>die</strong> CAPD-pasiente was 288+55x109/1,<br />
Hb: 9.8?1.9g/dl en plasma-urelm en keatinien<br />
202 2mmol/l en 988 ?261pmol/l onderskeidelik Die<br />
gemiddelde plaatjietehg <strong>van</strong> <strong>die</strong> HD-pasiente was<br />
189+45x109/1 Hb. 8.8? 1.5g/dl ea plasma-ureum en -<br />
kreatinien 28 2 71ll11lol/l en 1101 i 570umol/l onderskeidelik.<br />
Die resultate word gegee as <strong>die</strong> mediaan (Med.) en<br />
reikwydte (R.W.).<br />
Meting CAPD HD Normaal<br />
Med. R.W. Med. RW. Med. R.W.<br />
Bloeityd(minute) 75 3.7-20.0 55 3.0-10.0 5.0 35-7.0<br />
W%) 155 105-265 4.0 15-8.0 75 1.0-15.0<br />
SPAV 0.B 0.664.83 089 0.78-0.96 0.91 081-1.0<br />
Plasminogeen(%) 116 94-U5 101 70-120 % 82-108<br />
&~ntiplasmien(%) 116 68-143 94 80-1l3 105 W107<br />
p'4I@/min) 0.0 0.0-9.0 25 0.0-35 15 0.0-5.0<br />
t-PA(E/&) 9 4-14 3 1-10 5 110<br />
SA =. Spontane Agppk<br />
SPAV = Sikulerende plaatjie aggregaat verhoudiag<br />
PT = Protromb'intyd<br />
F+lT = Par&% tromboplastien tyd<br />
PAI = Piasminoga aldmeerder inhibeerder<br />
t-PA = Weefsel plasminogeen aldiveerder<br />
In vitm-aggregasiestu<strong>die</strong>s het getoon dat plaatjies <strong>van</strong> beide<br />
<strong>die</strong> asiEntgroepe meer sensitief was vir laer konsentrasies<br />
AD%. Die bloe~tye <strong>van</strong> veral <strong>die</strong> CAPD pasiente was effens<br />
verleq. Dit was egter nie klinies betekenisvol nie, en kan<br />
ook me toegeskryf word aan <strong>die</strong> verlaagde plaatjiefunksie<br />
nie. Dit kan egter moontlik gedeeltelik toegeskryf word aan<br />
anemie. Die plaatjie-hiprreaktiwiteit kan klinies belae wees aangeslen hierdle pasiente 'n h& insidensie <strong>van</strong><br />
aterosklerose en kardiovaskulEre siekte het. Dit wil ook<br />
voorkom asof <strong>die</strong> CAPD-pasiEnte 'n groter kans het om<br />
aterosklerose te ontwikkel as <strong>die</strong> HD-pasiEnte.
-<br />
geinedre E Otto A.C. Dun M.<br />
~kpartmenf of Nudear Medicine Bloemfonteia.<br />
Stable labem of polydonal immunoglobulin with Tc 9hn can be done in a<br />
simple, relatively ;.expensive and safe manner. Rislrs of dLed handiing of<br />
blood are reduced and the procedure is less time consuming.<br />
-fhe purpose of this study was to compare the effectivity of the two above-<br />
flentioned techniques to localise ' " ation.<br />
f-Zteen patients with a h@yobabillity of a localized inflammatory process<br />
Mere examined with a Tc - HMPAO white cell study. On completion of<br />
tbe study written consent was obtained from each and a Tc . whrdonal .<br />
1g~studywasdonewithin48ho~~~ofthefirststu~.<br />
Results are summarized in Table l.<br />
'ABLE 1.<br />
AREA OF I NO. OF PT.<br />
INFECIlON CELLS<br />
POS/NEG<br />
SKELETAL 5 4 1<br />
ABDOMINAL 5 2 3<br />
PULMONAL 5 4 1<br />
Comparative images of the different techniques will be displayed.<br />
CONCLUSION-,<br />
Tc 99~labe~ed white blood cells showed better ability to detect and localise<br />
inflammatory processes in the lungs.<br />
Although the two techniques showed good comparison for detection of<br />
abdominal infedions the target-to-background ratio was consistently lower<br />
with labelled IgG.<br />
Both techniques showed reasonable efficacy for deteding peripheral skeletal<br />
inflammatory disease<br />
DIE EFFEK VAN VWTRAAGDE SKEIDING VAN<br />
BJXEDWONSTERS OP KREATINIEN OPRUIHING<br />
H.J. <strong>van</strong> Wvk, A.J. Groenewald, H. Viljoen<br />
Serum kreatinienkonsentrasies en<br />
kreatinienopruiming word algemeen in <strong>die</strong><br />
kliniese praktyk gebruik om glomerul&re<br />
funksie te beoordeel. Daar is egter baie<br />
analitiese en pre-analitiese faktore wat<br />
plasma kreatinien en kreatinienopruiming<br />
minder geskik maak vir hier<strong>die</strong> doel. Van<br />
<strong>die</strong> pre-analitiese faktore sluit ondermeer<br />
onakkurate kolleksies en veranderinge in<br />
plasma kreatinienkonsentrasies met verhoogde<br />
inname <strong>van</strong> protexne in. Onlangse<br />
literatuurstu<strong>die</strong>s toon dan ook In styging<br />
<strong>van</strong> kreatinienkonsentrasie met tyd, in<strong>die</strong>n<br />
serum nie <strong>van</strong> selle geskei word nie.<br />
Die doel <strong>van</strong> ons stu<strong>die</strong> was dan om <strong>die</strong> effek<br />
<strong>van</strong> vertraagde skeiding <strong>van</strong> monsters op<br />
VOL 82 DECEMBER 1992 461<br />
SAMJ<br />
kreatinienopruiming te bepaal. Urine en<br />
bloed is by gesonde persone (n=4)<br />
gekollekteer asook bloed by 'n groep<br />
pasiente (n=10) met chroniese nierversaking.<br />
Serum is op tye 0-, 24-, 48- en 72 uur na<br />
kolleksie, <strong>van</strong> <strong>die</strong> selle geskei en<br />
kreatinienkonsentrasie daarna bepaal. Die<br />
urine is vir periodes 0-, 24- en 48 uur na<br />
kolleksie geanaliseer. Kreatinien is d.m.v.<br />
'n roetine kinetiese Jaffe metode op 'n<br />
Technicon DAX~ analiseerder bepaal .<br />
Urine kreatinienkonsentrasies het tussen O-<br />
en 48 uur na kolleksie stabiel gebly. Serum<br />
kreatinienkonsentrasies in normale persone<br />
het egter In styging <strong>van</strong> f 25% (piek<br />
verandering by 48 uur <strong>van</strong> tussen 23 - 40<br />
umol/l) getoon. Kreatinienopruimings vir<br />
normale persone het gevolglik na 48 uur 'n<br />
gemiddelde daling <strong>van</strong> 25,28 ml/min p <<br />
0.01 (19,6 - 32,7 ml/min) getoon. In<strong>die</strong>n<br />
bloed egter in 'n yskas by 1'C gehou word,<br />
het hier<strong>die</strong> daling in kreatinienopruiming<br />
nie voorgekom nie. Serum<br />
kreatinienkonsentrasies , <strong>van</strong> pasiente met<br />
chroniese nierversaking (reikwydte 300<br />
umol/l - 1200 umol/l) het egter geen<br />
betekensvolle verandering na 48 uur getoon<br />
nie .<br />
In hier<strong>die</strong> stu<strong>die</strong> is aangetoon dat<br />
interfererende substans(e) <strong>van</strong>uit <strong>die</strong><br />
bloedselle vrygestel word wanneer serum vir<br />
24- tot 48 uur in kontak met bloedselle bly.<br />
Hier<strong>die</strong> effek is klinies betekenisvol op<br />
plasma kreatinien en kreatinienopruiming <strong>van</strong><br />
persone met normale nierfunksies. Bloed vir<br />
kreatinienopruirning moet dus dadelik<br />
afgeswaai, of in 'n yskas gestoor word,<br />
tydens voltooiing <strong>van</strong> 'n 24 uur urien<br />
kolleksie.<br />
THE EFFECT OF BODY POSTURE ON THE RATE OF<br />
GASTRIC EMFTYING IN ADULTS<br />
*F TEOM, J DIEDERICKS, MJ UNGERER, P KRUGER, CP<br />
HERBST, DJR DU MIT<br />
Department of Anaesthesiology and Biophymcs, UOFS<br />
Conflicting stu<strong>die</strong>s have been published regarding<br />
gastric emptying and body posture.l.2 The purpose<br />
of this investigation was to determine if position<br />
does make a difference to the rate of gastric<br />
emptying and to determine the least time necessary<br />
for fasting in a supine adult awaiting surgery.<br />
The study was done with consent of the UOFS<br />
ethical committee for human research. Gastric<br />
emptying stu<strong>die</strong>s were done in both the sitting and<br />
left lateral lying positions. The latter position was<br />
chosen because anatomically it is the least ideal<br />
position for gastric emptying. Ten healthy adult<br />
volunteers were used. On different occasions, at<br />
least a week apart, they received either 200ml radio<br />
active marked orange juice or a radio active marked<br />
light breakfast consisting of a muffin and a poached<br />
egg. The radio active marker used was 3mCI 99mTc<br />
colloid. Gastric content was measured with a gamma<br />
camera immediately after ingestion Icontrol) and<br />
then everv 30 minutes until radio activity was less<br />
than 10% (20ml) of the original activity. T-tests for<br />
comparison at individual time points between sitting<br />
and lying measurements were done. The emptying<br />
times of sitting and lying values were compared,<br />
using 95% confidence intervals.
The gastrid'emptying rate for orange juice is faster<br />
in the sitting than in the lying position lp
M)UBLEBmRANM)BfrzEDcaOSSOVERTRIAC<br />
OF NocmRNAL TaEOPHYLUNE<br />
SUPPLEMENTATION OF A TWICEDAILY<br />
SUsTAINED-aELEASETHEOPEYLLlNET~m<br />
FORMULATION. MV-Middle, F.O.Miiller, RSchall Dept.<br />
of Pharmacology, University of the Orange Free State,<br />
Bloemfontein, RSA<br />
Theophylline chmnotherapy of asthma dictates that the<br />
highest plasma theophylline concentrations (PTO is needed<br />
during the early morning hours when bronchoconstriction and<br />
risk of lifethreatening asthma is greatest To investigate the<br />
response to nocturnal supplementation of a 12hdy regimen<br />
of a specific sustained release theophylline (SRT) formulation<br />
(Nuelin SAR) with a non-sustained release theophylline elixir<br />
(NSRT), marketed as Nuelin LiquidR, a prediction equation,<br />
established for addition of th'e NSRT in healthy volunteers,<br />
was used in sixteen asthmatic patients who were diurnally<br />
active between 06hOO and 23h00, during the South African<br />
spring of 1991. During the run-in phase the patients were<br />
stabilized on individual Nueli SAR doses necessaq to<br />
maintain a steady state PTC of 8-10 Wml. The treatment<br />
regimens were Nuelin SAR 12hurly plus evening<br />
administration of either placebo or Nuelin LiquidR. The<br />
Nuelin LiquidR dose was determined individually to arbitrarily<br />
raise the early morning PTC to 18 &m1 (upper end of<br />
therapeutic range), by means of the prediction equation. The<br />
11 day trial included two 24 hour inpatient periods during<br />
which PTC and lung functions were obtained 2-hourly. The<br />
mean average (standard deviation) early morning PTC and<br />
lung function variables for the period Olh00-05h00 were as<br />
RATKS<br />
Placebo N.eti. %<br />
PTC lrglhl 8.6(27) 1730.7) 206<br />
PEF vs 'fi(L6) UP) 110<br />
1 3.1 (1.4) 3.4 (1.2) 114<br />
m25-75% l/S ZO(1.9 =(L3 123<br />
FVC I 4.7 (1.3 5.0 (m 10s<br />
90% confidence interval Nuelin SAR + Nuelin<br />
Nuelin SAR + Placebo<br />
90% CI*<br />
The prediction equation proved reliable for this specific<br />
SRT/NSRT combination. The incidence and severity of<br />
nocturnal bronchOCOIlStriction in asthmatics can possibly be<br />
attenuated by supplementing a 1241ourly Nuelin SAR regimen<br />
with nocturnal Nuelin LiquidR.<br />
Key words<br />
asthma, chronotherapy, theophylline, prediction equation<br />
PLASMA CELL MORPHOLOGY AND FATJY ACID PROFILE<br />
OF A SKULL PLASMACYTOMA<br />
L iouw*, A-M. ~n~elbrecht* and F. cloete;<br />
Of Anatomy and Cell Morphdogy and Department *-<br />
f-laematology, University of the O.F.S., MerhxB~ n.<br />
The major objective of this study is to present the fatty acid<br />
profile of neoplastic odls in a skull plasmacytoma, h a<br />
patient with underiying systemic myelomatosis. Emphasis is<br />
placed on the relative of linoleic acid, in<br />
m-on wim -a cSSology, as an<br />
~feafwetorevealthedegreedmalignancyfor<br />
hs not so common case. .<br />
%<br />
VOL 82 DECEMBER 1992 463<br />
SAMJ<br />
PATIENTS AND METHODS: Roubine P-<br />
i-: histocytdog'i gi in-7 marrow<br />
examination; metastabjc bone suyey; serum<br />
electrophoresis and immunoelectrm. Fatty acids<br />
from samples (n=6) were e m according to a<br />
modification of the dassic Folsch-method and the methyl<br />
esters were prepared according to the method of Morrison<br />
and Smith. Idmtkith and calculation of the teldtive<br />
percentagefattyacidmethylesterswerebasedonthe<br />
retention times of known standards.<br />
RESULTS: The prm skull<br />
plasmacytomamorphology,<br />
as a mature plasmacytic skuH plasrnacytoma<br />
morphology. The fatty adds detected were: palmitiC acid<br />
(C16:O = 25.06%); stearic acid (C18:O = 10.75%); oleic<br />
acid (C18:lrS = 38.89%); vaccenic acid (C18:ln7 =<br />
2.57%); linoleic acid (C18: 2n6 = 17.84%); arachidonic acid<br />
(CB: 4-16 = 3.54%) and dihomo-gama lindeic acid (CB:<br />
31-16 = 0.74%). Compared to linolac acid levels in &Went<br />
human tumor entjbes with high grade malignancy, a<br />
significantly h i level of lindeic acid occured here.<br />
CONCLUSIONS: It is postulated that the relative percentage<br />
of linoleic acid, in correlation with plasma cell morphology<br />
and our hypothesis: that higher levels of linoleic acid reveal<br />
low-grade mali nancy, while low levels of linobii acid reveal<br />
high grade dgnancy; is reprBsBntativB as a level for lour-<br />
grade malignancy in this skull plasrnacytoma at the time of<br />
investigation. Further investigation is needed to vatidate this<br />
phenomenon for plasmacytomas.<br />
PHYSICAL PROPERTIES OF A HYDRODYNAMIC<br />
EQUATION APPLICABLE TO THE<br />
BLOEMFONTEIN CLINICAL INTERSTITIAL<br />
HYPERTHERMIA TECHNIQUE (BCIICT).<br />
G. A. palmer*, J. Duvenagem, and G. J. Van<br />
Huyssteen+. 3partments of Paramedical !!kiences,<br />
Technikon OFS , Biophysics, University of the Oran<br />
F= Statem and Omotherapy, National ~ospital?<br />
Bloemfontein, South Afkica.<br />
Clinical results indicate the importance of the BCIHT in<br />
the treatment of cancer. A physical model (PM) of the<br />
BCIHT, of which hydrodynamics play an integral part, is<br />
essential in order to optirnize the BCIHT<br />
technologically, to obtain the required hyperthennic<br />
protocol and quality control, and to evaluate the<br />
accuracy of numerical models necessary for quantitative<br />
thermal dosirnetry.<br />
A hydrodynamic flow rate equation (HFRE) was<br />
theoretically derived from first principles utilizing<br />
hydrodynamic equations by Euler, Bernoulli, Darcy,<br />
Weisbach, Hagen and Poiseuille.<br />
The HFRE, as well as the experimentally measured<br />
hydrodynamics (EMH) of the BCIHT, verify that the<br />
flow rate increases linearly as a function of the number<br />
of arrays utilized (N), and that Reynoldr diameter<br />
number, Re - 2 382 if N = 29, causing turbulent flow<br />
in the in- ant outlet manifolds.<br />
The HFRE can be incorporated into a computer<br />
program to form part of a global PM of the BCIHT. It<br />
contains the hydrodynamic s stem parameters of the<br />
BCIHT, which can be mod' 2 ed to suit and enhance<br />
specific types of treatments. Significant physical<br />
hydrodynamic applications are easily obtained from the<br />
equation. The HFRE compares favourably with the<br />
EMH of the BCIHT, which will be presented.
464 VOL 82 DESEMBER 1992<br />
SAMJ<br />
'N 24 UUR-PROFIEL VAN BAWE SEROTONIEN-<br />
KONSEHTRASlES IN MENSLIKE SERUM<br />
EH de Wet, WE en JMC Oosthuizen<br />
Departement Geneeskundi Fisiologie, <strong>Universiteit</strong> <strong>van</strong><br />
<strong>die</strong> <strong>Oranje</strong>-<strong>Vrystaat</strong>, Bloem 8" ontein<br />
INLEIDING: Serotonien (5-HT) is 'n indoolverbinding en<br />
'n metaboliet <strong>van</strong> triptofaan. Dit ageer multipotent as<br />
neuro-oordragstof / neuromoduleerder / hormoon /<br />
voorlopersubstans <strong>van</strong> metoksi-indoolverbindings<br />
(byvoorbeeld melatonien). Die sirka<strong>die</strong>se sekresie-<br />
patroon <strong>van</strong> melatonien is welbekend. Alhoewel sirka-<br />
- <strong>die</strong>se fluktuasies in sentrale weefselserotonien-<br />
konsentrasies reeds aangetoon is, ontbreek inligting met<br />
' ' l - betrekking tot sirka<strong>die</strong>se fluktuasies <strong>van</strong> serotonien-<br />
! -. - konsentrasies in plasma- / serum ("perifere" serotonien).<br />
DOEL: Die doe1 <strong>van</strong> <strong>die</strong> stu<strong>die</strong> was om vastte stel of<br />
sirka<strong>die</strong>se fluktuasies in rnenslike serumserotonien-<br />
konsentrasies ("perifere" serotonien) voordoen. Die<br />
bepaling <strong>van</strong> plasmakonsentrasies <strong>van</strong> 5-HT is oorweeg,<br />
vir logistiese oorwegings laat vaar.<br />
pfionsentrasies, onekonomies)<br />
MATERIAAL EN METODE: Veneuse bloedmonsters vir<br />
<strong>die</strong> bepaling <strong>van</strong> serumserotonienkonsentrasies is uurliks<br />
tydens 'n aaneenlopende periode <strong>van</strong> -24 uur, <strong>van</strong> vyf (5)<br />
normaalgesonde mans, bekom. Hormoonkonsentrasies<br />
is vervolgens, volgens 'n aanvaarde radio-immuun-essai-<br />
prosedure gevalueer.<br />
RESULTATE: Resultate <strong>van</strong> <strong>die</strong> stu<strong>die</strong> toon duidelik 'n<br />
bifasiese patroon <strong>van</strong> sekresie met prominensies tussen<br />
06:00 en 10:00, asook 18:OO en 2200 onderskeidelik.<br />
(Hier<strong>die</strong> tendense strook nie met <strong>die</strong> sirka<strong>die</strong>se<br />
sekresiepatroon <strong>van</strong> enige <strong>van</strong> <strong>die</strong> metaboliete <strong>van</strong> 5-HT<br />
nie.)<br />
GEVOLGTREKKING: Dit wil dus voorkom asof 'n<br />
"outonome" sirka<strong>die</strong>se sekresie atroon vir "perifere"<br />
serotonien we1 ook vwrkom. Uitgreiding <strong>van</strong> d~e stu<strong>die</strong><br />
word tans onderneem. (n =5 + n = 15)<br />
A RETROSPECTIVE PROFILE OF,CARDIAC<br />
ANAESTHESIA FOR 1990 AT A TEACHING HOSPITAL<br />
IN BLOEHFONTEIN<br />
*JJ REYNEKE. WL Rabe<br />
Department of Anaesthesiology and<br />
Biophysics, U.0.F-S, BLOEMFONTEIN<br />
This survey Is an analysis of peri-<br />
operative data of 378 patients admitted for<br />
coronary artery bypass surgery andjor valve<br />
replacement. The purpose was to compare<br />
the morbidi tv and mortality of traditional<br />
anaesthesia with different low dcsaqe<br />
opiate 'supplements with the conce~t of<br />
different high dosage opiates wlus<br />
supplements for amnesia or further<br />
analgesia<br />
THE HETHOD consisted of a collection of<br />
data which mav had influenced the course of<br />
the operation and peri-operative outcome.<br />
tiorbiditv and mortality factors included<br />
post operative number of davs in the<br />
cardiothoracic intensive care unit or in<br />
the ward. Further incidents or<br />
complications were evaluated and calculated<br />
aaainst- a diaital scale and added to the<br />
morbidity score. Anaesthetists decided<br />
lndividuallv on monitoring- premedication.<br />
induction agents. tvpes and dosages of<br />
oplates used. Patients with mlssinp<br />
records or vague information were excluded.<br />
The objective parameters included age,<br />
mass, operation time, bypass time, aorta<br />
cross clampins time, and types and dosaoes<br />
of different opiates. . These parameters<br />
were compared with peri-operative morbidity<br />
and mortality.<br />
RESULTS :<br />
NOETALITY HOEEIDITY<br />
CEOUP PATIENTS fOST OF DlYS SPENT IN UOSPITAL<br />
1-318 1-18 3DAYS 4DlYS SDAYS - 6DlYSt<br />
FENTANYL<br />
SUFENTA<br />
HORPHINE<br />
268<br />
58<br />
10<br />
13f4,81<br />
315,2)<br />
2f20)<br />
10f3:91<br />
-<br />
66!25,91<br />
11f20)<br />
l(12.51<br />
79f311 100<br />
19f34.5) 25<br />
3f37.51 4<br />
EXCLUDED 42<br />
CAUSES OF DEATH:<br />
1. Surgical .......................... 3<br />
2. Low cardiac output ................ 8<br />
3. Fatal arrhvthmlas .................<br />
4. Cerebral lnfarction ...............<br />
5. Pulmonarv embolism ................ 1<br />
6. OrSan failure. (mu1 tl') sepsis .....<br />
REMARKS-:-<br />
1. There was no correlation between anv<br />
of the above-mentioned parameters and<br />
mor tall tv .<br />
2. The tvpe and dose of anaesthetic had<br />
no effect on outcome of the operation<br />
done.<br />
3. No patient in the SUFENTA arouo was<br />
discharged from hospital before the<br />
FOURTH oost operatlve dav.<br />
4. Patients in the FENTANYL qrou~ were<br />
discharged as from the THIRD ~ost<br />
operative dav.<br />
DIE EFFEK VAN NALOKSOON OP BASALE<br />
SEKRESIE VAN RENDORFIEN EN LEUSIEN-<br />
ENKEFALIEN<br />
EH HC Barnard, R Schali, *MS Bornman en<br />
JMC ~osthu'izen<br />
Departemente Geneeskundige Fisiologie, Chemiese<br />
Patolwie en Farrnakoloaie. <strong>Universiteit</strong> <strong>van</strong> <strong>die</strong> Oranie-<br />
~ryst&t, Bloemfontein lasbok 'Departement ~rologie,<br />
<strong>Universiteit</strong> <strong>van</strong> Pretoria, Pretoria<br />
INLEIDING: Sekresie <strong>van</strong> endogene opioiede (Rendorfien<br />
/ leusienenkefalien), wat wrsprong neem uit<br />
prwpiomelanokortien, word deur biologiese negatiewe<br />
terugvoermeganisrnes, eksogene faktore asook sekere<br />
farrnakologiese agense gemoduleer. Naloksoon ('n<br />
suiwer opioiedreseptorantagonis) vertoon in terapeutiese<br />
doserings, ~ egend affiniteit vir mu-opioiedreseptore.<br />
Die affiniteit wr delta-reseptore is waarskynlik weglaatbaar<br />
laer.<br />
DOEL: Die doe1 <strong>van</strong> <strong>die</strong> stu<strong>die</strong> was om <strong>die</strong> effek <strong>van</strong><br />
intravenellse toe<strong>die</strong>ning <strong>van</strong> 0,4mg naloksoon op <strong>die</strong><br />
bade sekresie <strong>van</strong> Rendorfien asook leusienenkefahen<br />
vir 'n periode <strong>van</strong> 4 uur, te evalueer.
~AERIAAL EN METODES: Elf normaalgesonde, man-<br />
like vrywilligers is, in 'n enkeldosering, gerandomiseerde<br />
oorkruisstu<strong>die</strong> met 'n plasebofase, as proe rsone aan-<br />
gewend. Veneuse bloedmonsters vir <strong>die</strong> E paling <strong>van</strong><br />
plasma-B-endorfien- en -leusienenkefaiienkonsentrasies<br />
(R.1.A.-prosedures), is !JurIiks tussen 06:00 en 10:00 <strong>van</strong><br />
proefpersone bekom. Kovariansie-analise is vir statistie-<br />
se verwerking <strong>van</strong> data gebruik.<br />
RESULTATE: Naioksoontoe<strong>die</strong>ning verlaag plasma-&<br />
endorfienkonsentrasies statistics beduidend en fisio-<br />
logies rele<strong>van</strong>t sonder om leusienenkefaliensekresie te<br />
be1 nvloed.<br />
GEVOLGTREKKINGS: 'n Moontlike verklaring vir <strong>die</strong><br />
effek <strong>van</strong> naloksoon op Sendorfiensekresie, is dat mu-<br />
reseptorblokkade, r ulerende negatiewe terugvoer-<br />
rneganismes aktiveery potensieer. 'n Verklaring vir <strong>die</strong><br />
gebrek aan effek op leusienenkefaliensekresie, is dat <strong>die</strong><br />
aangewende dosis <strong>van</strong> naloksoon waarskynlik te laag<br />
was om merkbare effek op delta-reseptore (hoe<br />
leusienenkefalienaffiniteit) uit te oefen.<br />
PLASMAMELATONIENKONSENTRASIES AS ADDI-<br />
SIONELE BIOCHEMIESE MERKER VIR OVULASIE<br />
EH de Wet, EJ Wilson, BH Meyer en JMC Oosthuizen<br />
Departemente Geneeskundige Fisiologie en Farmako-<br />
logie, <strong>Universiteit</strong> <strong>van</strong> <strong>die</strong> <strong>Oranje</strong>-<strong>Vrystaat</strong>, Bloemfontein<br />
INLEIDING: In <strong>die</strong> kliniese praktyk word pro esteroon-<br />
konsentrasies (tydens <strong>die</strong> geprojekteerde lutegee fase) as<br />
indikator <strong>van</strong> ovulasie gebruik. Fasespesifieke ftuktua-<br />
sies in sekresie <strong>van</strong> verwante geslagshormone (asook<br />
melatonien), tydens <strong>die</strong> menstruele slklus / ovulasie, is<br />
bekend. Kontroversie bestaan egter steeds oor <strong>die</strong> ver-<br />
band / interaksie tussen erkende geslagshormone en<br />
melatonien. Uit beskikbare inligting wil dit voorkom asof<br />
resiproke sekresiepatrone <strong>van</strong> melatonien en lutropien<br />
gedurende ovulasie voorkom.<br />
DOEL: Die doe1 <strong>van</strong> <strong>die</strong> stu<strong>die</strong> was om plasma-<br />
melatonienkonsentrasies (op grond <strong>van</strong> resiproke<br />
prestasie tot lutropien), -as addisionele biochemiese<br />
merker vir ovulasie te evalueer.<br />
MATERIAAL EN METODE: Veneuse bloedmonsters, vir<br />
<strong>die</strong> bepaling <strong>van</strong> - plasmamelatonienkonsentrasies, is<br />
daagliks (Dag 12 tot en met Dag 16 <strong>van</strong> <strong>die</strong> menstruele<br />
siklus) op dleselfde tyd, <strong>van</strong> ses (6) normaalgesonde<br />
vrouens (ouderdom 18 tct 48 jaar), bekom.<br />
Omgewingsbsligting was deurgaans r 350 Lux.<br />
Bykomstig is bloedmonsters vir <strong>die</strong> bepalin <strong>van</strong> serum-<br />
progesteroonkonsentrasies op dag 21 <strong>van</strong> e ke proefper-<br />
soon bekom. Horrnoonkonsentrasies is vervolgens, vol-<br />
gens aanvaarde radio-immuun-essaiprosedures gekwan-<br />
tifiseer.<br />
RESULTATE: Resultate <strong>van</strong> hier<strong>die</strong> stu<strong>die</strong> toon 'n<br />
rominente nadir in midsiklus plasmamelatonienf:<br />
onsentrasies aan in proefpersone 1, 2 en 6. Geen<br />
opmerklike basislynverskuiwings in plasmamelatonienkonsentrasies<br />
<strong>van</strong> oroef~ersone 3. 4 en 5 kon vir <strong>die</strong><br />
spesifieke sik1~i.s ' uitgew* word nie.<br />
Serumprogesteroonkonsentras~es vir proefpersone 1 en<br />
6 strook met verwagte postovulasie waardes.<br />
GEVOLGTREKKING: Gesien teen <strong>die</strong> agtergrond <strong>van</strong><br />
<strong>die</strong> waarskynlike fisiologiese verband tussen lutropien en<br />
rnelatonien (asook <strong>die</strong> resuitate <strong>van</strong> hier<strong>die</strong> bepekte<br />
stu<strong>die</strong>), wil dit voorkorn asof plasmamelatonien-<br />
konsentrasies we1 klinies sinvol in geselekteerde gevalle,<br />
as misionele biochemiese merker vir ovulasie<br />
aangewend kan word.<br />
B<br />
VOL 82 DECEMBER 1992 465<br />
SAMJ<br />
Verspreiding <strong>van</strong> sekresiegranules in gestimuleerde<br />
B-selle <strong>van</strong> <strong>die</strong> pankreas<br />
AM de Beer en A Crous<br />
Dept. Geneeskundige Fisiologie,<br />
<strong>Universiteit</strong> <strong>van</strong> <strong>die</strong> OVS, Bloemfontein<br />
Glukosestimulasie <strong>van</strong> 5selle veroorsaak 'n toename in<br />
insulienvrystelling gevdg dew 'n nadir, waarna <strong>die</strong><br />
tempo <strong>van</strong> vrystelling weer toeneem en vir <strong>die</strong> duur <strong>van</strong><br />
stimulasie vdgehou word. lnsulienvrystelling geskied by<br />
wyse <strong>van</strong> <strong>die</strong> eksositose <strong>van</strong> sekresiegranules. Die<br />
insulienkonsentrasie in <strong>die</strong> bloedplasma is gevolglik 'n<br />
funksie <strong>van</strong> <strong>die</strong> beskikbaarheid <strong>van</strong> granules in <strong>die</strong><br />
omgew~ <strong>van</strong> <strong>die</strong> selrnembraan. Die doe1 <strong>van</strong> <strong>die</strong><br />
onder was orn <strong>die</strong> regionale verspreiding <strong>van</strong><br />
sekresiegranules in <strong>die</strong> sitoplasma tydens glukose<br />
gestimuleerde insulienvrystelling morfornetries te bepaal.<br />
METODE: Glukose gestimuleerde eilandweefsel is na 2,5<br />
min., 53 min., M min., 30 min. en 72 uur fikseer en vir<br />
elektronmikroskopie voorberei. Sekresiegranules is op<br />
elektronmikrograwe geidentifiseer en hul voorkoms in<br />
<strong>die</strong> omgewing <strong>van</strong> <strong>die</strong> sdkern en selmembraan<br />
morfornetries bepaal. Granules in <strong>die</strong> res <strong>van</strong> <strong>die</strong><br />
sitoplasrna is ook in berekening gebring.<br />
RESULTATE: Kort na aan<strong>van</strong>g <strong>van</strong> stimulasie (23 min.)<br />
neem <strong>die</strong> voorkoms <strong>van</strong> sekresiegranules in <strong>die</strong><br />
omgewinf <strong>van</strong> <strong>die</strong> selmembraan skerp af. In <strong>die</strong> res <strong>van</strong><br />
<strong>die</strong> &top asma was geen verandering te bespeur nie.<br />
Met volgehoue stimulasie het <strong>die</strong> granule verspreidings-<br />
digtheid in hier<strong>die</strong> area geleidelik toegeneem om na 30<br />
minute <strong>die</strong> verspreidings trwn <strong>van</strong> ongestimuleerde<br />
selle aan te neem. Efs na langdurige glukose<br />
stimulasie word sodanige verspreiding gehandhaaf.<br />
BESPREKING: Instandhoudim <strong>van</strong> 'n normale<br />
granuulverspreidingspatroon in -<strong>die</strong> B-selsitoplasma,<br />
tvdens volaehoue insulienvrvstellina. toon dat <strong>die</strong> status<br />
duo <strong>van</strong> 8e granuulpopul&ie gekndhaaf word deur<br />
insuliensintese en -vrystelling. Die aan<strong>van</strong>klike<br />
verandering in <strong>die</strong> verspreidingspatroon <strong>van</strong> <strong>die</strong><br />
sekresiegranules word direk in verband gebring met <strong>die</strong><br />
fasiese aard <strong>van</strong> insuliertsekresie. Die morfometriese<br />
waarnemings toon dat selfs :n geringe afnarne in<br />
sekresiegranules in <strong>die</strong> subplasrnalemrnagebied <strong>die</strong><br />
verd tot insuliensekresie beduidend beperk.<br />
AN AUTOMATED HIGH PERFORMANCE LIQUID<br />
CHROMATOGRAPHY METaOD FOR THE<br />
DETERMINATION OF CEFETAMET IN PLASMA.<br />
KJ Swart, I <strong>van</strong> Heerden and HKL Hundt<br />
Dept of Pharmacology & Farmovs Institute of Clinical<br />
Pharmacology and Drug Development, UOFS,<br />
BLOEMFONTEIN.<br />
Introduction<br />
Cefetamet is the main metabolite and active form of the oral<br />
cephalosporin antibiotic cefetamet pivoxyl. Cefetamet pivoxyl<br />
is very unstable in plasma and it is rapidly converted to<br />
cefetamet. Cefetamet plasma concentrations are therefore<br />
determined since no cefetamet pivoxyl concentrations can be<br />
determined unless special precautions are taken.<br />
Aim<br />
Our aim was to develop an automated HPLC method for the<br />
determination of cefetamet in a large number of plasma<br />
samples.
Method<br />
To -1 plasma was added 50qtl water- Extractions were<br />
done by a Gihn SPEC (Automatic Sample Preparation with<br />
Extraction CoIumn~) system using Varian Bond Elut (1-&<br />
C18 packing) extntction columns Each column was<br />
canditioned with methand followed by 0-lM HQ just befiore<br />
use. The plasma mixbm was loaded onto the column and<br />
washed with lml 0.1M HCI. lk analytes were eluted with<br />
30qrl methanol, the eluate mixed with 30qrl water and lm<br />
injected onto the HPLC column.<br />
Chromatography was performed in the reverse phase mode on a<br />
Waters Novapak (38, 4p, 150x3-9 mm stainless steel column<br />
with a mobile ppbse consisting of sodium &ate buffer and<br />
acetonitiile (9223) (pIlt=3.9) and the analyta detected by a<br />
Hewlett-Packard W detector at Ui5 nm.<br />
Results<br />
Calibration curves were to at last ~ glml for &tarnet,<br />
with a limit of quantification set at 0.1-1 (CV% of 13.8 at<br />
O.O!X?&ml)-<br />
Concl*n<br />
The method was sensitive enough to determine ccfetamet<br />
cancentrations in plasma samples for up to 12 hours after a<br />
single 500mg ceft%amet pivoxyl oral dose. An internal standard<br />
was not used sime the extraction, elution and injection was<br />
done by the ASPEC system with excellept precision and<br />
aqwacy.<br />
ANTIBIOTIC CROSSRESI~ANCE EN PSELIDOMO&lS<br />
AERUGINOSA.<br />
-<br />
M M Theron, M J de Kock, Department of Medical<br />
Microbioh. Universitv of the Orange - Free State,<br />
~loemfont&<br />
Elevated &lactam antiic resktmxe in hospital isolates<br />
of Gram negative organhs is often attributed to a single<br />
factor (altered pemcillin-bindiag oteins [PBP], &<br />
inttctivatim- a iqte4tyr L is widely<br />
believed that cross-resstance results fmm hype reduction<br />
of s p e c i ~ c E-lactamases ~ l mediated& mufatcd<br />
chromosomal g e or ~ from &lactamases mediated by<br />
conjugative plasxmds aspired in hospitals The level of &<br />
lactamase resistance relates to the amonnt of enzyme<br />
roduced and to the kinetics of the activity of the e-e.<br />
%l,rmeabiLity is manifested by high nmimrl inhiiltmy<br />
concentration (MC) values in the absence of&-.<br />
METHODS: Minimal inhibitory -ns of she<br />
antibiotics for 252 isolates were determined by the agar<br />
dilution method. Semiquantitative substrate rdes of<br />
crude Bhctamaa preparations were determinex!for 47 of<br />
these isolates.<br />
The magnitude of cross-resistance in Ikhmmzs<br />
was assessled by comparison of the MICs of the<br />
EEEF&nrn amia Quunitartrr measures of<br />
cross-resistanct were determined over the 6nn range of MIC<br />
values of the different 5~1tiiiotics.<br />
RESULTS: Chs-resistance was demonstrated between<br />
pairs of antibiotics tested. Imipenem, sbolwing m, cross-<br />
resistance with any of the 6-lactam antibiotks, was the only<br />
exception. RLactamase acthi was not &monstrsted in<br />
r~isolates&~><br />
F&=N: Tbk indicates that resistance d cr--<br />
resstame to the &lactans stu<strong>die</strong>d are doe to both the<br />
praduction of &hcUmass and impefmeability of the outer<br />
membrane.<br />
NUMERICAL ANALYSIS OF SEMI-QUANTITATIVE &<br />
LACTAMASE SUBSIRATE PROFILES.<br />
M J de Kock, M M Theron, C J <strong>van</strong> Rensburg, Department<br />
of M d d Microbiology, University of the Orange Free<br />
State, Bloemfontein.<br />
Semiquantitative substrate profiles of Rlactamases from<br />
l18 Gram negative bacterial strains (in& 20 reference<br />
Rlacmmases producing strains) were recor 2<br />
METHODS Strains were grouped according to their<br />
substrate profiles using mean m e cluster analysis and a<br />
similarity measure based on the degree of overlap between<br />
traces.<br />
Z-Depe- they were produced, & on the bacterial strains by which<br />
profiles were divided into<br />
seven major group.<br />
The first group contained profiles of B-lactamases produced<br />
by Adnetobacter strains and two reference B-lactamases<br />
(OM-3 and OXA-4). The second group consisted of B-<br />
ktamaws h m PseudoinroMs aemghma and one reference<br />
Rlactamase (ROB-l). Group 3 was a small mixed group of<br />
Rlactamases from Xmtthomoma maltophilia, Pseudornonas<br />
aerugirtosa and a reference Blactamase (SW-2). The<br />
remaining X~homonas Rlactamases formed a loosely<br />
grou (group 4), distinct from all the other<br />
=Group !exclusiveb contained rofiles derived from<br />
reference Blaetlmaws (RE-l, PS&, PSE-3, OXA-6<br />
TEM-1, TEM-2, --l, 0-1, HMS-1, SW-1, TLE-i<br />
and OXA-7) and plasmid mediated &lactamases from<br />
Bloemfontein hospitals. Group 6 repreygted seven &<br />
lactamases from Pseudontollcls and one reference &<br />
lactamase (OXA-2). Group 7 contained two subgroups, the<br />
first subgroup from lasmid mediated Rlactamases and the<br />
second subp gom standard (OXA-I,<br />
OXA-5 and P&-l). Subgroups and dusters could be<br />
delineated in aIl lar er groups.<br />
ONCLUSION: h approach to anal of fi-lactmme<br />
substrate rofiles offers a valuable tool ~epidemiologid<br />
surveys OF &L.ldamases present in different bacteria and<br />
environments.<br />
AN AUTOMATED HIGH PERFORMANCE LIQUID<br />
CHROMATOGRAPHY METHOD FOR THE<br />
DEIERMINATION OF ~ ONAZOLE IN PLASMA<br />
KJ Swart. JC <strong>van</strong> der Merwe and HKL Hundt.<br />
Dept of Pharmacology & Farmovs Institute of Clinical<br />
Pharmacology and Drug Development, UOFS,<br />
BLOEMFONTEIN.<br />
-<br />
Iatrodoetion<br />
Ketoconazole belongs to the mole family of the antifungal<br />
compounds. Although a number of methods exists for the<br />
determination of ketoconazole in plasma they are either<br />
microbiological methods or HPLC methods which are time<br />
consuming, labour intensive and not automated.<br />
Aim<br />
Our aim was to develop an automated HPLC method for the<br />
determination of ketoconazole in a large number of plasma<br />
samples.<br />
. .<br />
Method<br />
To 0Sml plasma was added the internal standard,<br />
perphenazine, and 0Sml 0.01M NaOE Extractions of the<br />
@asma samples were done by a Gilson ASPEC (Automatic<br />
Sample Preparation with Extraction Columns) sy&m. The<br />
L _
ASPEC was programmed to condition each Varian Bond Elut<br />
(lOOmg, C18 packing) extraction column with methanol<br />
followed by 0-01M NaOH just before use. The plasma mixture<br />
was loaded onto the extraction column and washed with lml<br />
0.01M NaOH. The analytes were eluted with 30qrl methanol<br />
the eluate mixed with air and a l0qrt aliquot automatically<br />
injected onto the HPLC column.<br />
Chromatography was performed in the reverse phase mode on a<br />
Waters Novapak C18 4p, 150~3.9 mm, stainless steel column<br />
with mobile phase consisting of methanol, water, acetic acid<br />
pnd triethylamine (750+250+5+5) @H=6.0), and the analytes<br />
detected by a Shimadzu W detector at 242nm.<br />
Rcwlts<br />
Calibration curves were linear to at least M m 1 for<br />
ketoconazole. The limit of quantification was set at 0.12Clg/ml,<br />
a level at which the analyte could still be detected with good<br />
precision and accuracy (CV% of 6.6 at 0.162 Mml, and CV%<br />
of 23 at O.O82pg/ml.<br />
Conclusion<br />
This method was sensitive enough to determine ketoconazole<br />
concentrations for up to 12 hours in plasma samples after a<br />
single UlOmg oral dose. Determinations can be done 24 hours<br />
of the day since the extraction, injection, chromatography and<br />
dab reduction are completely automated.<br />
AUTOMATED ANALYSIS OF CEFACLOR IN PLASMA<br />
BY HIGH PERFORMANCE LIQUID<br />
CHROMATOGRAPHY.<br />
KJ Swart, T Malherbe and HKL Hundt<br />
Dept of Pharmacology & Farmovs Institute of Clinical<br />
Pharmacology and Drug Development, UOFS,<br />
BLOEMFONTEINNTEIN<br />
Introduction<br />
Cefaclor is a cephalosporin antibiotic with a broad antibacterial<br />
spectrum against Gram-positive and Gram-negative bacteria<br />
Cefaclor is very unstable in solutions above pH=4.5 and<br />
degrades rapidly at room temperature. Existing methods were<br />
not automated and did not control the temperature of the<br />
samples during extraction.<br />
Aim<br />
Our aim was to develop an automated HPLC method for the<br />
determination of cefaclor in a large number of plasma samples<br />
mder conditions which ensured the stability of the analyte.<br />
Method<br />
Plasma (0.5ml) was immediately acidified with 0.51111 0.1M<br />
&Cl after blood collection and centrifugation. Before<br />
extraction, cefalexin was added as internal standard and the<br />
mples loaded into a temperature controlled rack at O'C in a<br />
Gilson ASPEC (Automatic Sample Preparation with Extraction<br />
Columns) system. Extraction was done on Varian Bond Elut<br />
(lOOmg, C18 packing) extraction columns Each column was<br />
tonditioned with methanol followed by 0.1M HCI just before<br />
W.<br />
VOL 82 DECEMBER 1992 467<br />
SAMJ<br />
The plasma mi.mue was loaded onto the extraction column and<br />
washed with lml 0.1M HCl. The analytes were eluted with<br />
300@ methanol, the eluate mixed with 20qrl water and SW1<br />
automatically injected onto the HPLC column.<br />
Chromatography was performed in the reverse phase mode on a<br />
Bihoff Spherisorb ODS II, 4p, 125x4.6mm stainless steel<br />
column with mobile phase consisting of sodium citrate buffer<br />
and acetonitrile (W8) @H=3.8). The analytes were detected by<br />
a Shimadzu UV detector at 265nm.<br />
Results<br />
Calibration curves were linear to at least 281rglml for cefaclor<br />
with a limit of quantification set at OSqrglml (CV%=12 at<br />
0.4&g/ml).<br />
coacwn<br />
This procedure provided us with a method that was sensitive<br />
enough to determine cefaclor plasma levels for 10 hours after a<br />
single 5OOmg oral dose. Determinations can be done 24 hours<br />
of the day since the extraction, injection, chromatography and<br />
data reduction are completely automated. The stability of the<br />
analyte in the plasma samples is ensured by the addition of acid<br />
shortly after sample collection and by keeping the samples at<br />
K befoie analysis.<br />
'N ONDERSOEK NA DIE INSIDENSIE VAN EKTOPIESE<br />
SWANGERSKAPPE NA WEETOORDRAG IN DIE<br />
BLOEMFONTEINSE REPRODUKTIEWESORGEENHEID<br />
Wessel S PH, Sournbassis E, Venter D<br />
Reprodukt iewesorgeenhe id, Departement<br />
Obstetrie en Ginekologie, UOVS,<br />
Bloemfontein.<br />
DOEL: Die doe1 <strong>van</strong> hier<strong>die</strong> stu<strong>die</strong> was om vas<br />
te stel of Gameetoordrag, soos in <strong>die</strong><br />
p1 aasl i ke eenheid aangebied, met 'n<br />
verhoogde insidensie <strong>van</strong> ektopiese<br />
swangerskappe geassosieer is.<br />
STUDIE-ONTWERP: 'n Retrospektiewe stu<strong>die</strong> is<br />
ui tgevoer op a1 l e ektopi ese swangerskappe<br />
wat <strong>van</strong>af 01 Januarie 1985 tot 31 Desember<br />
1990 in <strong>die</strong> Universitas Hospitaal<br />
gediagnoseer en behandel i S.<br />
PAS18NTE: A1 le pasiente met ektopiese<br />
swangerskappe, wat by <strong>die</strong> p1 aasl i ke<br />
Infertil iteitskl iniek behandel is, is<br />
geidentifiseer. Hulle kl iniese data is<br />
noukeurig nagegaan en <strong>die</strong> oorsaak <strong>van</strong> hul<br />
infertil itei t asook <strong>die</strong> tipe behandel ing wat<br />
hull e ont<strong>van</strong>g het, i S geidenti f i seer. Geen<br />
ektopiese swangerskap wat na behandeling by<br />
<strong>die</strong> plaaslike kliniek ontstaan het, is oor<br />
<strong>die</strong> hoof gesien nie.<br />
---<br />
- ,<br />
-<br />
-- i
F - -<br />
,<br />
: 8<br />
p- - p<br />
I r 468 VOL 82 DESEMBER 1992<br />
9, *:<br />
SAMJ<br />
RESULTATE: In <strong>die</strong> periode is 55<br />
swangerskappe deur middel <strong>van</strong> gameetoordrag<br />
verwek teenoor 360 swangerskappe met ander<br />
behandel ingsmetodes. 'n Totaal <strong>van</strong> 17<br />
ektopi ese swangerskappe i S gedi agnoseer.<br />
Slegs 3 ektopiese swangerskappe het na<br />
gameetoordrag ontstaan teenoor 14 na ander<br />
behandel ingsmetodes. Die waarskynl i kheid om<br />
'n ektopiese swangerskap te ontwikkel is<br />
5'45% na gameetoordrag en 4'10% na ander<br />
behandel i ngsmetodes . Geen statisties<br />
betekenisvol le bf kl inies betekenisvolle<br />
vers ki l kon waargeneem word ni e .<br />
GEVOLGTREKKING: Die risiko om 'n ektopiese<br />
swangerskap na gameetoordrag in <strong>die</strong><br />
plaaslike eenheid te ontwikkel is nie<br />
betekenisvol ho@r as na enige ander<br />
behandel ingsmetode nie.<br />
I&? - im SP~~~~LPMIDDEL vt~ 1y<br />
W D~WIESE<br />
PASISAT MET W BILATERALE N W PARALISE<br />
M <strong>van</strong> Vuuren<br />
DepL Arbeidsterapie - Pefonomi Hospitaal<br />
Die pasii5ni het 'n bilaterale N W paralise opgedoen, na 'n<br />
SkedeIbasisfraktum.<br />
Om 'n hulpmiddel te ontwerp wat eet en spraak verbeter.<br />
- sykw<br />
'n Aksienavo~ode is gebruik aangesien 011s bier met 'n<br />
unieke geval te doen het en so 'n tipe hulpmiddel nog nie<br />
voorheen ontwerp is nie.<br />
Metode 1 'n Statiese spalk is gemaak <strong>van</strong> temoplastiese<br />
materiaal wat oor <strong>die</strong> pas%?& se ken pas en met vier<br />
BesPrtaat 1 Die spalk het sy lip effektief geeleveer, maar as hy<br />
sy l$ dilateer kon <strong>die</strong> spalk nie <strong>die</strong> onderlip weer outomaties<br />
eleveer sodat <strong>die</strong> mond toegaan nie.<br />
Mecoae 2 'n Diaamiese S@ is gemaak, <strong>die</strong> leerbandjiies by<br />
metode l is met rek vervaag.<br />
lkdtaat 2 Die hoelr waarken <strong>die</strong> kragte <strong>van</strong> <strong>die</strong> rek trek ;as<br />
nie groat genoeg om <strong>die</strong> mond outomaties toe te maak nie.<br />
Metode3 Diehaekewaartesn<strong>die</strong>kraetetrekisveranderenso<br />
ver moontlik laudreg opmekaar m& sodat <strong>die</strong> trekhag op<br />
<strong>die</strong> onderlip superioraraslits verhoog.<br />
Redtaat 3 Die mand kon outomaties toemaak. Die<br />
hdpzddel het egter nie in posisie gebly nie.<br />
Metode 4 Die hulpmiddel is versterk dew 'n kopstuk gedeelte<br />
by te voeg.<br />
Resnltaat 4 Die hulpmiddel kon in posisie bly en was<br />
k(hglletiesaaaMarbaar.<br />
Metode 5 lbm hulpmiddek is gemaak. Die een, wat vir<br />
spraakdoeleindes ontwerp is, is uitgevoer met watteersel om<br />
druksere op <strong>die</strong> ken te voorkom. Die ander een was sonder <strong>die</strong><br />
watteersel en vir ee& e e t e bed&<br />
Resubat 5 Die hdpmiddel was effektief.<br />
' .<br />
'n ICosmetiese hnlpmiddel is ontwerp wat onafhanklikheid<br />
'teweeg gebring het ten opsig&e <strong>van</strong> spraak en eet.<br />
DIE MVII3ED VAN ~IOlCSIDAN!L' VITAMIN<br />
AAmmLLING WENS MOKARDIALE<br />
ISGELZIE/RKPEWUSIE.<br />
H <strong>van</strong> Jaarsveld, Jn Kuyl, DW Alberts<br />
Departement Chemiese Patologie, UOVS ,<br />
Bloemf mtein<br />
Produksie <strong>van</strong> suurstofradikale tydens<br />
miokardiale isgenie/ reperfusie is<br />
gedeeltelik verantwoordelik vir <strong>die</strong><br />
mitochondriale beskadiging wat waargeneem<br />
word. Lae molekul&re gewig yster (MY) tree<br />
as katalis op om <strong>die</strong> minder reaktiewe<br />
suurstof spesies (OZ-, H20 ) om te skakel na<br />
<strong>die</strong> baie toksiese hidroksfelradikaal (OH. ) .<br />
Antioksidante is molekule soos vitamien C,<br />
a-tokoferol en B-karoteen wat<br />
suurstofradikale inaktiveer en onskadelik<br />
stel. Die doel <strong>van</strong> hier<strong>die</strong> stu<strong>die</strong> was om te<br />
bepaal of antioksidant aanuulling<br />
mitochondriale beskadiging tydens isgemie<br />
reperfusie kan venninder. Drie<br />
eksperimentele groepe is ondersoek naamlik:<br />
1) rotte wat geen addisionele vitamiene<br />
ont<strong>van</strong>g het nie: 2) rotte wat B-karoteen en<br />
a-tokof er01 ont<strong>van</strong>g het <strong>van</strong>af speenouderdom;<br />
en 3) rotte wat B-karoteen, a-tokoferol en<br />
vitamien C ont<strong>van</strong>g het <strong>van</strong>af speenouderdom.<br />
Hitochtmdriale f unksie, LMMY en a-tokof er01<br />
is bepaal. Beide <strong>die</strong> suplementasie groepe se<br />
mitochondriale funksie het 'n verbetering<br />
getoon ten opsigte <strong>van</strong> <strong>die</strong> kontrolegroep<br />
tydens isgemie en reperf usie , alhoewel <strong>die</strong><br />
LlMY uitermate verhmg was. a-Tokoferol was<br />
betekenisvol hoer in hide suplementasie<br />
groepe, maar <strong>die</strong> groep wat slegs 8-karoteen<br />
en a-tokof er01 ont<strong>van</strong>g , het *n a-tokof er01<br />
konsentrasie <strong>van</strong> ongeveer dubbel <strong>die</strong> <strong>van</strong> <strong>die</strong><br />
groep vat ook vitamien C aanvulling gekry<br />
het. Die groep wat nie vitamien C ont<strong>van</strong>g<br />
het nie se a-tokof er01 konsentrasie het<br />
egter vinnig uitgeput tot 'n konsentrasie<br />
laer as <strong>die</strong> groep met vitamien C aanvulling.<br />
Ons km dus tot <strong>die</strong> gevolgtrekking dat<br />
aanvulling <strong>van</strong> antioksidant vitamiene we1<br />
miokardiale isgemie/reperfusie besering tot<br />
'n mate verminder (ten spyte <strong>van</strong> 'n<br />
verhoogde LHNY) en dat vitam~en C nodig is<br />
on <strong>die</strong> vitamien E konsentrasie in stand te<br />
hou .<br />
-. .<br />
.- .<br />
* .- -. .<br />
- -<br />
' A 1 -<br />
'N VERGELYEFCNDE STUDIE TUSSEN El23<br />
TIROIED-OPNAMES SOOS BEPAAL MET 'N<br />
SINITIUSIETELLEI EN GAMMA-KAMERA<br />
TEGNIEK<br />
J. <strong>van</strong> der Wath, H Naudi, M Utter.<br />
Departemeut Kemgeneeskunde, Bloemfontein.<br />
l231 is teoreties <strong>die</strong> optimale spoorder om <strong>die</strong> tirozed te<br />
bestudeer. Beelding en kvcrantifisering <strong>van</strong> in<strong>van</strong>gs kan<br />
as 'n enkele prosedure gdoen word Dit is voordelig<br />
Iwz standaard in<strong>van</strong>gsbepalings wat aLfsonderlik met 'n<br />
sintillasieteUer gedoen moet word en tydrowend is.<br />
Die doel <strong>van</strong> hier<strong>die</strong> stu<strong>die</strong> was om in<strong>van</strong>gs soos bepaal<br />
met 'n gamma-kamera tegniek te vergelyk met 'n<br />
sintillasietellertegniek ms beskryf deur Chervu et al.<br />
60 P dnte is bestudeer en <strong>die</strong> resultate word in al <strong>die</strong><br />
@eke en tabeile saamgevat. Volgens hsgenoemde<br />
a daar we1 'n baie goeie korrelasie tussen <strong>die</strong><br />
sintillasietellertegniek en <strong>die</strong> Gamrna-kamera tegniek.<br />
.-?!<br />
-
13ETA-LACMM AND QUINOLONE RESISTANCE:<br />
13EFORE AND AFIER.<br />
PI. Botha, W. de Kock, UU Theron, 7<br />
I partment of Medical Microbiology, University of the<br />
(hnge Free State, Bloemfontein.<br />
~n ~ ~mfotein hospitals most antimicrobid agents were<br />
freely available for therapy. Resistance to second and third<br />
line drugs inmased sharply during 1990. This wa~ @i'b~ted to ~ ~U~~UOUS use. Reduction of the selective<br />
pressure on the emergence of resistance became imperative.<br />
19 policy was instituted, restricting the prescription of B-<br />
@dam aad quinolone agents to consultants serving on the<br />
Adiiotic Subcommittee.<br />
lk aim of this study was to detect change in resistance<br />
profiles of four Gram negative pathogens, after restriction<br />
bad been enforced for a period.<br />
The restriction policy came into effect on 5 June 1991. The<br />
iesistauce profiles of the four pathogens against three<br />
aminoglycosides and the six restricted antimicrobial agents<br />
were stu<strong>die</strong>d for a period of six months prior to and after<br />
this date. The first period was utilized to document existing<br />
profiles and then compared with the second to detect<br />
changes. For each organism and antimicrobial agent the<br />
number of sensitive and resistant isolates in the two periods<br />
were compared and tested for significance by the chi-square<br />
test.<br />
In general, resistance in Universitas Hospital decreased. In<br />
Pelonomi however it was noted that resistance to some<br />
drugs increased. Exceptions were noted: The resistance of<br />
P~ltuwlc~s significantly increased to piperacillin in<br />
Universitas Hospital. At Pelonomi a significant decrease in<br />
resistance to cefotagime was observed in MebsieIla.<br />
These results show that only restriction of prescriid<br />
antimicrobial agents does not totally alleviate the selective<br />
pressure producing increased ltos~comial resistance.<br />
Judicious use of antimicrobial agents should prolong the<br />
efficacy of individual drugs. An established hospital regime<br />
for antimicrobial therapy would contniute greatly towards<br />
autailing resistance. The simultaneous reinforcement of<br />
hospital hygiene should enhance this effect.<br />
DIE GEBRUIK VAN DIE POLIMEBASE<br />
EE'ITINGREAKSIE VIR DIE AANTONING EN DIREKTE<br />
'IIPERING VAN HERPES SIMPLEX VIRUS IN<br />
SEREBROSPINALE VOG, MOND-, KEEL EN<br />
GENITALE DEPPERS<br />
HMM P i MS Smith, E vd Ryst<br />
Die ontwikkeh <strong>van</strong> effektiewe antivirale terapie teen<br />
Herpes simplex wrus (HSV) infeksies genoodsaak <strong>die</strong> vroeC<br />
diagnose <strong>van</strong> HSV infeksies. Toetse wat gebruik word om<br />
<strong>die</strong> aanwesigheid <strong>van</strong> HSV in Wese monsters aan te toon,<br />
kan nie altyd met sukses aangewend word om 'n vr& en<br />
gkkurate diagnose te maak nie.<br />
bOEL VAN DIE STUDIE: Die doel <strong>van</strong> <strong>die</strong> stu<strong>die</strong> was om<br />
<strong>die</strong> sulcsesv011e toepassing <strong>van</strong> <strong>die</strong> polirnerase kettingreaksie<br />
KR) vir <strong>die</strong> gelyktydige aantoIung en ti ring <strong>van</strong> HSV<br />
g NA in serebrospiuale vog (SSV), mod-, P eel- en genitale<br />
deppqrs feevalueer. .<br />
. . ., L<br />
PASIENTE EN METODES: Die polimerase kettingreaksie<br />
(PKR) is eers toegepas op HSV tipe 1 (HSV-1) en HSV tip<br />
2 (HSV-2) DNA, wat verkry is <strong>van</strong>af VERO selle wat<br />
eihfekteer is met kliniese monsters waaruit HSV-l en<br />
&V-2 onderskeidelik geisoieer is en tipering uitgevm b<br />
mbv fluoressiengemerkte tip-spesifieke monoklonale<br />
antiliggame. Twee SSV monsters, twee monddeppers, twee<br />
keeldeppers en twee genitale de pen <strong>van</strong> pasiEnte met<br />
HSV-1 of HSV-2 letseh h met &e PKR get- .vir <strong>die</strong><br />
teenwoordi eid <strong>van</strong> HSV DNA. Hier<strong>die</strong> monsters reeds<br />
positief verG vir <strong>die</strong> teenwoordigheid <strong>van</strong> HSV dmv virus<br />
~solasie. Deur gebruik te maak <strong>van</strong> een a1 emene opgaande<br />
8 %<br />
voorloper en twee ti -spesifieke af aan e voorlopers <strong>van</strong><br />
23 baslsse elk, is & e h <strong>van</strong> <strong>die</strong> SV tip 1 (HSV-l) en<br />
tipe 2 (HSV-2) DNA polimerase geen gearnplifiseer om<br />
produkte <strong>van</strong> verslcillende groottes te produseer. Die<br />
Southern klad tegniek is gebruik om <strong>die</strong> identiteit <strong>van</strong> <strong>die</strong><br />
geamplifiseerde produk te bevesti dew gebruik te maak<br />
<strong>van</strong> 'n peiIer wat spesifiek is vir beide HSV-1 en HSV-2.<br />
RESULTATE: Produkte <strong>van</strong> verwagte groottes (469 en<br />
391bp vir HSV-l en HSV-2 onderskeidelik) was op 'n<br />
ethidiumbromied gekleurde gel sigbaar en bevestig <strong>die</strong><br />
spesifisiteit <strong>van</strong> <strong>die</strong> PKR toets. A1 agt <strong>die</strong> monsters is<br />
positief getoets vir <strong>die</strong> teenwoordigheid <strong>van</strong> HSV-1 of HSV-<br />
2 DNA.<br />
SAMEVATTING: Die ampHhsie <strong>van</strong> W e DNA dmv<br />
PKR was gen sensitief en c k vir <strong>die</strong><br />
<strong>van</strong> F i n bogenoemde as monsters.<br />
EZ'Truik te mask <strong>van</strong> <strong>die</strong> mie voorlopers, was dit<br />
moon& am gelyktydig <strong>die</strong>HSV stam te tipeer.<br />
PHGRMACOKINETICS AND COMPARATIVE<br />
BIOAVAILABILITY STUDY OF<br />
EM Moeilnicka, M <strong>van</strong> Dyk, HKL Hundt, FO Miilter, R Schall,<br />
LW Brown<br />
Farmovs Institute, University of Orange Free State, Bloemfontein<br />
Maprotiline belongs to the second-generation antidepressants and<br />
represents the goup of tetracyclic compounds.<br />
=.<br />
. 3 A<br />
+ t<br />
.<br />
i .<br />
I -<br />
*%<br />
l f i<br />
F >:-<br />
n<br />
-.3<br />
A-,<br />
-.<br />
Maprotiiie has been used for treatment of mild to severe ,- c -. +<br />
depression for many years but the phannacokinetic data both in : id '<br />
healthy volunteers and patients with depre-sj~n are poorly<br />
- -+d<br />
documented.<br />
.<br />
_<br />
-"<br />
For the present study we used 20 healthy white males. Th~s<br />
single-blind, singledose, randomized, cross-over study with a 21<br />
day wash-out period. The volunteers received two different tablets<br />
of 75 mg maprotiline HCI: products A and B, according to the<br />
randomization schedule. The study was approved by the Ethics<br />
Committee of the UOFS, Bloemfontein.<br />
.Q<br />
r:. 4<br />
' i<br />
4 ,<br />
9,<br />
2 . 1; . - .<br />
e<br />
Maprotiline was assayed by high performance liquid<br />
I r:<br />
chromatography in plasma samples collected over a 12 day period.<br />
The pharmacokinetic variables of the products were comparable<br />
was a - - f<br />
and the respective means for LudiomiP and the generic product<br />
were as follows: C,: 13.4 and 13.7 nglml; T,: 6.7 and 7.7 2<br />
hours; AUC$-oo: 788 and 821 ng.h/ml; tin: 36.3 and 37.1 hours.<br />
*<br />
The presented data are not in agreement with previously published<br />
L<br />
results. t<br />
emm l -92/vc L<br />
I:<br />
f<br />
\ --<br />
- r'<br />
. *
2<br />
470 VOL 82 DESEMB<br />
p . r A , . T - SAMJ ,;<br />
~ .' ..$*>--G-<br />
. , . .L., . , . . .<br />
DIE INVLOED VAN DIE IIEO-ANALE<br />
RFSERVOIRPRCBJDURE OP DIE MUKClsAJE<br />
FUNKSIE VAN DIE TERMINALE ILEUM-<br />
S.P. pbler*. V.A. Pomn, K.B. Hosie. El. ~avie', N.J.<br />
Birch . M.R.B. Keighley. Departmentof Surgery, University<br />
of the 0ranp;e Free State. South Africa . Dewrhnent of<br />
Doel, Om <strong>die</strong> mvloed <strong>van</strong> <strong>die</strong> ileo-anale mwvoir op <strong>die</strong><br />
struktuut en funksie <strong>van</strong> <strong>die</strong> slymvlies <strong>van</strong> <strong>die</strong> terminale ileum<br />
in<strong>die</strong>menstebestwkr.<br />
Metodes. Terminale ileum slymvliesmoasters is ten tye v%<br />
<strong>die</strong> aan<strong>van</strong>klike ileo-anale r e s e r v o versamel ~ en met<br />
seriele mukosale biopsies <strong>van</strong> <strong>die</strong> iieo-anale reservoir vergelyk.<br />
Aktiewe mukosale FP-=P M""""<br />
sintetaseaktiwiteit ( E<br />
vermkinge is beaordeel.<br />
l l (GS) en histologiese<br />
Galsoutopname GS aMiwit<br />
bdd45min) (IrrndlhrkJ<br />
1. Reop. ileum(n =39) 12.3 (11-15) 21.5 (17-25)<br />
2. Ileale reservoir;<br />
(a) gedefunksioneerd (n= 18) 8.0 ( 4-12), 8,3 ( 7-18)*<br />
Cb) 1-3 made-<br />
vorige ileostomie (*= l l) 11 .O ( 8-14) 14.0 ( 6-18)*<br />
geen ileostomie (n = 9) 11.2 ( 6-22) 25.0 (14-38)<br />
(c) 2 4 maande-<br />
vorige ileostomie (n=26) 13.7 (1 1-18) 19,4 (14-2)<br />
geen ileostomie (n=13) 13,3(7-20) 20.2(14-27)<br />
Slotsom, Die gedefuoksioneerde ~ m o iopenbar r<br />
vertaagde aktiewe galsoutopname amok GS-aktiwiteit wat tot<br />
drie maande mag neem om tot preoperatiewe vlakke te styg.<br />
Mukosale fuaksie in gevestigde dundemueservoom blyk nie<br />
nadelig beinvloed te wees nie, ten spyte <strong>van</strong> <strong>die</strong> wisselende<br />
mate <strong>van</strong> viueuse atrofie en chroniese inflammatoriese<br />
infiltraat.<br />
EH de Wet, R Schall en JMC Oosthuizen . z5-<br />
Departemente Geneeskundige Fisidogie en Farmako-<br />
logie, <strong>Universiteit</strong> <strong>van</strong> <strong>die</strong> <strong>Oranje</strong>-<strong>Vrystaat</strong>, Bloemfontein<br />
INLEIDING: Dit is welbekend dat pineaalkliirfunksie<br />
(rnelatoniensintese / -sekresie) onlosrnaaklik funksioned<br />
gekoppel is aan adrenoreseptwkinetika Daar word<br />
geredelik aanvaar dat spesifiek &reseptore (met nor-<br />
adrenalien as bindmiddel) in hide funksie 'n<br />
prorninente rol vervul. Modulasies aan metdtsi-indad-<br />
produksie na B-reseptorbbkkade lit' ) (prop<br />
nolol) is reeds wyd gsapporteer. $%%%%strydig =<br />
melatonien 4 / 7 ) Daar bestaan egter in &enstelling,<br />
duidelik 'n kortval in ken& / begrip <strong>van</strong> metdtsi-indod-<br />
produksie onder <strong>die</strong> invloed <strong>van</strong> konvensioneie<br />
i mimetika, (isopenalien aangesien fannakologie-<br />
kyi&kasie <strong>van</strong> hier<strong>die</strong> WC/, "onverwagte* negatiewe<br />
resultate (melatonien onveranderd) aplewer. Ulteenlo-<br />
pende venluidelikings word aartgebied orn hierdi<br />
tendens te verantwmd. Meer potente ("onkonvensione-<br />
le") (Skedule 7) simpatomimetika (fendimetrasienbitar-<br />
traat) se effekte 9 pinesalfunksie is egter nog nie in<br />
<strong>die</strong>pte ondersoek me.<br />
-<br />
4 I .- ,. $.<br />
D&L: 'D@ doel <strong>van</strong> <strong>die</strong> stu<strong>die</strong> was om dig effek <strong>van</strong><br />
fendirnetrasienbitartraat (ObesarF) (wat adrenerge<br />
neurotrammit&wmstellina Dotensieer / hermname inhi-<br />
beer), op basale pianealos&ffinksie te ebaluek. -~* -=<br />
-* >"$&<br />
MATERlAAL EN METODE: Elf n~rrnaal~esondej-inin<br />
like proetpewne het 'n enkddosering, gerandorniseer-<br />
de oorkruisstu<strong>die</strong> met plasebotoediining as kontrde,<br />
vdtooi. V e m Moedmortsters vir <strong>die</strong> bepaling <strong>van</strong><br />
plasmamelatonienkonsentrasies (R.I.A.) is asodc<br />
een (1) wrliks gedurende 'n 4 W-periode (06:00 - 10:00)<br />
bekom. Omgewingsbeligting 2 350 Lux<br />
RESULTATE: Resuitate <strong>van</strong> <strong>die</strong> stu<strong>die</strong> toon 'n klein<br />
verskil (4%) in gerniddelde hormoonkonsentrasie (AUC).<br />
(Fendirnetrasienbitartraat > plasebo) Die wye 95%<br />
vertrouensintewal bring egter mee dat geen definitiewe<br />
gevolgtrekking met betrekking tot <strong>die</strong> effek <strong>van</strong><br />
fendimetrasienbi op bade metatoniensekresie<br />
gemaak kan word nie. Hier<strong>die</strong> resultaat is voarsien.<br />
GNOLGTREKKING: Eenvoudige adrenoreseptor-bind-<br />
rniddelinteraksie verteenwwdig duidelik nie <strong>die</strong> volfe<br />
spektrum <strong>van</strong> biochemiese 'gebeure' rondorn funksiona-<br />
liteit <strong>van</strong> db pinealosiet nie. 06nskynlik is endogene<br />
(natuurlike) (katecholamienvrystelling uit senu-eindes)<br />
adrenoreseptorstimulasie meer effektief in <strong>die</strong> uitlok <strong>van</strong><br />
'n betekenisvolle respons, as ek ne ("meer onnatuur-<br />
like*) stirnulasie (simpatomimeti~ Uiteindelik wil dit<br />
voorkom asof simpatiese tonus ( C / t ) <strong>die</strong> pi&-<br />
klier, vry <strong>van</strong> enige eksogene invloed (direkte 6-<br />
reseptorblokkade / -stimukasie), "dryP.<br />
--<br />
m.<br />
- .<br />
- -:<br />
< $-<br />
..";<br />
> -.<br />
. VERDAGTE VASKUL6RELElSEl.S BY DIE<br />
KAROTIS BIFURgASIE :<br />
ROLVAN DUPLEKS DOPPLEROND~EK<br />
A ~tepbeq *, R Bany , cw ~erfbn~er~n, ~JC<br />
Bill Venter Eenheid vir Vaskuibe Chimrgie, UUOVS,<br />
Bloemfontek<br />
7st % :<br />
, 7<br />
- ,<br />
. X<br />
Hier<strong>die</strong> stu<strong>die</strong> is onderneem om <strong>die</strong> rol <strong>van</strong> Dupleks<br />
Doppler (DD) in pasiEnte met massas <strong>van</strong> moontlike<br />
vaskul6re oorsprong by <strong>die</strong> kamtis bifurkasie<br />
'n DD ondersoek is oor h 3 @ode (1967 - 1991)<br />
uifgevoer op alle pasihte (n = 50) met 'n<br />
kaakhaeknmssa <strong>van</strong> 'n moontlike vaskul&e oorsprong<br />
Met kliniese ondemoeke is kamtis llggaam tumore in 29<br />
gediagnoseer- PasEnte is volgens <strong>die</strong> gebruiklike<br />
metode. wat arteriogafie hges1uit het, ondersoek.<br />
DD het karotis liggaam tumore in 11 pasiEnte,<br />
aneurismes in 5, non-vaskul2e letsels in 1, kamtis<br />
pasi~nte-&gposeer. In 23 <strong>van</strong> <strong>die</strong> 50 pasihte (46%)<br />
was geen patologie (ontvouinplf em prominente vate) '
DD is 104% akkuraat bewgs dew arteriogafie edof<br />
c&urgie<br />
@dinpp<br />
in <strong>die</strong> diagnose <strong>van</strong> <strong>die</strong> IetseIs Die DD<br />
in <strong>die</strong> kmtis bgpm more het 'n<br />
ww<br />
bifurkasie gedemonstreer. In <strong>die</strong> biirkasie<br />
M 'n letsel met eggo's sowel as arteriEie en veneuse<br />
vlmi aanwesig Lae weerstand vloei in <strong>die</strong> eksterne<br />
urdis erie was teenwoordig in 80% <strong>van</strong> <strong>die</strong> pasitnte<br />
*t <strong>die</strong> MoedwwNSieniag <strong>van</strong><strong>die</strong> tarnor aandui<br />
PasiEnte met massas <strong>van</strong> moontlike<br />
vaddi5~ oorsprong by <strong>die</strong> karotis<br />
bihrkasie behoort eerstens deur middel<br />
<strong>van</strong> DD ondersoek te word. In 46% sou<br />
Bospitalisasie en verdere ondemoeke nie<br />
nodig wees aie.<br />
ASPECF~~cfodetermincspknLvolumwas~ kwrdiniEaud<br />
seol~dpodmndrtio~witha~daamiaatio.? Spknicvcduweanbc<br />
obtaiDcdin30miaUmthmmakingitapphbkformuhncdinicalusc Itsalso<br />
pDssiMt m gyar spcnic volume dmgcs with certain in-<br />
The obrcnratioa d iaacascd qiak vdumc afta food intake was pmkdy<br />
rcptatssapaitinoata,~~*. ~ p q m c o f ~ ~ w a s t o<br />
~thcsbolhmCDtjOPOd~qmYjYO.<br />
a-dYpnwr~ eoosbndd5matrolaadUtc9sobjccb,AUsub~wcrenilper<br />
osflm22baotkdaypliortothc~~~SPECT~aasQae<br />
*.E - " timd5~9!hTctiacdlddIbtberdiae~,coaaistiagd~<br />
imagcs(21k/ii)wa~.cquircdmal23~128fDLmat IBkstudy-foUwdby<br />
abxeakfaaSubcq~agmsdtamogapsiertudyaasrqvirrduhiag~aqlliritaDplotoeaSpkcnvcdmcdCbothhtpdicsaas&terminedvsingaI<br />
VOL 82 DECEMBER 1532 471<br />
SAMJ<br />
UNOLEIC ACID: A DIAGNOSTIC FEATURE TO IDENTIFY<br />
TUMORS WITH AN AGGRESSIVE GROWTH PATTERN?<br />
L Low*, A-M. En g 1 brecht* and F- *Department<br />
of Anatomy and U Morphology and Department of<br />
Haematology, University of the O.F.S., Bbemionten.<br />
Investigations were inii, based on observsrhons from<br />
preliminary research in our laboratory, to formulate a<br />
hypothesis that high lindeic acid levels are characteristic of<br />
benign neoplastic cdls, while low Iindeic acid levels are<br />
of malignant neoplastk: cells. vs paper<br />
resents evidence in favour of this phenomenon m diirent<br />
man turnors.<br />
PATIENTS AND MHHODS: Tumor biopsies (n=10) of the<br />
brain, prostate and skin were carefully selected,<br />
hiiocytolog'i classified and analysed by capillary gas-<br />
liquid chromatography. Extraction and preparation of fatty<br />
acid methyl esters from 0,129 samples were carried out<br />
according to a known gas-liquid chromatographic method.<br />
Identification and calculation of the methyl esters were<br />
based on the comparison of retention times with known<br />
standards.<br />
RESULTS: The relative percentages of lindeic acid (G18:2)<br />
for the tumors investigated were: benign astrocytoma<br />
(25.45%) aggressive malignant glioblastoma multiforme<br />
(4.03%), benign adenomyomatous hyperplasia of the<br />
prostate (16.24%). malignant adenocarcinoma of the<br />
prostate (4.82%), benign meningothdiomatous meningioma<br />
(20.67%) aggressive malignant atypical meningioma<br />
non-aggressive mal' nant basal carcinoma<br />
15.1 l%), aggressive malignant m (8.25%),<br />
non-ag ressive malignant squamws epithelii carcinoma<br />
(19-748)), aggressive rnaligrmnt squamw epithelial<br />
carcinoma (9.50961, benign dermatofibroma (21.40%) and a<br />
non-aggressive malignant dennatofibrosarcorna protuberame<br />
(1 1 .m). All turn with an aggressive growth<br />
pattemsho~edsigniilowerlev&0flindeicacid.<br />
CONCLUSIONS: The above mentioned results strengthen<br />
our hypothesis. To posii validate our hypothesis,<br />
current investigation is based on easily accessible cervical<br />
tumors for a more statistically significant analytical study.<br />
THE TREATMEIW OF PRIMARY HYPERHIDROSIS BY<br />
IOmPHORESIs<br />
MGL S~ruvt. E Botes. M du Toit. EJ Monk RS du Toit. CJC Nel.<br />
Depts of Surgely and Physiotherapy. UOFS and Unfversitas<br />
Hospital. Bloemfontein.<br />
AIM<br />
musshe emotionally Sulsulated sweaung is socially<br />
unacceptable to most people. We assessed the efRciency of<br />
tapwater kmtophoresis as a treatment modality for prfmary<br />
hyperhidrosts. as well as its acceptabfflty to patients.<br />
l-<br />
4<br />
t
-82 DE! . . - -2<br />
3AMJ<br />
PATIENIS AND METHODS<br />
Patients with hypufildrosis were recruited by zuhms4s and<br />
referrals from general practttfone~~ in the area.<br />
wasdefinedas:<br />
- the inability to write without an extra sheet of paper to<br />
prevent blottfqg by excessive sweaUng<br />
- the necessity to change clothing during the day due to<br />
sweatin€!<br />
- avoidisg hand contact with others<br />
- medical help having been sought for the problem<br />
- special anti-penpirants used.<br />
TECHNIQUE<br />
A simple source of direct current of low voltage and low<br />
amperage was used to give iontophoresis. ~a~ents were<br />
evaluated subjectively according to a persanal score kept by the<br />
patient before, during and after the trealment. Reliance was<br />
placed on cllnical evaluation by therapist and patient.<br />
RESULTS<br />
Patients: Total I8 Hands 15<br />
Male 5 Feet 2<br />
Female 13 Agillae 3<br />
Hands and feet 1<br />
Hands and axllIae 1<br />
IniUalsuccess: 13/14<br />
Dry at 6 wks: 7. Dxy at 2 mo.: 5.<br />
Dry at 4 mo.: 4.<br />
Side-effects: 2 (redness. ikhiwss)<br />
CONCLUSION<br />
We believe that. although iantophoresis does not achieve<br />
permanent relief in primary hyperhidrosis. it is a practical. safe<br />
and simple solution to the problem in patients who are not<br />
prepared to undergo surgery.<br />
YERIFICATION OF A VARYBUG THRESHOLD<br />
EDGE DETECTION SPECl' TECHNIQUE ON<br />
SPLEEN VOLUME: A COMPARISON TO CT<br />
VOLUMES.<br />
P A <strong>van</strong> Aswegen, M G Utter, C P Herbst,<br />
M G Nel A C Otto.<br />
Departments of Biophysics and Nuclear Medicine,<br />
Umversity of the Orange Free State, Bloemfontein.<br />
The introduction of single photon emission<br />
computerized tomography (SPECT) facilitated<br />
quantitation of organ volume with radionuclide<br />
techniques emp1oying edge detection methods. In<br />
phantom stu<strong>die</strong>s we showed that a negative correlation<br />
exists between volume size and threshold value and<br />
proposed a calibration curve to overcome this difficulty.<br />
The aim of this study was to evaluate the accuracy of<br />
volume determination with SPECT against vohunes<br />
obtained from computed tomography (0. Twenty<br />
patients were included in the study. Patients underwent<br />
a radionuclide as well as a x-ray tornogram which were<br />
both reconstructed employing a filtered backprojection<br />
algoritm. CT volumes were calculated from manually<br />
drawn R01 while SPECT volumes were calculated<br />
employing an automated algorithm. A variance in<br />
volume was also determined for SPECT. -Regression<br />
adysis yielded a regression coefficient of 0,996 (y =<br />
097x + 7.07) when comparing SPE
?im= POSTSTRgPTOCOCCAt<br />
Q p l . T I s IN HOSPITALISED<br />
VOL 82 DECEMBER 1992 473<br />
SAMJ<br />
CS---<br />
- Pelser: Dept Paediatrics and Child<br />
last 2 weeks of treatment, resulting in a<br />
total dose of 69 Gy. All patients<br />
received a high proteinlhigh calorie <strong>die</strong>t<br />
and a special mouthwash (3x daily) to<br />
Health, University of the <strong>Oranje</strong> Free counteract the expected increased acute<br />
st-ate, Bloemfontein, South Africa<br />
toxicity. All patients completed the<br />
-ION:<br />
accelerated protocol and no feeding tubes<br />
scatistics of our nephrology ward reveal were required. Confluent mucositis<br />
that acute poststreptococcal persisted on average until day 45 then<br />
g~omerulonephritis (APSGPJ) is the single subsided quite rapidly (avg. 15 days).<br />
~ s cammon t renal disease (53%).<br />
@SILTS :<br />
Complete tumour regression occurred in<br />
m e clinical features and course of<br />
16/26 patients (62 %). Of this group 7<br />
these patients were typical of APSGN.<br />
patients developed tumour recurrence 2-9<br />
The majority were 3 to 10 years old,<br />
months after treatment.<br />
with a peak 5 to 6 years. The sex<br />
Consideration must be given to increasing<br />
ificidense was equal. 88% Presented with the total dose to 72 or 74 Gy as it<br />
acute nephritis i.e. hypertension, appeared as if normal tissue tolerance,<br />
oedema and heamaturia. Only 8% based on acute toxicity repair, had not<br />
pzesented with nephrotic proteinuria. been reached.<br />
nnpetigo were diagnosed in 89%. Most of<br />
our patients come from lower socioeconomic<br />
circumstances.<br />
Acute<br />
complications<br />
(hypertensive<br />
eacephalopathy , cardiac and kidney<br />
failure) developed in 18%. Most (55%)<br />
were- discharged within one week ( 55%) . STIKSTOFMONOKSIED VERHOED MITOCHONDRIALE<br />
Of the remainder 35% were hospitalized BESKADIGING AS GEVOLG VAN MIOKARDIALE<br />
for 1-2 weeks and 6,5% 2-3 weeks. Two ISGEMIE/REPERFUSIE.<br />
patients with renal failure remained in<br />
H <strong>van</strong> Jaarsveld, JW Kuyl, MS Strvdom<br />
Dept. Chemiese Patologie, UOVS, Bloemfontein<br />
hospital for 52 and 53 days. All Miokardiale isgemie en isgemie gevolg dew<br />
patients recovered.<br />
reperfusie lei tot mitochondriale funksie<br />
Antistreptolysin 0 titers was positive beskadiging in <strong>die</strong> hartweefsel. Verskeie<br />
in 95%, anti DNASE-B and faktore kan hier 'n rol speel onder andere<br />
antihyaluronidase in 80%- At least one <strong>die</strong> endoteel funksie, wat *n nieof<br />
these test were positive in every trombogeniese oppervlakte verskaf. Die<br />
patient. Serum complement C3c showed a endoteel reageer op verskeie vasoaktiewe<br />
decrease in 91% and C4 24%.<br />
substanse dew endoteel-ontstaande<br />
~ S I O N :<br />
ontspanningsfaktor vry te stel. Die mees<br />
algemeen aanvaarde vorm <strong>van</strong> endoteel-<br />
Although the prognosis of APSW is good onstaande ontspanningsfaktor is<br />
it is preventable. Improved sosio- stikstofmonoksied (NO), aangesien NO<br />
economic standards leading to reduced bioloqiese eienskappe het wat identies is<br />
skin infections and early treatment aan endoteel-onst&de ontspanningsf aktor .<br />
would reduce the incidence and result in Dit word dan ook as <strong>die</strong>selfde substans<br />
considerable savings for the community beskou. Dit is reeds aangetoon dat NO <strong>die</strong><br />
and the country as a whole.<br />
nekrotiese area in <strong>die</strong> hart verminder tydens<br />
isgemie/reperfusie. Die doe1 <strong>van</strong> hier<strong>die</strong><br />
stu<strong>die</strong> was om te bepaal of NO in staat is om<br />
<strong>die</strong> mitochondriale funksie (wat as 'n<br />
parameter <strong>van</strong> intrasellul&-e beskadiging<br />
INITIAL EXPERIENCE WITH ACCELERATED<br />
beskou word) te beskerm teenoor miokardiale<br />
FRACTIONATION IN THE TRKAlWEIW OF HEAD isgemie/repf&f usie besering . Sprague Dawley<br />
AWD NRCK MALIGRANCIES.<br />
witrotte is as proef<strong>die</strong>re gebruik. Harte is<br />
gefsoleer. In <strong>die</strong> eerste groep was <strong>die</strong> harte<br />
H. Heunis, G <strong>van</strong> Huyssteen, L Goedhals nie aan isgemie/reperfusie onderwerp nie; in<br />
Dept. Oncotherapy, 'U.O.F.S.,<br />
9roeP I I was <strong>die</strong> harte aan<br />
Bloemfontein.<br />
isgemie/reperfusie onderwerp, maar het nie<br />
NO ont<strong>van</strong>g nie; groep I11 is aan<br />
isgemie/reperfusie onderwerp en het NO in<br />
Due to the poor tumour response and high <strong>die</strong> perfusaat ont<strong>van</strong>g. Mitochondria is<br />
rate of morbidity after conventional hierna gefsoleer en <strong>die</strong> funksie is bepaal.<br />
radiation techniques for ad<strong>van</strong>ced T3 and Die mitochondriale funksie <strong>van</strong> harte wat nie<br />
!P4 head and neck cancers, we decided to NO ont<strong>van</strong>g het nie, het 'n betekenisvolle<br />
investigate a concomitant boost technique beskadiging getoon in vergelyking met harte<br />
Pioneered by the MD Anderson Hospital. wat nie aan isgemie/reperfusie onderwerp is<br />
nie. Die groep wat NO ont<strong>van</strong>g het se<br />
?'he concomitant boost technique has been mitochondriale funksie was <strong>die</strong>selfde as <strong>die</strong><br />
Utilized in the treatment of 26 patients <strong>van</strong> <strong>die</strong> harte wat geen isgemie/reperfusie<br />
With T3 and T4 carcinomas of the head and ont<strong>van</strong>g het nie. Ons kom dus tot <strong>die</strong><br />
9eck. The protocol involves a treatment gevolgtrekking dat NO we1 in staat is om <strong>die</strong><br />
qose of 54 Gy in 30 fractions of 1 -8 Gy miokardiale mitochondriale funksie te<br />
Qaily for 6 weeks. A concomitant small beskerm. Dit dui dan ook <strong>die</strong> belang <strong>van</strong> <strong>die</strong><br />
tield boost of 1 -5 Gy was given daily (6 endoteel in <strong>die</strong> beskerming <strong>van</strong> <strong>die</strong><br />
hours after the 1 -8 Gy fraction) for the miokardiuar aan.
474 VOL 82 DESEMBER 1992<br />
SAMJ<br />
CLIHICAL RADIOBIOLOGY OF MALIGHAIOT<br />
- THE HATIOm HOSPITAL<br />
EXPERIENCE.<br />
K, Vorster, G <strong>van</strong> Huyssteen, L Goedhals<br />
and A Zerwick. Dept Oncotherapy ,<br />
Bloemfontein, U.O.F.S.<br />
Due to the current controversy regarding<br />
the radiotherapy of malignant melanoma, a<br />
retrospective clinical radiobiological<br />
analysis was carried out on 116 lesions<br />
treated at the National hospital between<br />
1966 and 1990.<br />
The vigorous statistical analysis of<br />
radiation effects in both tumour and<br />
normal tissue included frequency<br />
dis ributions, regression analysis; the<br />
5<br />
Chi -test and Fischerrs exact test.<br />
Treatment variables analyzed included<br />
total dose, dose per fraction, treatment<br />
time and field size for various levels of<br />
tumour response. The predictive<br />
abilities of time-dose models (TDF, CRE<br />
and LQ) were also analyzed.<br />
Both dose per fraction and treatment time<br />
influenced the outcome of treatment.<br />
Fractions > 600 cGy were more effective<br />
and radiotherapy should be completed in<br />
21 days. The Bloemfontein melanoma<br />
alphalbeta value is 4,06 Gy and target<br />
ETD for complete response 84,35 Gy. Late<br />
normal tissue effects (necrosis,<br />
fractures and fibrosis) occurred in 14,66<br />
% of the treated lesions.<br />
Iso-effect tables for the fraction range<br />
600 - 900 cGy have been developed<br />
together with the expected normal tissue<br />
effects using SRE and DS values.<br />
CLINICALLY UNEXPECTED PATENT DUCI'US<br />
ARTERIOSUS<br />
A D Bruwer T J <strong>van</strong> der Meme<br />
Dept. Paediatric Cardiology, UOFS, Bloemfontein<br />
INTRODUCTIONt In four children evaluated for a<br />
cardiac murmur, a patent ductus arteriosus (PDA) was<br />
found 11nexpeetedly.<br />
Although haernodynamically not significant, these<br />
lesions were corrected, three surgically and one by<br />
catheter occlusion as there is a risk for infective<br />
endoearditis.<br />
METHOD: The patients were evahreted clinically, by<br />
ECG, X-ray chest, echocardioeraphieally (colour and<br />
pdsed doppler) and by heart catheterization.<br />
l. CLINICAL<br />
Clinical findings, ECG and chest X-ray changes<br />
indicated the following:<br />
CASES land2 : Innocent murmurs (Still's<br />
murmurs)<br />
CASE 3 : Atrial septal defeet<br />
CASE 4 : Bicuspid aortic valve<br />
2. ECHOCARDIOGRAPHY<br />
An ad<strong>van</strong>ced technical laboratories ultnunark 9 system,<br />
capable of eolour as well as pulsed doppler stu<strong>die</strong>s,<br />
confirmed the presence of an ostinm seeundum atrial<br />
septal ddeet in case 3 and a bicuspid aortie valve in<br />
case 4. The other hvo patients hearts were structurally<br />
normal. In all four cases abnormal colour flow and<br />
pulsed doppler patterns were seen in the main<br />
pulmonary artery and were interpreted as being due to<br />
PDA flow.<br />
3. CARDIAC CATHETERIZATION<br />
No haernodynamic changes which could be ascribed to<br />
a PDA were found. Anpography, however,<br />
demonstrated a small left to nght shunt through a<br />
ductus arteriosus in all four cases.<br />
CONCLUSION; Echocardiography with colour<br />
doppler is in this situation, a sensitive non invasive<br />
diagnostic aid. Even if not haemodynamically<br />
si@cant, a small PDA can, if not ligated, be<br />
complicated by inlective endocarditis. Although not<br />
cost effective, the use of echocardiography with colour<br />
doppler in the evaluation of children with innocent<br />
murmurs is of value.<br />
CELL PROCESSES AND JUNCTIONS IN SQUAMOUS<br />
EPITHEUAL CELLS OF THE CERVUC<br />
L W,* L Sc$ort4,* AM. Engelbrechf* S. Cooper,'<br />
andLdeWrtt DeparbTlentofAnatomyandCell<br />
Morphology and '~epartment of Anatomical Pathology,<br />
Universii of the O.F.S.. BloemfwMi.<br />
~otphol&kal altdns characteristically occur during<br />
transformation of normal cells to modastic cells. This studv<br />
fowsses on the presence of mothdim cell p-,<br />
presumably as a pielude to cell iniqrationyand ahations in<br />
cell iunctions. characteristic of cell mfi'ttration in carcinomas.<br />
A fairly full &count on filowdia and desmosome numbers,<br />
as W& as desmosome mksurernents, is presented here m<br />
premalignant and malignant squatnous epithelia1 cells of the<br />
Cervix.<br />
PATIENTS AND Mm10DS: Normal tissues, prernaliiant<br />
tissues from cervical intraepithelial neoplasia (CIN It) and<br />
malignant tissues from carcinomas (stage I1 l b) were<br />
prepared for a transmission electron microscopic survey.<br />
Biopsies (n=6) from each grwp were selected. Small<br />
pieces of tissue were immersersmib